Bone mineral density of female long distance runners in Nelson Mandela Bay by Meier, Catherine Anne
  
BONE MINERAL DENSITY OF FEMALE LONG DISTANCE 
RUNNERS IN NELSON MANDELA BAY 
 
 
Catherine Anne Meier 
 
 
 
 
Submitted in fulfilment of the requirements for the degree Master of Arts 
(Human Movement Science) to be awarded at the Nelson Mandela 
University 
 
 
 
 
April 2018 
 
Supervisor: Prof. Rosa du Randt 
Co-supervisor: Ms. Sue-Anne Kock
 i 
 
 
DECLARATION BY CANDIDATE 
 
NAME: Catherine Anne Meier  
STUDENT NUMBER: 212248359 
QUALIFICATION: MA Human Movement Science (HMSV500) 
  
TITLE OF PROJECT: Bone Mineral Density of female long distance runners in Nelson 
Mandela Bay 
 
Declaration: 
I, Catherine Anne Meier 212248359, in accordance with Rule G5.6.3, hereby declare 
that the above-mentioned treatise/dissertation/thesis for the degree Masters of Art 
(Human Movement Science) to be awarded, is my own work and that it has not 
previously been submitted for assessment or completion of any postgraduate 
qualification to another University or for another qualification. 
 
 
SIGNATURE 
March 2018 
DATE 
 ii 
ACKNOWLEDGMENTS  
I would like to acknowledge and thank the following people who contributed towards 
the completion of this Masters dissertation: 
 My supervisor, Prof. Rosa du Randt, for her guidance, support, advice and late 
evening feedback consultations throughout the research.  
 My co-supervisor, Ms. Sue-Anne Kock, for providing constant support and 
reassurance and for her assistance and knowledge of the bone densitometer. 
 Ms. Thea Grobler and Ms. Marilyn Willemse, (radiographers), for always being 
there when needed and for conducting all the scans for the research.  
 Dr. Danie Venter, (statistician), for his assistance, consultation and contribution 
towards the statistical analyses of the data that were obtained.  
 Ms. Shona Ellis for her compassion and willingness to assist me throughout. 
 The running clubs of Port Elizabeth for encouraging their members to 
participate in this study, as well as the female runners themselves for taking the 
time to participate in this research.  
 The Faculty of Health Sciences Inter-Professional Health Research Network 
(IPHRN) for providing the funding and the opportunity to experience working as 
a team and the opportunity to present at a research conference. 
 The sponsors of the Dormehl Cunningham Bursary as well as to Nelson 
Mandela University (Postgraduate Bursary) for the financial support. 
 The language and technical editors for ensuring the finalisation of the 
dissertation. 
 The Biokinetics and Sports Science Unit, as well as the Human Movement 
Science department of the Nelson Mandela University, for all their support and 
contribution of resources during this research.  
 Lastly, my family, especially my mother, Marianne Meier and my boyfriend 
Jason Kümm, who continuously motivated and supported me throughout this 
time and encouraged me to accomplish my goals. Thank you for your patience.  
 iii 
ABSTRACT 
Long distance running may present positive and negative effects on the bone mineral 
density (BMD) of such participants. The advantage of high impact loads placed on the 
body of these runners may be neutralised or reversed, as too high a load may cause 
a decreased BMD. Furthermore, competitive female runners are generally considered 
to be leaner than their peers due to the nature of the sport. Therefore, it is expected 
that the majority of these runners would have a low body fat percentage (BF%) and 
body mass index (BMI) which may negatively affect the BMD, resulting in impaired 
bone quality. Due to the general inaccessibility of BMD assessments because of the 
cost involved, the incidence of risk for lowered BMD among long distance runners and 
particularly female runners are not readily known. The primary aim of the present study 
was therefore to determine the BMD rating and its association with body composition 
(BF% and BMI) and other selected factors among female long distance runners in 
Nelson Mandela Bay (NMB). The study utilized a quantitative approach and was 
exploratory, descriptive and non-experimental in nature. Non-probability, convenience 
sampling was implemented. A total of 40 female long distance runners between the 
age of 25 and 68 years (with a mean age of 43.6 ± 9.67 years) who have completed 
at least two marathon events were included in the study. The study utilized a 
questionnaire to collect demographic and other relevant information from the 
participants; a stadiometer and an electronic scale to measure height and weight and 
ultimately calculate BMI; and a bone densitometer with Dual-Energy X-ray 
Absorptiometry (DXA) (Hologic Discovery W) to determine the various BMD variables 
required as well as the BF%. Three densitometry scans were performed by a qualified 
radiographer which presented four analyses namely that of the relevant BMD variables 
for the hip, lumbar spine and total body, respectively, as well as of the BF% for the 
total body. The results of the study in respect of the overall BMD profile of the female 
long distance runners was considered to be normal except for the lumbar spine, found 
to be osteopenic when considering the mean T-score for this region of those 50 years 
and older. Overall the participants had an ‘average’ BF% (26.71 ± 6.33%) classification 
according to the ACSM classification rating system and were classified as ‘normal’ 
(22.80 ± 2.58 kg/m²) in respect of the BMI category rating. Significant correlations (r  ≥ 
0.312) were found between BMI and BMD related Z-scores for the hip, lumbar spine 
and total body, respectively. When considering the effect of selected variables on the 
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various BMD variables, BF% and BMI, respectively, the following significant (p < .05; 
d > 0.2) results were found: (1) BMD (one or more rating and or Z-score) was positively 
influenced (had higher ratings) in runners who were overweight, consumed alcoholic 
beverages of five or less per week and who ran less than 51 km/week, respectively; 
(2) BMD (one or more rating and or Z-score) was negatively influenced (had lower 
ratings) in runners who had more full-term pregnancies and among those who were 
menopausal, respectively; (3) BF% and BMI were both found to be lower in runners 
who: were not menopausal, competed in six or more ultra-marathon events, completed 
marathons in less than or equal to three hours and 50 minutes, had an incidence of 
breaking a bone due to a traumatic event, and engaged in an average weekly running 
distance of more than 50 km/week, respectively.  
 
KEYWORDS: Bone mineral density, long distance running, female runners, 
osteoporosis, body composition. 
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CHAPTER 1 
PROBLEM STATEMENT 
1.1 INTRODUCTION 
Exposing the body to physical activity, weight bearing activities and high impact loads during 
exercise, such as with resistance training or running, is responsible for increasing bone 
strength, mass and mineralisation, accounting for the bone mineral density (BMD) of the body 
(George, Leonard & Hutchinson, 2011:51). According to Hanekom and Kluyts (2003:15) and 
Selingerova, Dolezajova, Selinger and Sedlacek (2015:271), the optimal mineralization of 
bone occurs at age 25, but this is influenced by nutritional intake as well as the level of physical 
activity, especially during the pubertal and growth years.  
BMD may be influenced by a number of variables, such as age, gender, ethnicity, body mass 
index (BMI) and BF%, menstrual status and regularity, hormonal factors, nutrition or 
supplementation intake as well as the distance or the length of time over which an activity is 
performed (Hanekom & Kluyts, 2003:15; Pollock, Grogan, Perry, Pedlar, Cooke, Morrissey & 
Dimitriou, 2010:424; Bukhar, Nada & Header, 2012:679; Wentz, Liu, Ilich & Haymes, 
2012:376; Folscher, Grant, Fletcher & Janse van Rensburg, 2015:5).  
Literature indicates that running is a popular sport that provides a variety of health benefits 
but cautions against the potentially high-risk nature of the sport (Hanekom & Kluyts, 2003:15). 
Running could potentially have a positive or negative effect on BMD. Literature identifies 
athletes with a specific profile as potentially at risk for lowered BMD, specifically females older 
than 25, (as bone density begins to decline after reaching peak mineralisation), menopausal, 
with a family history of osteoporosis, having had menstrual irregularities, hormonal 
imbalances, a low body mass or BF%, taking part in intense and prolonged training, nutritional 
deficiencies and so forth (Hanekom & Kluyts, 2003:15; Manore, 2004:53; Pollock et al., 2010; 
Wentz et al., 2012:376).  
Running, whether for social, competitive or recreational reasons, is a widely supported form 
of physical activity that continues to gain popularity (Geo, 2012; Jenkins, 2014). For 
competitive purposes, running can be performed over a wide range of distances, typically 
5km, 10km, 21km and 42 km (Jenkins, 2014). Running is not only popular for its own sake but 
is part of triathlons and biathlons and the majority of sports that are presented today, as it is a 
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physical activity that can be enjoyed all year round (Duncan, Blimkie, Cowell, Burke, Briody & 
Howman-Giles, 2002:292; Jenkins, 2014; Byrd, Hew-Butler & Martin, 2016:54).  
Running events chosen by participants depend on individual preference and personal 
cardiorespiratory endurance levels (Gallo, Plakke & Silvis, 2012:244; Benca, Ziai, von 
Skrbensky, Ahmetović, Windhager & Krpo, 2013:346). A reduced risk of strokes, the 
prevention or stabilization of type 2 diabetes mellitus, weight loss, improved self-esteem as 
well as strengthening the immune system are ways in which running provides health benefits 
and a means to maintain fitness (Geo, 2012; Folscher et al., 2015:1).  
Although running is a popular activity and well supported due to the advantages it provides, 
there are certain disadvantages that need to be considered (Geo, 2012). These include the 
increased likelihood of developing injuries in the lower extremities (Barrack, de Souza & Rauh, 
2014:955; Callahan, 2015), the increased risk of developing osteoporosis or not being able to 
reach peak bone mineralisation, being classified as underweight due to intense training or 
abnormal eating patterns, as well as females developing amenorrhea, which when all are 
combined, is known as the female athlete triad (Hanekom & Kluyts, 2003:15; Blake & 
Fogelman, 2007:509; Wentz et al., 2012:376; Rauh, Barrack & Nichols, 2014:950).  
In terms of long distance running, the advantages of high impact loads placed on the body 
may be neutralised or reversed, as too high a load may cause a decreased BMD, which in 
turn increases the risk of fractures, the most common being stress fractures (Hanekom & 
Kluyts, 2003:15; Wentz et al., 2012:374; Barrack et al., 2014:955; Selingerova et al., 
2015:272). According to Wentz et al. (2012:374), a stress fracture occurs due to repetitive 
mechanical loading on the body that causes a disturbance between the balance of bone 
resorption and bone formation.  
Competitive female runners are usually lean due to the nature of the sport and the majority 
will have a low BF% and BMI, which may affect their BMD (Pollock et al., 2010:418). According 
to Pollock et al. (2010:419), females with a low BMI may have a low BMD resulting in impaired 
bone quality, which leads to an increased risk of fractures.  
Aging is also related to the decline of bone-forming cells within the body, which correlates with 
a declining BMD rating (Smith, Wang and Bloomfield, 2009:272). On reaching menopause, 
the BMD in females declines, which increases the risk of fragile bones due to bone loss 
(Pollock et al., 2010:424). Hanekom and Kluyts, (2003:15) and Folscher et al. (2015:5) hold 
that the protective benefits provided by weight-bearing exercise may be outweighed in 
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postmenopausal and ageing women due to the high intensity training load that is placed on 
the body during long distance running.  
Intense movement activities such as running will positively influence the bone mineral content 
(BMC) in those areas exposed to the load (Selingerova et al., 2015:271). However, areas that 
are not directly exposed may have a decrease in bone density, which can result in 
osteoporosis and an increased risk of fractures (Selingerova et al., 2015:271). In order to 
determine whether or not an individual has osteoporosis, certain tests can be performed to 
observe and analyse BMD (Krans, 2015). A BMD test is conducted by means of a bone 
densitometer and can identify low BMD and ultimately osteoporosis, as well as predict the 
potential risk for bone fractures (Blake & Fogelman, 2007:509; George et al., 2011:51; Sheu 
& Diamond, 2016:35).  
Osteoporosis may be primary or secondary. Primary osteoporosis is the natural loss of bone 
that occurs due to ageing and secondary osteoporosis can be caused by a number of 
disorders (Sheu & Diamond, 2016:35). Dual-Energy X-ray Absorptiometry (DXA), which was 
previously referred to as DEXA, is the method used with the bone densitometer to test for 
osteoporosis as well as to identify BF% and muscle development. (Giangregorio & Webber, 
2003:305; Silva, da Rosa, Fernandes, Lumertz, Dinz & dos Reis Damiani, 2014:224; 
Hammad, 2015:557; Krans, 2015).  
There is a general inaccessibility of BMD assessments due to the cost and availability of the 
equipment required and the expertise required by qualified professionals to operate the 
densitometer and interpret the results. The incidence of lowered BMD among long distance 
runners, particularly female runners, is not readily known. The researchers of this study were 
interested in ascertaining the BMD status of female long distance runners, whether a 
relationship exists between BMD and body composition and the nature of the relationship of 
each of these variables with other relevant factors.  
There are more than 26 registered running clubs in Nelson Mandela Bay (NMB) whose 
members regularly participate in competitions. From a health perspective it is imperative to 
establish the status of BMD among such runners and the association that may exist with body 
composition and other relevant factors.  
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1.2  RESEARCH AIM AND OBJECTIVES 
1.2.1  Research Aim 
Given the background provided, the main aim of this study was to determine the bone mineral 
density rating of female long distance runners in Nelson Mandela Bay and its association with 
body fat and other selected factors. 
1.2.2  Research Objectives 
In order to achieve the study’s aim, the following objectives were set. 
1. To describe the BMD, BF% and BMI of female long distance runners.  
2. To determine the relationship between the BMD of female long distance runners and 
their BF% and BMI respectively. 
3. To determine the effect of age, anthropometric measurements, female reproductive 
variables, bone health indicators, disease history, medication, lifestyle factors, training 
load, running shoe and running style on the BMD, BF% and BMI of female long distance 
runners. 
1.3 SCOPE OF THE STUDY 
The study utilised a quantitative approach with a non-experimental, descriptive, correlational 
research design. To qualify for inclusion to participate in the study, the person had to be a 
female long distance runner who had completed at least two marathon events, was over the 
age of 25 years and a resident in Port Elizabeth. A total of 40 female long distance runners 
qualified for inclusion and agreed to participate in the study. Of these 40 participants, a total 
of 32 were members of running clubs in Port Elizabeth. The remaining 8 participants were 
long distance runners who regularly compete in long distance running events but were not 
officially registered with a club. Three measuring instruments were used in the study. The first 
was a questionnaire (see Appendix D), by means of which demographic, biographic, health 
and training related information was collected. The second was anthropometric assessment 
tools to determine height and weight and to subsequently calculate BMI. The third measuring 
instrument was the bone densitometer utilizing DXA to measure the BMD of the hip (femoral 
neck and hip total), the lumbar spine and the full body (total BMD), as well as to determine 
body composition and more specifically BF%. 
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1.4  CONCEPT CLARIFICATION  
The following concepts are clarified in order to facilitate the understanding of this research 
project.  
1.4.1  Bone Mineral Density (BMD) 
BMD is defined as the strength of bones in relation to the calcium and phosphorus content 
(Greydanus & Patel, 2004:16; Wilkin, Jackson, Sims & Haddock, 2010:200; Jenkins & Tortora, 
2013:176; Wakamatsu, Sakuraba, Tsuchiya & Yamasawa, 2013:149) and is used to diagnose 
osteopenia and osteoporosis (Hammad, 2015:557).  
1.4.2  Dual-Energy X-Ray Absorptiometry (DXA)  
DXA is a method of assessment using the bone densitometer to measure and analyse BMD 
and BF% (Blake & Fogelman, 2007:511; Heidari, Khashayar, Homami, Pajouhi, Soltani & 
Larijani, 2014:2). The Hologic Discovery W, the bone densitometer used in this study, 
produces two X-ray beams, a high and a low energy beam that pass through and measure 
the thickness of the bone (Maghraoui, 2012; Doroudinia & Colletti, 2015:648).  
The DXA utilizes an imaging technique that uses a low dose of radiation to present a detailed 
image of the body (Blake & Fogelman, 2007:510; Heidari et al., 2014:2). DXA is recognized 
as the most accurate means of measuring BMD and is referred to as the gold standard of 
measurement (Blake & Fogelman, 2007:510; Carey & Delaney, 2010:114; Heidari et al., 
2014:2; Silva et al., 2014:224; Tonuk, Koybasi, Bicer & Alkan Temel, 2015:151).  
1.4.3  Osteoporosis 
Osteoporosis is defined as a chronic, systemic, skeletal disorder of weak and brittle bones 
leading to bone tissue deterioration that results in bone fragility and an increased risk for 
fractures when exposed to minimal trauma or stress, such as falling or sneezing (George et 
al., 2011:51; Hammad, 2015:556; Abd El Mohsen, Abd El Ghaffar, Nassif & Elhafez, 
2016:2576; Mayo Clinic, 2016).  
According to the World Health Organization (WHO), a BMD rating of less than 2.5 standard 
deviations below the mean is classified as osteoporosis (George et al., 2011:51; Heidari, 
2014:2). 
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1.4.4  Osteopenia  
Osteopenia is defined as a low bone mass when compared to peak bone density, and can 
develop into osteoporosis (Pentyala, Mysore, Pentyala, Rahman, Urbanczyk, Tumillo & Khna, 
2013:6; Abd El Mohsen et al., 2016:2576). Osteopenia is a more common condition than 
osteoporosis but the effects of osteoporosis are more detrimental (Abd El Mohsen et al., 
2016:2576).  
1.4.5  Long Distance Running 
People may engage in long distance running for the social aspect and enjoyment thereof, or 
they could participate competitively for rewards, either monetary or for recognition or personal 
goals, or as a means to keep fit and healthy (Byrd et al., 2016:54).  
Running can be performed over a wide range of distances, anything from a sprint to a 42km 
marathon - as well as longer distances known as ultra-marathons or ultra-events (Jenkins, 
2014). For the purposes of this study, participation in long distance running will imply 
competitive participation in marathons and or ultra-marathons.  
1.5  SIGNIFICANCE OF STUDY 
The outcome of the study provided information regarding the BMD status of long distance 
female runners in NMB. The study provided baseline data for future studies aimed at (1) 
comparing female long distance runners to sedentary females to ascertain the potential value 
of participating in this type of weight bearing activity and associated competitive events and 
(2) determining the risk factors for osteoporosis in female runners and motivating for 
intervention strategies to minimize the onset of this condition. 
The running population in NMB may benefit from the study through a broader understanding 
of BF%, BMD and overall health status.  
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1.6  OUTLINE OF THE CHAPTERS 
This document follows a set format of chapters with Chapter 2 providing the literature review, 
which comprises in-depth information regarding the BMD, BF%, BMI and the related variables 
mentioned in the objectives, in order to provide background to the study and to report on 
relevant and related research.  
Chapter 3, the research methods and procedures section, provides information regarding the 
research design, the sampling method, the measuring instruments, the pilot study, the data 
collection process and the data analysis, as well as the ethical considerations regarding the 
study.  
Chapter 4 presents the results obtained from the study and the statistical analyses of the 
quantitative data. The results are presented in a tabular format and where appropriate, in a 
graphical format.   
Chapter 5 presents a discussion of the relevant results in detail and in relation to the findings 
from the literature in an attempt to meet the objectives of the study. Chapter 5 also provides 
a summary of the findings of the study, while incorporating and discussing the study’s 
limitations. To conclude, suggestions and recommendations are put forward for a follow-up 
study and for conducting future, related studies. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1  INTRODUCTION 
The purpose of this study is to ascertain the BMD of female long distance runners and to 
explore how certain factors may potentially have affected this rating. The focus of this chapter 
is on a literature review that could provide background information about BMD, what it entails, 
how it is developed and maintained, factors that can influence the rating, how long distance 
running could potentially affect this rating and also what empirical research findings in this 
regard have revealed.  
2.2  BONE MINERAL DENSITY (BMD) 
BMD is defined as the amount of calcium and minerals present in bone, which is known to be 
an indication of how strong bones are (Greydanus & Patel, 2004:16; Wilkin et al., 2010:198; 
Maghraoui, 2012; Wakamatsu et al., 2013:149; Isley, 2017:95). BMD is calculated by the 
measurement of the bone mineral content (BMC), identified in grams (g), and the area of the 
bone being measured, identified in square centimetres (cm2), and expressed in g/cm2 
(Giangregorio & Webber, 2003:306; Greydanus & Patel, 2004:16; Wilkin et al., 2010:198; 
Maghraoui, 2012). BMD can be used to determine low bone mass and is a predictor of 
osteoporosis (Greydanus & Patel, 2004:16; Wilkin et al., 2010:198). The amount of bone mass 
accumulated at the end of the skeletal growth period during the pubertal years can determine 
BMD, but bone mass begins to decline after peak bone mineralization has been achieved 
(Burrows & Bird, 2000:288; Wilkin et al., 2010:198).  
A decreased BMD in females can be associated with a deficiency of the hormones oestrogen 
and progesterone, irregular and missed menstrual cycles and a low caloric intake, which may 
result in a low body mass, insufficient nutritional intake, such as a lack of calcium in the diet, 
as well as physical activity levels (Burrows & Bird, 2000:289; Hanekom & Kluyts, 2003:15; 
George et al., 2011:52; Kim, So, Kim & Sung, 2016:2). Oestrogen overpowers the effect of 
osteoclast activity, which is the breaking down of bone that occurs (George et al., 2011:52; 
Jenkins & Tortora, 2013:176; Isley, 2017:95). Hormones are essential to prevent the 
breakdown of bone that results in low BMD and the increased risk of fractures (Hanekom & 
Kluyts 2003:15; Bemben, Buchanan, Bemben & Knehans, 2004:220; Egbunike, Wood & 
Grant, 2009:661; George et al., 2011:52). 
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Undergoing a BMD test is recommended for females older than 65 years and for males older 
than 70 years of age (Doroudinia & Colletti, 2015:648; Hammad, 2015:557). A bone 
densitometer with DXA is known as the criterion method or the gold standard used to measure 
BMD and to determine, or to diagnose, osteopenia and osteoporosis risk factors, according to 
the WHO guidelines (Blake & Fogelman, 2007:511; Singh, Nimarpreet, Ashima, Das, Kumar 
& Prakash, 2013:2832; Heidari et al., 2014:2; Kim & Yang, 2014:2; Silva et al., 2014:227; 
Tonuk et al., 2015:151; Isanejad, Sirola, Mursa, Kroger, Tuppurainen & Erkkila, 2017:623). 
There are two types of DXA scan that can be administered, namely central DXA, which 
involves a scan of the hip, spine and bones of the torso and peripheral DXA, which involves a 
scan of the forearm, wrist, fingers or heel bones (Krans, 2015). 
A bone densitometer is used to conduct a DXA scan and is performed to determine BMD, 
which is then compared with the BMD of a healthy adult of the same age and expressed as a 
standard deviation (SD) score and interpreted in relation to normative data developed by the 
WHO (George et al., 2011:51; Abd El Mohsen et al., 2016:2576). A standard deviation (SD) 
score is defined as the measure of how the set of data is dispersed around the mean value 
(NIH, 2016; Gravetter & Wallnau, 2008:91).  
BMD is also expressed as a T-score and a Z-score. The T-score represents the difference 
between the measured BMD of the subject to the BMD of a younger adult population of the 
same gender at peak bone mass. The Z-score represents the difference between the 
measured BMD of the subject in relation to the BMD of a population of the same age, gender 
and ethnicity (Carey & Delaney, 2010:114; Wilkin et al., 2010:199; George et al., 2011:51; 
Heidari et al., 2014:2; Hologic, 2014:83; Doroudinia & Colletti, 2015:648; Tonuk et al., 
2015:151).  
T-scores are calculated according to the National Health and Nutrition Examination Survey III 
(NHANES III), by subtracting the BMD from what is considered as the ‘young, normal value’, 
which is of the age group of 20 to 30 years, then divided by the SD of the young adult 
population (Carey & Delaney, 2010:114).  
T-score= measured BMD of the subject - mean BMD of young healthy reference group  
                                           Standard Deviation of the reference group 
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According to the World Health Organization, BMD is interpreted according to the relevant 
associated T-score and Z-score values. A T-score (only available for people 50 years and 
older), is considered normal when it is greater than 1 SD below the mean value (also referred 
to as above -1 SD). Osteopenia, known as a decreased BMD, is identified when the T-value 
is between 1 and 2.5 SD below the mean (also referred to as between -1 and -2.5 SD). 
Osteoporosis, a further decline in BMD, is defined as having a value of more than 2.5 SD 
below the mean (also referred to as less than -2.5 SD) (Blake & Fogelman, 2007:510; Wilkin 
et al., 2010:200; George et al., 2011:51; Maghraoui, 2012:3; National Health Service, 2014; 
Abd El Mohsen et al., 2016:2576; Lespessailles, Cortet, Legrand, Guggenbuhl, & Roux, 
2017:12). According to the International Society for Clinical Densitometry (2013), Carey & 
Delaney (2010:119) and The National Osteoporosis Foundation (2017), a Z-score that is 
greater than or equal to 2 SD below the mean (also referred to as equal to or less than -2.0), 
can be classified as a low BMD. 
Advantages of using bone densitometry other than determining the status of BMD and the 
subsequent risk for osteoporosis or osteopenia, are the short scanning time, the ease of set-
up, the low dose of radiation exposure and precise, stable calibration (Blake & Fogelman, 
2007:510; Heidari et al., 2014:2). 
BMD is influenced by genetic and environmental factors such as age, gender, ethnicity, BF% 
or BMI, menstrual status and history, genetics, family history of osteoporosis, nutritional 
intake, calcium intake, training regime and physical activity (Hanekom & Kluyts, 2003:14-15, 
Wilkin et al., 2010:200, George et al., 2011:52, Bukhar et al., 2012:679, Kim, Chung, Kim, 
Seo, Oh, Yi & Kim, 2013:710). 
Details regarding the influence that certain factors have on BMD are presented in the following 
sections.  
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2.3  DEMOGRAPHIC VARIABLES AND THE EFFECT ON BMD 
The effects of age, gender and ethnicity on BMD is reviewed in the section that follows. 
2.3.1  Age 
According to Benca et al. (2013:345), there is a dearth of information on the way in which age 
affects BMD. Ageing can be related to an increased incidence of injuries in runners due to a 
decrease in BMD and strength (Dugdale, 2012; Runolfsdottir, Sigurdsson, Franzson & 
Indridason, 2015:22). Age is a risk factor for the occurrence of osteoporotic fractures (Sheu 
and Diamond, 2016:35).  
The age at which peak bone mineralization occurs differs from one study to another, as 
research has produced conflicting results. The maximum level of bone mineralisation is 
reached between the ages of 25 and 30 (Vorster, Venter, Beetge and Steyn, 2001:20; Wilkin 
et al., 2010:198; Selingerova et al., 2015:271). Tonuk et al. (2004:149) hold that BMD is at its 
peak by the age of 18 in females and 21 in males. The studies of Hanekom and Kluyts 
(2003:15) and Carey and Delany (2010:114) hold that peak bone mass of the spine and the 
femur is reached between the ages of 20 and 25 in both males and females. Results of a 
study by Chan, Liu & Chi (2004:61) indicated that the peak BMD in females occurred at 
different ages for the lumbar spine and proximal femur respectively. The peak BMD for the 
lumbar spine was achieved from 30 to 39 years of age, whereas the peak BMD for the proximal 
femur was achieved between the ages of 17 and 29. Achieving peak BMD depends on a 
variety of factors based on nutritional intake during the growth and developmental years, as 
well as participation in physical activity (Tonuk et al., 2004:149). 
Bone mass slowly decreases in females from the age of 35 to 40, accelerating during the peri-
menopausal stage and slowing down again until the age of 70 (Greydanus & Patel, 2004:16). 
The initial loss of bone mass is referred to as osteopenia and can be accompanied by an 
increased loss of muscle mass, known as sarcopenia. (Heaney and Layman, 2008:1569S).  
In their study on females undergoing BMD testing, Silva et al. (2014:209) found that there is 
a negative relationship between BMD and increasing age. According to the results from the 
study by Chan et al. (2004:61), the BMD of the lumbar spine begins to decrease after the age 
of 50, whereas the BMD of the proximal femur begins to decrease after the age of 40, which 
indicates the more rapid decline of the BMD of the hip. Runolfsdottir et al. (2015:4) found the 
BMD of the femoral neck to be lower in females over the age of 40 compared to their male 
counterparts.  Benca et al. (2013:346) hold that there is a greater risk of fractures in females 
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over the age of 50, whereas Zheng, Tobias, Duncan and Evans (2012:3) have found 
osteoporotic fractures occurring after the age of 65 in females.  
Bone mass and osteoporotic fractures are influenced by peak bone mass achieved during 
puberty (Runolfsdottir et al., 2015:23; Hammad, 2015:559). There is a greater risk for bone 
mass loss in postmenopausal women. A loss of bone mass may be due to a more profound 
deficiency of energy as well as low oestrogen levels that affect normal bone remodelling and 
increase the risk of fractures (Folscher et al., 2015:8). Research findings have determined that 
there is a relationship between the decline in BMD and increasing age (Duncan et al., 
2002:288; da Silva, Mendonça, Conceição, Zahar, & Farias, 2007:943). 
From the above-mentioned evidence it is clear that age is associated with a change in BMD 
and therefore it seems justified for the present study to investigate the impact of age on the 
BMD of female long distance runners.  
2.3.2  Gender 
Females are more prone to osteoporotic fractures than males due to a lower BMD and the 
reduction of collagen elasticity (Benca et al., 2013:346). According to Henry and Eastell 
(2000:513), the occurrence of an osteoporotic fracture is lower in black individuals and in 
males. The findings of the study by Runolfsdottir et al. (2015:24) indicate that firstly, BMD is 
lower in females and secondly, BMD begins to decline at an earlier age in females than in 
males. Females over the age of 40 have been found to have weaker bones due to the decline 
in BMD that occurs more rapidly than in males. Females have a different physiological make-
up than their male counterparts, as they have a wider pelvis, a menstrual cycle, higher levels 
of oestrogen, a smaller ejection fraction of the heart and lower vital capacity (Benca et al., 
2013:347).  
After menopause the risk for osteoporotic fractures in females is increased due to a reduced 
BMD that can be related to sex hormones, growth factors, body fat composition, nutritional 
habits and lifestyle (Wilkin et al., 2010:200; Runolfsdottir et al., 2015:23; Folscher et al., 
2015:2). A study conducted by Runolfsdottir et al. (2015:24) indicated that the femoral neck 
and the total hip BMD are lower in females than males, which may account for the increased 
risk of osteoporotic fractures among females. Males have a lower risk of osteoporosis due to 
their testosterone level, which stimulates bone growth and delays the decline of bone loss 
(Runolfsdottir et al., 2015:23).   
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Given the above-mentioned evidence that females are more likely to incur osteoporotic 
fractures due to an earlier decline in BMD, it seems justified to focus on the females rather 
than on the males if time and funding for a study are limited and a choice in respect of the 
focus of the study needs to be made. 
2.3.3  Ethnicity 
It has been found that BMD rates and fracture occurrences differ between ethnic groups 
(Micklesfield, Norris & Pettifor, 2011:261). In studies conducted in America by Wilkin et al. 
(2010:204) and Wallace, Ballard, Holiday & Wells (2005:204), the results indicate that black 
females have a greater BMD with a more delayed loss of skeletal mass with aging than their 
white counterparts. 
Femoral neck fractures have been found to be less prevalent in the black population of South 
Africa who have a higher BMD at the hips, more specifically, the femoral neck (Chantler, 
Dickie, Goedecke, Levitt, Lambert, Evans, Joffe and Micklesfield, 2012:543). The prevalence 
of osteoporosis of the lumbar vertebrae has been found to be lower in the black population 
than the white population, according to Micklesfield et al. (2011:261). However, according to 
Chantler et al. (2012:534), black females have a lower BMD of the lumbar spine, which 
predisposes them to a risk of osteoporosis and ultimately, of fractures. Wallace et al. 
(2005:204) found that white females have a greater genetic predisposition and family history 
of the occurrence of broken bones. 
According to Micklesfield et al. (2011:261), white females generally engage in more vigorous 
physical activity than black females, but most black females walk as a form of transport and 
that is a type of mechanical loading. Black South African females consume a diet that is lower 
in calcium and protein but with a higher fat content, have a lower alcohol consumption and 
commonly use injectable contraception methods (Wallace et al., 2005:204; Chantler et al., 
2012:543).  
In summary, the literature on demographic variables such as age, gender and ethnicity have 
indicated an association with BMD and subsequently serve as a motivation for considering 
these variables when selecting the sample of long distance runners as well as including these 
variables when investigating factors that may impact on the BMD of female long distance 
runners.  
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2.4  ANTHROPOMETRIC MEASUREMENTS 
The respective relationships of body mass index (BMI) and BF% with BMD, as found in the 
reviewed literature, are discussed next. 
2.4.1  Body Mass Index (BMI)  
BMI is defined as the relationship between height and weight that is used to classify individuals 
into categories (Kim et al., 2013:709; Silva et al., 2014:224; Nuttall, 2015). BMI is calculated 
by dividing body weight, which is measured in kilograms, by the squared value of height, which 
is measured in meters (ACSM, 2014:63). It can be used to indicate an individual’s fatness and 
is used to determine potential health risks and certain health issues (Nuttall, 2015). Body 
composition involves the measurement of lean mass and fat mass to provide a more accurate 
representation of body weight (Kim et al., 2013:709). 
Table 2.1 illustrates the categories used to classify individuals based on their BMI values. 
These categories include underweight, normal weight and overweight or obese (Aguado 
Henche, Rodriqueaz Torres & Gomez Pellico, 2008:1440; Kim et al., 2013:710; ACSM, 
2014:63; Nuttall, 2015).  
Table 2.1: Classification of BMI depicting nutritional status 
Classification BMI (kg/m²) 
Underweight <18.5 
Normal 18.5-24.9 
Overweight 25.0-29.9 
Obesity Class  
1 30.0-34.9 
2 35.0-39.9 
3 ≥40 
(ACSM, 2014:63) 
A high BMI rating as well as a high bodyweight may predispose runners to an increased risk 
of injury and osteoporotic fractures (Benca et al., 2013:346).  Individuals with a BMI greater 
than 25kg/m² are predisposed to injuries due to the increased amount of stress and 
biomechanical impact that is placed on the joints, especially when running (Newman, 
Witchalls, Waddington & Adams, 2013:237; van der Worp, ten Haaf, van Cingel, de Wijer, 
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Nijhuis-van der Sanden & Staal, 2015:1373; Isanejad et al., 2017:629). According to a study 
conducted by Silva et al. (2014:224) and in contrast to Benca et al. (2013:346), a BMI greater 
than 25kg/m² can provide protective benefits, such as a decreased risk of a hip fracture. 
Findings by Cavkaytar, Sevel, Atak, Findik, Ture & Kokanali (2015:691) emphasise the 
protective benefits of an elevated BMI, as a BMI greater than 32kg/m² can protect against the 
onset of osteoporosis. 
Fat mass has a positive influence on BMD due to its effect on the mechanical loading on bone, 
whereas lean mass has a positive effect on the formation of bone (Cardadeiro, Baptista, 
Zymbal, Rodrigues & Sardinha, 2010:2310; Isanejad et al., 2017:629). The amount of fat mass 
or lean mass that is present is dependent on age, sex, pubertal and menopausal status, 
ethnicity and nutritional intake (Aguado Henche et al., 2008:1440). According to studies 
conducted by Kruger, Kruger, Wentzel-Viljoen & Kruger (2011:751), Kim et al. (2014:715) and 
Hammad (2015:557), there is a positive association between body weight and BMD. As one 
ages, BMI increases, and this influences BMD.  
According to separate studies by da Silva et al. (2007:946) and Marwaha, Garq, Tandon, 
Mehan, Sastry and Bhadra (2013:353), obesity is a factor that increases BMD and the total 
BF% has been found to have a positive relationship with BMD in both females and males. Da 
Silva et al. (2007:946) hold that there is a positive relationship between BMI and BMD at all 
body sites and osteoporosis occurs far less in females classified as obese. Da Silva et al. 
(2007:947) also hold that obese females have a higher BMD due to the increased load placed 
on the musculoskeletal system and that BMD has a slower decline after menopause. The 
study indicated that obese females have an increased production of oestrogen, including 
during menopause, compared to non-obese counterparts and that can delay the decline of 
BMD. BMD declines at a slower rate in obese females compared to non-obese females. 
According to Kim et al. (2014:716), females who are classified as obese may have lowered 
BMD levels due to the secretion of adipokines from adipose tissue, which cancels the 
beneficial aspects of mechanical loading on the skeleton.  
BMI does not measure the actual fat mass and is merely a guide for measuring the excess 
body weight, despite gender or ethnic differences. The use of BMI may therefore be an 
inaccurate measure to formulate classifications (Aguado Henche et al., 2008:1440; Kelly, 
Wilson & Heymsfield, 2009:1). An individual who is predominantly mesomorphic, where most 
of their body weight is based on muscle mass, may hinder the results for BMI (Aguado Henche 
et al., 2008:1440). The classifications of BMI do not distinguish between muscle and fat when 
measuring weight (Aguado Henche et al., 2008:1441).  
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As previously mentioned, a high BMI can increase the risk of injury occurrence. However, the 
same can be said for those with a low BMI rating, as per the findings of the study by Pollock 
et al. (2010:423). According to findings by Pollock et al. (2010:423) and Thralls, Nichols, 
Barrack, Kern, & Rauh (2016:18), females with a low BMI may have a low bone mass and 
subsequently lowered BMD, regardless of adequate nutritional intake and hormonal status. 
Individuals that have a low BMI may have an impaired quality of bone, which may hinder 
performance of physical activities due to a lack of support for their bodies and joints (Pollock 
et al., 2010:423; George et al., 2011:52; Benca et al., 2013:346).     
According to the study by Barrack et al. (2014:953), a BMI of 21kg/m², which is classified as 
‘normal’ (Table 2.1), has been linked to bone injuries.  A low BMI rating is one of the conditions 
related to the female athlete triad, involving poor nutritional habits, amenorrhea and 
osteoporosis (ACSM, 2011). There seems to be a relationship between body weight and the 
maintenance of BMD in terms of weight loss, creating a potential risk factor for bone loss in 
the older population (Pollock et al. 2010:423; Runolfsdottir et al., 2015:24). It has been found 
that a weight below 58kg can be linked to an increased risk of fractures and osteoporosis 
(Silva et al., 2014:224).  
In spite of the limitations mentioned earlier, it is important to determine the influence BMI may 
have on BMD. 
2.4.2  Body Fat Percentage (BF%) 
An individual’s BF% is based on the amount of fat within the body (Kim et al., 2013:710; 
ACSM, 2014). Once the pubertal years have concluded, it has been found that females have 
a greater amount of fat mass resulting in the incidence of obesity, whereas males contain 
more fat-free mass (Gloria-Bottini, Cervelli, Giarrizzo, Martinoli, di Renzo & de Lorenzo, 
2007:373). According to Vorster et al. (2001:21), BMD can decrease if one has a low body 
weight or a low BF%. As per the findings of Knechtle, Rust, Patrizia & Knechtle (2012:254), 
there is an association between a low BF% and the time it takes to complete a long distance 
running event. Research conducted by Bukhar et al. (2012:678) found that a lower BF% and 
body weight can influence bone to be healthier.  
However, a low BF% has been found to increase the occurrence of bone injuries (Barrack et 
al., 2014:953). BF% can be measured by taking skinfold measurements and incorporating 
those values into a formula to obtain an estimated BF%. BF% can also be determined by a 
DXA scan (Giangregorio & Webber, 2003:306; Aguado Henche et al., 2008:1440).  
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Table 2.2 illustrates the normative data for the interpretation of BF% in females according to 
the various age categories. 
Table 2.2: Categorised BF% for Females in different age groups 
 Age 
Female BF% category 20-29 30-39 40-49 50-59 60+ 
Essential fat 10-13 10-13 10-13 10-13 10-13 
Excellent 14.5-17 15.5-17.9 18.5-21.2 21.6-24.9 21.1-25 
Good 17.1-20.5 18-21.5 21.3-24.8 25-28.4 25.1-29.2 
Average 20.6-23.6 21.6-24.8 24.9-28 28.5-31.5 29.3-32.4 
Below average 23.7-27.6 24.9-29.2 28.1-32 31.6-35.5 32.5-36.5 
Poor >27.7 >29.3 >32.1 >35.6 >36.6 
(ACSM, 2008:59) 
According to the reviewed literature it seems that both an elevated and a low BMI and BF% 
can influence the BMD rating. Furthermore, a study conducted by Bukhar et al. (2012:682) 
indicated that there is a relationship between osteoporosis, which is identified from a low BMD, 
with increased BMI and BF% respectively and it is vital to analyse the anthropometric 
measurements to determine the influence on BMD. The BMD rating can be influenced by 
demographic variables, anthropometric measurements as well as other factors that will be 
explained in the review that follows. 
2.5  FEMALE REPRODUCTIVE VARIABLES 
Factors pertaining to one’s menstrual cycle, contraception usage and pregnancy could affect 
BMD and hence the age of menarche and menopause, menstrual cycle regularity, the type 
and benefits of contraceptive use and the effect of pregnancy and lactation are elucidated in 
the subsections that follow.   
2.5.1  Menarche to Menopause 
Menarche is defined as a female’s first menstrual period (Hanekom & Kluyts, 2003:15; Karp, 
2015:113) and the beginning of the reproductive phase of a woman’s life (Mishra, Cooper, 
Tom and Kuh, 2009:175). Menarche usually occurs between the ages of 11 and 14 but may 
also occur earlier or later in life (Hanekom & Kluyts, 2003:15; Karp, 2015:113). Once 
menarche has commenced, menses will continue until menopause (Hanekom & Kluyts, 
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2003:15; Karp, 2015:113). The age at which menarche begins may be delayed by at least one 
or two years in those who engage in high performance training, increasing their risk for the 
potential onset of osteoporosis later in life (Korsten-Reck, 2011:157). 
Menopause is defined as the end of the female reproductive phase and can occur from 40 to 
60 years of age (Mishra et al., 2009:175; Karp, 2015:113). Menopause has been found to be 
related to the imbalance of bone metabolism.  According to Chan et al. (2004:61) and da Silva 
et al. (2007:944), the highest rate of bone loss occurs five to ten years after menopause, at a 
rate of 1% to 4% per year. Ultimately, bones become fragile and the risk of fracture increases 
as a result of the increase in bone resorption (Bacelar, Almeida, Sauaia, Novais, Furtado, 
Quintanilha, Pulcherio, Filho & Gambassi, 2015:95).  
According to Mishra et al. (2009:175) and Korsten-Reck (2011:157), a variety of factors are 
responsible for the age at which menarche or menopause begins, such as environmental, 
psychological and physiological factors. According to Hanekom and Kluyts (2003:15), there 
are no clear indications of the effects of delayed menarche on BMD due to the lack of 
longitudinal studies. Optimal bone mineralisation is achieved during the puberty years in order 
to prepare for the loss of bone that occurs with aging later in life (Hanekom and Kluyts, 
2003:15). However, it has been found that a delay in menarche and, therefore, the onset of 
puberty, has a negative effect on the accumulation of bone mass which may ultimately hinder 
BMD (Hanekom and Kluyts, 2003:15). Furthermore, a delay in menarche may potentially 
increase the risk for osteoporosis according to Korsten-Reck (2011:157). A menstrual 
dysfunction or abnormality is more common amongst elite female runners which will negatively 
affect BMD (Pollock et al., 2010:424; Korsten-Reck, 2011:157).  
Menstrual dysfunctions or abnormalities are determined by the number of menstrual cycles 
one has had in a year (Burrows & Bird, 2000:289; Hanekom & Kluyts, 2003:15; Procter-Gray, 
Cobb, Crawford, Bachrach, Chirra, Sowers, Greendale, Nieves, Kent & Kelsey, 2008:1206). 
These dysfunctions or abnormalities include oligomenorrhea and amenorrhea. 
Oligomenorrhea is defined as having four to nine menstrual cycles per year and can also be 
known as a menstrual cycle that occurs for a prolonged duration of 35 days. Amenorrhea is 
defined as having only three menstrual cycles per year or when there is no onset of 
menstruation (Burrows & Bird, 2000:289; Hanekom and Kluyts, 2003:15; Procter-Gray et al., 
2008:1206; George et al., 2011:52; Thralls et al., 2016:18).   
The age at which menarche occurs is an important determinant of BMD and the strength of 
an individual’s bones. Bone mineral accumulation during the pubertal years influences the 
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peak BMD, which then undergoes the inevitable decline once menopause occurs. It is vital 
that emphasis is placed on the need to increase BMD during the years when it can still be 
achieved. 
2.5.2  Contraception 
Chantler et al. (2012:543) hold that contraception usage has an influence on BMD and that 
black South African females have been found to commonly use injectable contraception 
whereas white South African females commonly use oral contraception (Chantler et al., 
2012:543). 
The main form of oral contraceptive is the pill, which can be monophasic, biphasic or triphasic 
contraceptives (Karp, 2015:114). The monophasic type of oral contraceptive has been found 
to be the most commonly used. It has a fixed dose of oestrogen and progesterone released 
for 21 days followed by a placebo for 7 days (Karp, 2015:114). The biphasic type of oral 
contraceptive involves a switch of hormones that occurs once throughout the 21 days of the 
menstrual cycle, whereas the triphasic type releases 3 different oestrogen doses that increase 
progressively throughout the menstrual cycle (Karp, 2015:114). Oral contraception is useful 
for increasing BMD through the release of oestrogen, which can potentially delay the onset of 
osteoporosis and prevent the risk of fractures (Karp, 2015:114). 
Oral contraception regulates the menstrual cycle, eases menstrual cramps, treats acne and 
certain allergies and allows for planned parenthood by preventing pregnancy (Procter-Gray et 
al., 2008:1206). Drawbacks of ingesting oral contraceptives are the possibility of an increase 
in body weight and BF% as well as nausea and fatigue (Karp, 2015:114). Procter-Gray et al. 
(2008:1206) hold that the findings of their study revealed that those who used oral 
contraception gained less weight and less body fat while accumulating lean muscle mass but 
this was only applicable to those who were classified as eumenorrheic.  
Kruger et al. (2011:756) found that females who use injectable progestin have an increased 
loss of bone and an inadequate BMD compared to those who administer non-hormonal 
contraception. On the other hand, according to Isley (2017:94), those who use the intrauterine 
device (IUD), progestin-only implants or the pill, do not jeopardize their BMD and have a lower 
risk of fractures. Certain contraceptives influence BMD negatively in that the development of 
peak bone mass may be hindered and the loss of bone could occur at an earlier stage of life 
(Modesto, DalAva, Monteiro & Bahamondes, 2015:1387). The use of progestin-only 
contraception has a positive influence on BMD and a reduced risk of fracture occurrence 
(Costa, Cecatti, Krupa, Rehder, Sousa & Costa-Paiva, 2012:95; Isley, 2017:95) 
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Hysterectomies have been found to act as a protective mechanism for osteopenia (Silva et 
al., 2014:225). Females who underwent a hysterectomy while conserving their ovaries, were 
found to have higher BMD in the lumbar spine, femoral neck, calcaneus and the tibia (Cheng, 
Sievanen, Heinonen, Uusi-Rasi, Carbone, Tylavsky, Halleen & Kannus, 2003:13). The density 
and strength of the bones, with the ability to resist bending, was far greater in females who 
had undergone a hysterectomy, and this implies that the uterus may be responsible for the 
maintenance of bone formation and resorption without the presence of oestrogen (Cheng et 
al., 2003:12). 
Contraception usage is a common phenomenon and most females will be exposed to, or will 
use, contraception within their lifetime. It is therefore necessary to understand the different 
types of contraception that can be administered and the effects they present for BMD. 
2.5.3  Pregnancy 
During pregnancy and lactation the BMD of the pregnant mother decreases, as indicated in 
studies conducted by Shao, Tao, Jing & Lu (2012:572) and Derakhshan, Mahmoudi & 
Shahsawari (2016:45). The foetus makes use of 20-30g of the maternal calcium due to 
increased intestinal absorption. This results in a loss of BMD in the maternal skeleton to enable 
foetal skeleton formation during pregnancy (Shao et al., 2012:572; Cavkaytar et al., 
2015:692).  
A decrease of nutrients such as calcium is a common occurrence in pregnancy and induces 
nausea and vomiting. This deficiency will not necessarily be rectified with the use of 
supplementation (Shao et al., 2012:571). The results of the study by Shao et al. (2012:573) 
found a positive correlation between the levels of calcium, phosphorus and alkaline phosphate 
with overall BMD. Maternal vitamin D during pregnancy can be related to bone growth in early 
childhood development. Maternal vitamin D is needed for sufficient bone growth in children 
and to ensure strong and healthy bones (Shao et al., 2012:572; Jenkins & Tortora, 2013:177). 
The transfer of calcium from the mother to the foetus occurs at the rate of approximately 50 
mg/day at 20 weeks and at 35 weeks the daily amount increases to 330 mg due to the 
development of the foetal skeleton (Yumusakhuylu, Turgut, Icagasioglu, Baklacioglu, Atlig, 
Murat & Suer, 2013:763). The findings of the study by Derakhshan et al. (2016:45) indicate 
that during breast-feeding, the BMD of the lumbar spine and of the femoral neck is lower than 
in those who do not breast feed, due to the loss of calcium. This loss of calcium decreases 
BMD and increases weight due to the pregnancy and places the bones under extreme loads, 
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which can result in the increased incidence of fractures, especially of the femoral neck 
(Kasahara, Kita, Kawasaki, Morisaki, Yomo & Murakami, 2017:1069).  
However, the results of the study conducted by Lebel, Mishukov, Babchenko, Samueloff, 
Zimran & Elstein (2014:4) contradict those of Derakhshan et al. (2016:45) in claiming that the 
act of breast feeding had no effect on the BMD T-scores of the participants. Those who did 
not breast feed still had a higher mean T-score and Z-score for the BMD of the lumbar spine 
and the femur (Lebel et al., 2014:3). 
Findings by Derakhshan et al. (2016:48) indicate that the BMD of the lumbar spine and femur 
is lower in those who have had more than five pregnancies and who breast fed for more than 
60 months, which can lead to the increased prevalence of osteoporosis. Furthermore, 
according to a study conducted by Kasahara et al. (2017:1069), pregnancy can cause 
transient osteoporosis of the hip (TOH), resulting in pregnancy-associated osteoporosis. 
Researchers have claimed that BMD will return to normal conditions six to twelve months after 
lactation has ceased but there have been no clear longitudinal studies conducted in this 
regard. This creates a level of uncertainty as to what the long-term effects will be on BMD.  
Although pregnant females were excluded from this study, the effect of past pregnancies on 
BMD and their long-term impact needs to be considered when evaluating the BMD of long 
distance female runners. 
2.5.4  Female Athlete Triad 
The female athlete triad is a condition that is more commonly found in physically active 
females than those who are less active, according to Hanekom & Kluyts (2003:15). The 
findings of the studies conducted by Pollock et al. (2010:421) and Folscher et al. (2015:5) 
indicated that female endurance athletes, as in long distance runners, are exposed to a 
greater risk for the female athlete triad. These researchers noted that menstrual abnormalities, 
which can occur due to an increase in the intensity and frequency of exercise, accompanied 
by an inadequate nutritional intake and a low BMD, can result in the female athlete triad. 
Findings by Wentz et al. (2012:380) correspond to those of Pollock et al. (2010:421) and 
Folscher et al. (2015:5), in saying that long distance runners present with a lower BMD. The 
number of hours spent training is negatively associated with the BMD of the lumbar spine and 
the femoral neck. This decrease in BMD is due to reduced energy levels, potentially caused 
by intense training or insufficient caloric intake, which in turn results in low availability of 
oestrogen and the process of bone formation is affected negatively. Female athletes are 
predisposed to developing the female athlete triad if they have a poor nutritional intake, an 
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irregular menstrual cycle, a low body mass, a genetic predisposition for osteoporosis, as well 
as an intense and frequent training regime (Hanekom & Kluyts, 2003:15; Korsten-Reck, 
2011:157).  
There are three interrelated health concerns that constitute the female athlete triad. These 
involve disordered eating, irregular menstruation, or the cessation of menstruation and having 
a low BMD (ACSM, 2011; Rauh et al., 2014:949; Folscher, 2015:2; Thralls et al., 2016:18). 
Disordered eating accompanied by poor nutritional habits can lead to low energy availability. 
Amenorrhea and low BMD can result in osteoporosis, thereby increasing the risk of fractures 
and musculoskeletal injury due to a low bone mass (ACSM, 2011; Rauh et al., 2014:949; 
Folscher, 2015:2).   
The triad can occur as a result of a caloric deficit and is not entirely due to exercise but is 
commonly seen in sports or endurance activity that require leanness (Pollock et al., 2010:424; 
George et al., 2011:52; Folscher et al., 2015:3). According to Pollock et al. (2010:424), ACSM 
(2011) and Wright and Botha (2014:120), nutritional abnormalities with disordered eating and 
excessive physical exercise can induce menstrual irregularities. Adequate nutrients are 
important for the maintenance of muscle mass, for the repair of tissue damage caused by 
exercise and to aid recovery from illness (Folscher et al., 2015:3). Menstrual irregularities that 
occur amongst female runners may increase the risk of stress fractures upon minimal impact 
due to a decreased BMD (Manore, 2004:49; Pollock et al., 2010:424; Karp, 2015:115). The 
results of the study by Wentz et al. (2012:380) hypothesise that there is an increased incidence 
of stress fracture occurrence in relation to menstrual abnormalities, older age menarche, 
longer history of running, inadequate calcium intake and a decreased BMD. A stress fracture 
occurs due to the constant and repetitive stress and increased workload that is placed on 
normal, healthy bone (Korsten-Reck, 2011:156). As bone constantly undergoes remodelling, 
repetitive stress affects this remodelling process negatively (Korsten-Reck, 2011:158). 
More recently, the female athlete triad has become known as the relative energy deficiency in 
sports (RED-S), providing a more descriptive title of the condition that affects females and 
males (Mountjoy, Sundgot-Borgen, Burke, Carter, Constantini, Leburn, Meyer, Sherman, 
Steffen, Budgett & Ljungqvist, 2014:16). RED-S is a syndrome that occurs due to a deficiency 
in energy, where the energy remaining after energy expenditure is not enough to maintain 
normal physiological processes for one’s health and performance (Mountjoy et al., 2014:16; 
Ba & Matzkin, 2015:33; Slater, Mclay-Cooke, Brown & Black, 2016:421). These physiological 
processes include metabolic rate, menstrual functionality, maintaining healthy bones, 
providing immunity against pathogens or foreign invaders as well as cardiovascular health 
 23 
(Mountjoy et al., 2014:16; Wright & Botha, 2014:120; Ba & Matzkin, 2015:33). Insufficient 
dietary intake, as in a caloric deficit, will result in inadequate amounts of energy available after 
energy expenditure, such as through exercise (Mountjoy et al., 2014:16; Ba & Matzkin, 
2015:33; Slater et al., 2016:421). 
The present study included female long distance runners and as RED-S is a common 
occurrence among long distance runners, there was a need to determine the BMD status of 
this population.  
In summary, female reproductive variables are of importance to study in determining the 
relationship they present with BMD. 
2.6  BONE HEALTH INDICATORS 
The influence that BMD can have on the health status of bones, as well as the genetic 
predisposition and development of bone that can influence BMD, is presented in the following 
subsections.  
2.6.1  Osteoporosis 
Osteoporosis is defined as a metabolic skeletal disorder whereby the bones of the body have 
become weak and have a low bone mass due to inadequate bone accumulation during growth 
and development, especially during the adolescent years (Smith et al., 2009:270-279; George 
et al., 2011:51). According to Smith et al. (2009:270-279), The National Institute of Health 
(NIH) defines osteoporosis as:  
“…a skeletal disorder characterized by compromised bone strength predisposing to an 
increased risk of fracture. Bone strength reflects the integration of the main features: bone 
density and bone quality”.  
Osteoporosis may be related to a genetic predisposition involving a low BMD and bone 
deterioration that occurs due to the imbalance between bone formation and bone resorption, 
which may result in fractures occurring from falls that are of minimal trauma (Vorster et al., 
2001:21; Wallace et al., 2005:357; George et al., 2011:51; Pentyala et al., 2013:5; Hammad, 
2015:556; Abd El Mohsen et al., 2016:2576; Kim et al., 2016:2; Brozgol, Arbiv, Mirelman, 
Herman, Hausdorff & Vaisman, 2017:174).  
Bone constantly undergoes remodelling via bone breakdown and formation (Morseth, 
Jorgensen, Emaus, Jacobson & Wilsgaard, 2011:174; Hambli, 2014:1; Mayo Clinic, 2016). 
Bone formation is initiated via osteoblasts and the bone breakdown and removal is initiated 
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via osteoclasts (Egbunike et al., 2009:661; Morseth et al., 2011:175; Hambli, 2014:1; Jenkins 
& Tortora, 2013:167-168; Pentyala et al., 2013:5). Remodelling of bone occurs when the 
bones damaged by fatigue are repaired by new bone formation, which is a cyclic process that 
occurs between the osteoclasts and the osteoblasts (Egbunike et al., 2009:665; Morseth et 
al., 2011:175; Jenkins & Tortora, 2013:176; Pentyala et al., 2013:5). As one ages, the 
accumulation and formation of bone decreases, which can result in a lowered BMD rating and 
an increased risk of a fracture (George et al., 2011:52). The onset of lowered BMD is as a 
result of bone fragility and porosity due to the development of large spaces within the bone 
(Pentyala et al., 2013:6). 
Bone resorption, which occurs via osteoclast activity, is enhanced when movement, such as 
walking or physical activity decreases, leading to potential bone loss (Jenkins & Tortora, 
2013:176; Min, Lee, Choe, Kim, Shin and Lee, 2016:2533). Pollock et al. (2010:422) found 
that BMD is influenced by mechanical loading, and areas that are not exposed to this loading 
will be prone to low BMD which coincides with the findings of Jenkins & Tortora (2013:176) 
and Min et al. (2016:2533).  
The decrease in bone mass is related to the calcium and protein levels in the bone (Bukhar et 
al., 2012:679). Bone health, specifically bone cells and bone metabolism, is determined by 
the presence of the nutrients calcium, magnesium, casein phosphopeptides, isoflavones and 
vitamins D and K (Lesola, Wood & Grant, 2010:94; Jenkins & Tortora, 2013). Bone formation 
is increased by the ingestion of milk proteins, especially during the puberty years, which 
increases BMD by suppressing the resorption of bone (Lesola et al., 2010:94).  
Osteoporosis occurs in both males and females of all races but mainly in white and Asian 
females who are older or post-menopausal, as they are at a greater risk of osteoporosis and 
osteoporotic fractures (Baheiraei, Pocock, Eisman, Nyguyen & Nguyen, 2005:2; Doroudinia & 
Colletti, 2015:647; Mayo Clinic, 2016; Stiles, Metcalf, Knapp & Rowland, 2017:2). 
Osteoporosis is referred to as a silent disease, as the signs and symptoms are not easily 
presented and can only be identified by means of a scan (Abd El Mohsen et al., 2016:2576).  
There are a number of risk factors that can increase the likelihood of developing osteoporosis, 
such as an insufficient calcium intake, family history, inadequate physical activity levels, 
menstrual irregularities, low body mass and BF%, alcohol consumption, cigarette smoking, 
certain chronic diseases and medication usage (Greydanus & Patel, 2004:16; Wilkin et al., 
2010:198; Kim et al., 2013:709; Doroudinia & Colletti, 2015:656; Stiles et al., 2017:2). The 
results of a study by Bukhar et al. (2012:682) indicated that osteoporosis has a positive 
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association with BF% and BMI. According to Vorster et al. (2001:21) and Karp (2015:115), 
females are more at risk for developing osteoporosis after the cessation of menstruation along 
with low oestrogen levels and hormonal imbalances, especially during the period when bone 
mass is increasing. A female in her twenties who does not have a regular menstrual cycle 
may jeopardize bone mass development, which may result in the increased risk for fractures, 
especially in later life (Manore, 2004:49; ACSM, 2011). 
Oestrogen is a vital hormone the body needs to allow the absorption of calcium into the bones, 
but when oestrogen levels are low, an increased intake of calcium and vitamin D is 
recommended (Karp, 2015:115). The reduction in oestrogen production as well as other 
factors such as age, a low or elevated BF%, inadequate physical activity levels, white ethnicity, 
genetics and increased cigarette smoking can cause a rapid increase in bone loss during the 
post-menopausal stage of females (da Silva et al., 2007:944; Pollock et al., 2010:424; 
Wakamatsu et al., 2013:150; de Almeida Carvalho, Bittar, Marangoni & Santili, 2014:5; Karp, 
2014:113). Decreased oestrogen levels lead to lowered BMD levels, which makes one more 
susceptible to osteoporosis, according to de Almeida Carvalho et al. (2014:5) and Folscher et 
al. (2015:2).  
Osteoporosis has become a worldwide concern, resulting in continuous recommendations to 
undergo regular tests to enable early detection (Hammad, 2015:556). Osteoporosis can be 
arrested by engaging in weight-bearing exercise, following a healthy diet and using 
medication, such as calcium supplements to strengthen the bones and minimize bone 
breakdown (Mayo Clinic, 2016). The recommended calcium supplementation requirements 
are 1000-1200 mg per day to treat and prevent osteoporosis (ACSM, 2011; Zheng et al., 
2012:5). 
The investigation into the relationship that occurs between decreased BMD and the onset of 
osteoporosis is imperative. The prevalence of osteoporosis could be regulated, managed and 
maintained accordingly with an increased knowledge of BMD. The onset of osteoporosis can 
result in an increased risk of a fracture occurrence, which will be explained in the following 
subsection. 
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2.6.2  Broken Bones 
The incidence of a broken or fractured bone can occur due to a traumatic event such as a 
motor vehicle accident or from a non-traumatic event such as with a bone disease like 
osteoporosis.  
Bone grows in both length and width (Jenkins & Tortora, 2013:175). Growth of bone 
lengthwise involves an epiphyseal plate, which is found between the diaphysis (shaft) and the 
epiphysis (head) of the bone (Jenkins & Tortora, 2013:175). As bone grows, the epiphyseal 
plate continues to shift upwards due to the deposition of new chondrocytes and the activity of 
the osteoblasts to build new bone (Jenkins and Tortora, 2013:175). Once bone growth ceases, 
which is usually at 18 years for females and 21 years for males, the epiphyseal plate closes 
and forms an epiphyseal line (Jenkins & Tortora, 2013:175).  
If a bone fracture occurs and damages the epiphyseal plate, it may result in a shorter than 
normal bone on the injured side, symbolised by the epiphyseal line, which will be seen despite 
reaching adulthood (Jenkins & Tortora, 2013:176). This phenomenon occurs due to the 
cartilage of the damaged bone being avascular and not able to receive the vital nutrients for 
growth, due to an accelerated process of bone ossification (Jenkins & Tortora, 2013:176). 
Fractures that commonly occur in individuals with osteoporosis are of the femoral neck of the 
hip but can also occur in the spine or wrist (Maghraoui, 2012; Hernandez-de-Sosa, 
Athanasiadis, Malouf, Laiz, Marin, Herrera, Farrerons, Soria & Casademont, 2016:1; Mayo 
Clinic, 2016). According to a study conducted by Hernandez-de-Sosa et al. (2016:9), there is 
a positive correlation between a low BMD and those who have a genetic predisposition for 
osteoporosis. Stress fractures commonly occur in those who participate in endurance 
activities, namely long distance runners (Hazelwood, & Castillo, 2006:1058). The results of 
the study conducted by Wentz et al. (2012:376) indicated that stress fractures occur mainly in 
the tibia and fibula, followed by the metatarsals, the femur, the calcaneus and lastly the spine. 
With an increase in the intensity and frequency of running, energy levels are reduced, and this 
results in a decreased amount of oestrogen available for bone formation, causing BMD to 
decrease. A low BMD can result in the onset of osteopenia or to a greater extent, osteoporosis. 
When constant load is exerted on the bone, stress fractures can occur, inhibiting optimal 
physical performance (Manore, 2004:49; Hind, 2008:415; Korsten-Reck, 2011:156).   
The onset of osteoporosis can be as a result of a low BMD, which may then cause a further 
decline of BMD. Osteoporosis has become a worldwide concern and the need to delay or 
prevent the onset of osteoporosis is vital. Osteoporosis can be determined by a DXA scan via 
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the bone densitometer, or by a combination of a number of factors such as demographic 
variables, female reproductive variables, chronic disease conditions, medication, lifestyle 
factors and training load. The exposure to increasing knowledge of BMD status should be 
encouraged as a means to delay or prevent the onset of osteoporosis.  
2.7  CHRONIC CONDITIONS AND DISEASE HISTORY 
There are a variety of chronic diseases that are becoming increasingly more prominent and 
that can affect the quality and mass of bone (de Almeida Carvalho et al., 2014:1; Williams, 
2016:433). Chronic diseases and health disorders include, but are not limited to, diabetes 
mellitus, cardiac conditions, pulmonary disorders, gastrointestinal disorders, cancer, lupus, 
meningitis, ankylosing spondylitis, scoliosis, stress fractures, arthritis and osteoporosis. Each 
of these conditions can hinder the accumulation of peak bone mass (Hanekom & Kluyts, 
2003:16; Oschman, 2011:283; Thayer, Stolshek, Gomez Rey & Seare, 2014:43; Williams, 
2016:433; Veronese, Stubbs, Crepaldi, Solmi, Cooper, Harvey, Reginster, Rizzoli, Civitelli, 
Schofield, Maggi & Lamb, 2017:1127).  
Studies conducted by Williams (2016:435) and Veronese et al. (2017:1127) respectively, hold 
that those who are diagnosed with cardiovascular disease, cystic fibrosis, celiac disease as 
well as type 1 diabetes mellitus are more predisposed to a lower BMD due to inadequate bone 
mineralization that could lead to an increased risk of osteoporosis. A diagnosis of type 1 
diabetes mellitus can result in a lowered BMD rating of the hip and of the spine (Williams, 
2016:438), whereas type 2 diabetes mellitus has been found to be associated with an 
increased risk of a fracture occurrence in spite of the characteristic weight gain (Gilbert & 
Pratley, 2015:194). The findings of the study by Singh et al., (2014:2833) revolves around the 
inflammatory rheumatic disease known as ankylosing spondylitis (AS). Singh et al. 
(2014:2833) noted that individuals who have been diagnosed with AS are found to have an 
earlier onset of a loss of bone and a lowered BMD at all body sites but more so at the lumbar 
spine. According to Folscher et al. (2015:4), the incorporation of physical activity provides 
benefits that can affect chronic conditions positively.  
Chronic conditions are becoming more prevalent and are associated with a number of different 
types of conditions. It is imperative to gain an understanding of the different types of chronic 
conditions and to determine the effects they have on BMD. A review regarding the medications 
that potentially influence BMD follows. 
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2.8  MEDICATION 
There is a vast variety of medications that can influence BMD either positively or negatively. 
According to the study conducted by Cavkaytar et al. (2015:693), non-steroidal anti-
inflammatory drugs (NSAIDs) prevent the synthesis of prostaglandins that are responsible for 
increasing the role of bone resorption conducted by osteoclasts. It has been noted that BMD 
is higher in those who use NSAIDs compared to those who do not, but there is no indication 
of a decreased risk of a fracture (Cavkaytar et al., 2015:690). The use of paracetamol prevents 
the formation of bone by osteoblasts and has been linked to an increased risk of a fracture 
occurrence (Cavkaytar et al., 2015:690). 
Parathyroid hormone has been used in the treatment of osteoporosis and has been related to 
the production of osteoblasts in bone marrow, thereby promoting the formation of bone (Shao 
et al., 2012:572). The medication Forteo, in the parathyroid hormone class, is used to increase 
bone density and bone strength to prevent fractures (Harvard Women’s Helath Watch, 2004; 
Drugs, 2017). It is also used to prevent and treat osteoporosis in males and females (Jenkins 
& Tortora, 2013).  
Elevated thyroid hormone levels in the body result in increased bone loss due to the 
osteoblasts’ inability to produce new bone promptly (Kruger et al., 2011:750; Jenkins & 
Tortora, 2013; The British Thyroid Foundation, 2015). If thyroid levels remain too high in the 
blood, this results in decreased thyroid-stimulating hormone levels and ultimately increases 
the risk of developing osteoporosis (Kruger et al., 2011:750; Jenkins & Tortora, 2013; The 
British Thyroid Foundation, 2015). 
The medication class of bisphosphonates, which consists of Actonel (Risedronate), Fosamax 
(Alendronate), Reclast (Zolendronate) and Boniva (Ibandronate), alters bone formation and 
bone breakdown within the body (Harvard Women’s Health Watch, 2004; Drugs, 2017). This 
class of medication is used to treat or prevent osteoporosis as it slows down the amount of 
bone that is lost due to the function of osteoclasts, while continuing to increase bone mass 
due to the function of osteoblasts (Pentyala et al., 2013:8). Zolendronate acid is also used to 
prevent the release of calcium from the bones (Drugs, 2017). Boniva is also used in the 
treatment and prevention of osteoporosis in females post menopause (Drugs, 2017). 
According to Pentyala et al. (2013:8), 5mg of Alendronate has been found to prevent the onset 
of osteoporosis whereas 10mg of Alendronate is used in the treatment of osteoporosis.  
The medication class of Selective Oestrogen Receptor Modulators (SERM’s), which consists 
of Evista (raloxifene), is responsible for bone formation and bone breakdown within the body 
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and to reduce the amount of bone that is lost (Wakamatsu et al., 2013:150; Nakatoh, 2016:13). 
The study by Nakatoh (2016:7) found an increase in BMD of the lumbar spine and femur with 
the intake of Raloxifene. Evista is commonly used to treat osteoporosis in postmenopausal 
women (Drugs, 2017). An intake of 60 mg/day has been found to increase BMD in 
postmenopausal women (Pentyala et al., 2013:8).   
The medication Miacalcin (Calcitonin) is used to treat osteoporosis in menopausal females 
and it has been found to increase bone mass by 5-20% (Jenkins & Tortora, 2013; Pentyala et 
al., 2013:8; Ogbru, 2017). Miacalcin is a synthetic form of a hormone that usually occurs 
naturally within the thyroid gland (Drugs, 2017). 
The medication Protelos (Strontium ranelate) is used in the treatment of osteoporosis and it 
decreases the risk for fractures of the hip and vertebral column (Drugs, 2017). Administration 
of Strontium salts stimulates the formation of bone (Pentyala et al., 2013:8). 
Prolia (Denosumab), a medication in the class of monoclonal antibodies, is used in the 
treatment of osteoporosis as it targets and destroys only certain cells in the body while 
protecting healthy cells (Drugs, 2017). 
The use of corticosteroids such as glucocorticoids, which is used to treat asthma, has been 
found to decrease BMD and result in osteoporosis that has been termed ‘steroid-induced 
osteoporosis’ (Harding, 2015; Zaykoski, 2016). The use of glucocorticoid medication slows 
the effect of the osteoblasts’ function and inhibits the absorption of calcium from the 
gastrointestinal tract (Pentyala et al., 2013:6). According to Canalis and Delany (2002:73), 
glucocorticoids influence bone resorption by osteoclasts and prevent bone formation from 
occurring. Individuals exposed to glucocorticoids may develop ‘glucocorticoid-induced 
osteoporosis’, which results in early bone loss, thereby increasing the risk for fractures 
(Canalis & Delany, 2002:73). 
Medications used for the treatment and prevention of seizures such as anticonvulsants, affect 
the absorption of calcium and vitamin D within the body, thus affecting the strength of the bone 
and resulting in decreased BMD (Pentyala et al., 2013:6; Johnson, 2016). 
According to New, Robins, Campbell, Martin, Garton, Bolton-Smith, Grubb, Lee & Reid 
(2000:143), the administration of magnesium, vitamin C, fibre, zinc and potassium are 
positively related to BMD by elevating bone mass in females who are premenopausal. 
Osteoporosis may be a result of a deficiency in magnesium. 
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In summary, there is a broad array of medications that can be prescribed for the maintenance 
of BMD. The influence of each medication can either positively or negatively affect BMD. It is 
necessary to gain an understanding of the types of medication and to ascertain the effects 
related with each. It is imperative to know which types of medication can be used in order to 
delay the occurrence of lowered BMD and the associated conditions that could potentially 
follow. 
2.9  LIFESTYLE FACTORS 
There are a number of methods that can be used to minimise the reduction in BMD and delay 
the onset of osteoporosis (de Almeida Carvalho et al., 2014:1). These methods involve drug 
therapy such as hormone replacement and oestrogen receptor modulators (de Almeida 
Carvalho et al., 2014:5). The more cost-effective methods involve lifestyle changes in terms 
of proper nutrition, adequate calcium intake, incorporating resistance and load-bearing 
exercises, the cessation of smoking and to limit alcohol consumption (Kruger et al., 2011:749; 
de Almeida Carvalho et al., 2014:6). The subsections that follow provide details regarding the 
lifestyle factors that can influence BMD. 
2.9.1  Diet 
Heaney and Layman (2008:1569S) recommend a diet high in protein with an adequate 
calcium intake to increase bone mass and BMD. The consumption of protein enables muscle 
synthesis and muscle repair, which reduces the amount of muscle loss from breakdown 
(Potgieter, 2013:12; Williamson, 2016:9). Combining vitamin D and calcium with the intake of 
protein may reduce the incidence of stress fractures (Potgieter, 2013:14).  
Emphasis should be placed on incorporating more alkalinizing fruits and vegetables into one’s 
diet due to the positive influence they have on BMD (New et al., 2000:143; Heaney and 
Layman, 2008:1568S).  
Diet is an important area of focus to facilitate BMD formation and maintenance, as it can be 
controlled. The nutrients that we consume are needed to ensure adequate growth and 
development, implying that female long distance runners should monitor their diet. 
2.9.2  Calcium 
In older individuals, a calcium intake level of 1000-1200 mg/day is recommended to treat and 
potentially prevent osteoporosis (Warzecha & Czerwinski, 2016:778). Henning (2014:124) 
and Williamson (2016:11) recommend that 2000 mg of calcium should be consumed daily to 
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decrease the risk of stress fractures. It is advised to increase calcium intake via dietary 
sources as well as supplementation to increase or maintain BMD (Greydanus & Patel, 
2004:16; Lamy & Burckhardt, 2014:1; Tai, Leung, Grey, Reid & Bolland, 2015:1).   
An adequate intake of calcium during childhood and adolescence is necessary to regulate 
bone metabolism and remodelling to ensure sufficient BMD during the post-menopausal stage 
(Vorster et al., 2001:21; Wentz et al., 2012:374; Jenkins & Tortora, 2013:177; Ohta, Uenishi 
& Shiraki, 2016:208). In their study on the effect of milk intake during childhood and 
adolescence on bone mass, BMD and osteoporosis, Kalkwarf, Khoury & Lanphear (2003:262) 
found that the consumption of milk during childhood and adolescence influenced the BMD 
during adulthood, especially of the lumbar spine. Participants who consumed less than one 
serving of milk per week during their childhood had a lower BMD compared to those who 
consumed more than one serving of milk per day, which increased the risk and prevalence for 
osteoporotic fractures (Kalkwarf et al., 2003:262). An inadequate intake of calcium can result 
in osteoporosis and fractures, especially stress fractures, in endurance athletes (Baheiraei et 
al., 2005:2; Smith, 2012:272; Wentz et al., 2012:380). 
Calcium maintains homeostasis within the body as it is needed for bone remodelling (Smith, 
2012:272; Lamy & Burckhardt, 2014:1). Calcium is also responsible for bone tissue repair and 
nerve conduction, it enables muscular contraction and supports blood clotting (Smith, 
2012:273; Williamson, 2016:10). The absorption of calcium into the blood stream is aided by 
the presence of vitamin D as well as oestrogen (Smith, 2012:273).  
The intake of calcium influences BMD and is a factor that needs to be considered when 
determining BMD. 
2.9.3  Vitamin D 
Vitamin D is an essential vitamin needed to maintain sufficient calcium and phosphate blood 
levels within the body (Kruger et al., 2011:749; Rana, Morya, Malik, Bhadada, Sachdeva & 
Sharma, 2016:175; Williamson, 2016:10). Vitamin D is responsible for bone mineralisation, 
synthesis of proteins, adequate muscular contraction, nerve conduction, as well as cellular 
functionality of the body (Ogan & Pritchett, 2013:1857; Rana et al., 2016:175). A deficiency of 
vitamin D can result in the decreased formation of bone due to elevated bone resorption and 
ultimately the potential risk of a fracture occurrence (Kruger et al., 2011:749; Ogan & Pritchett, 
2013:1857; Kim et al., 2016:2; Rana et al., 2016:175).  
 32 
Vitamin D intake has been found to enable the absorption of calcium, thereby increasing bone 
strength and reducing the onset of stress fractures and hip fractures (Harvard Women’s Health 
Watch, 2004; Jenkins and Tortora, 2013:177; Ogan and Pritchett, 2013:1857; Henning, 
2014:124). Vitamin D production is initiated via the parathyroid hormone, which is released in 
response to low levels of calcium within the body (Smith, 2012:274; Jenkins & Tortora, 
2013:177; Ogan & Pritchett, 2013:1857). The recommended daily dose of vitamin D is 800-
1000 IU (International Units) and daily exposure to natural sunlight (Harvard Women’s Health 
Watch, 2004; Ogan & Pritchett, 2013:1859; Henning, 2014:124; Ohta et al., 2016:264).  
2.9.4  Cigarette Smoking 
The findings of the study by Baheiraei et al. (2005:8) hold that the BMD of the lumbar spine 
and femoral neck of cigarette smokers is lower than the BMD of non-smokers. Cigarette 
smoking is a controllable and modifiable risk factor that can prevent the decline of BMD if 
smoking is discontinued. Cigarette smoking in relation to decreasing BMD in both males and 
females can result in osteoporosis, according to Kruger et al. (2011:749) and Runolfsdottir et 
al. (2015:24). The negative effects of smoking are worse for males than females (Runolfsdottir 
et al., 2015:24). There is an increase in the risk of an osteoporotic fracture occurring in those 
who smoke cigarettes daily due to a higher rate of bone resorption (Baheiraei et al., 2005:2; 
Kruger et al., 2011:749). Cigarette smoking has been found to affect the production of 
oestrogen in the body due to the elements found in tobacco. Tobacco can also negatively 
influence calcium absorption from the gastrointestinal tract (Kruger et al., 2011:749).  
Non-obese individuals who smoke cigarettes have been found to have a lower BMD compared 
to their obese, cigarette smoking counterparts (Baheiraei et al., 2005:2). It has been noted 
that a positive correlation exists between the cessation of smoking and the BMD of the lumbar 
spine and the femoral neck (Baheiraei et al., 2005:2). 
2.9.5  Alcoholic Beverages 
The consumption of alcohol has been linked to the onset of osteoporosis (Kruger et al., 
2011:749). The consumption of large amounts of alcohol has been found to increase bone 
resorption, resulting in the increased loss of bone and the increased potential for fractures 
(Kruger et al., 2011:749; Jang, Hong, Han, Lee, Shin, Choi, Suh, Yang, Park & Bang, 2017:2). 
Consuming more than two drinks a day increased the likelihood of osteoporotic fractures in 
their sample of white females (Kruger et al., 2011:753). Conversely, Baheiraei et al. (2005:8) 
found no correlation between the consumption of alcoholic beverages and BMD.  
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Mukamal, Robbins, Cauley, Kern and Siscovick (2007:594) found a positive correlation 
between a greater amount of alcohol consumption and an elevated BMD. Mukamal et al. 
(2007:600) also found that consuming more than 14 alcoholic beverages per week was related 
to a higher BMD but their participants had an increased risk of self-reported falls. Findings by 
Jang et al. (2017:5) correspond to those of Mukamal et al. (2007:597) in that the BMD of the 
femoral neck of the hip is higher in those who consume alcoholic beverages, but this only 
applies to those who consume one to two glasses, two to three times per week. Alcohol 
consumption that occurs more than four days per week can result in low BMD. According to 
Jang et al. (2017:9), alcohol should be consumed two to three times per week of one to two 
glasses at a time to influence the BMD of the hip. 
2.9.6  Carbonated Beverages and Caffeine Intake 
The results of a study conducted by Bukhar et al. (2012:686) indicate that there is a positive 
correlation between the intake of carbonated beverages and decreased BMD. Bukhar et al. 
(2012:686) also mentions that the decreased BMD may be due to the elevated levels of 
phosphorus within the beverages, which causes the blood calcium levels to decrease and can 
ultimately lead to the onset of osteoporosis.  
Carbonated beverages are comprised of phosphoric acid, which influences calcium 
metabolism; as well as caffeine, which can cause BMD to decrease. There is a positive 
correlation between the intake of carbonated beverages on calcium and bone metabolism 
(Ogur, Uysal, Ogur, Yaman, Oztas, Ozdemir, & Hasde, 2007:334; Lamy & Burckhardt, 
2014:6). 
Obese individuals who consume carbonated beverages and have an unhealthy diet are prone 
to having a lowered BMD resulting in osteoporosis (Bukhar et al., 2012:679). According to 
Kim, Morton and Barett-Connor (1997:281), there is no association between BMD and the 
consumption of carbonated beverages. The afore-mentioned differences between the studies, 
indicate that there may be certain limitations regarding the knowledge of the effects that 
carbonated beverages present for BMD. However, the influence of carbonated beverages on 
BMD should be acknowledged as certain studies have found a positive association with 
carbonated beverages and a decreased BMD. 
The consumption of caffeine, such as coffee, in excess of three cups per day, has been noted 
to have an effect on BMD (Bukhar et al., 2012:686). The ingestion of a high caffeine content 
decreases the ability to absorb calcium, which can be linked to a lifetime risk of lowered BMD 
(Bukhar et al., 2012:679; Lamy & Burckhardt, 2014:6). This is contradictory to the findings of 
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Smith (2012:274), who found that consuming 5 cups of coffee daily poses no risk for lowering 
BMD. Smith (2012:274) however, does acknowledge that excessive caffeine intake may 
potentially cause urinary excretion of calcium, which can then lower BMD. 
2.9.7  Lactose Intolerance 
Lactose intolerance is caused by a deficiency due to an autosomal recessive condition 
(Obermayer-Pietsch, Bonelli, Walter, Kuhn, Fahrleitner-Pammer, Berghold, Goessler, Stepan, 
Dobnig, Leb & Renner, 2004:42). Intolerance to lactose can cause a decrease in BMD at 
different sites within the body of lactose deficient females, which may result in the risk for 
osteoporosis (Obermayer-Pietsch et al., 2004:42).  
A limited intake of milk, dairy products and calcium in adolescents has been related to a 
decreased BMC (da Silva, Lederman & de Morais, 2012:204). Individuals who are lactose 
intolerant may potentially be calcium deficient and will need to substitute with non-dairy 
products to provide a source of necessary nutrients (Smith, 2012:275). These non-dairy 
sources include broccoli, kale, bok-choi and calcium supplements (Smith, 2012:275). 
The inability to absorb lactose has been found to be related to age and as one grows older, 
the absorption of calcium within the body declines (Obermayer-Pietsch et al., 2004:43). The 
decline of calcium occurs from the age of 50 years as the body is no longer able to absorb 
calcium (Smith, 2012:274). Without an adequate intake of calcium during childhood and the 
growth years, the skeleton will not develop adequately, thereby increasing the risk for lowered 
bone strength, decreased BMD and the risk for osteoporosis later in life (Smith, 2012:275).  
According to da Silva et al. (2012:204), there is no correlation between the inability to absorb 
lactose, the consumption of calcium and the mineral content of bone. 
The above-mentioned lifestyle factors all contribute to BMD with either a positive or negative 
associated effect. The body relies on certain nutrients to maintain bone health and it is a 
necessity to monitor both nutrient intake as well as the BMD from time to time. Lifestyle factors, 
namely proper nutrition, adequate calcium intake, reduced caffeine and carbonated beverage 
consumption, the cessation of smoking and limited alcohol consumption can have a positive 
influence on BMD. Incorporating resistance and load-bearing exercises in accordance with 
the above-mentioned lifestyle factors can also influence BMD. A discussion on the effect that 
training load has on BMD is to follow. 
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2.10  TRAINING LOAD 
The following section includes an in-depth review of training load and how it relates to BMD. 
In this study the training load relates to the influence of physical activity levels, a strength and 
conditioning regimen and long distance running, namely marathons and ultra-marathons.  
2.10.1  Physical Activity 
It is recommended to incorporate physical activity such as resistance exercises and load 
bearing exercises into one’s training regime (Duncan et al., 2002:291; Halpert, 2004:80; Wilkin 
et al., 2010:198; Stunes, Syversen, Berntsen, Paulsen, Stea, Hetleid, Lohne-Seiler, Mosti, 
Bjornsen, Raastad & Haugeberg, 2017:13). According to separate studies by Bemben et al. 
(2004:225), Gibson, Mitchell, Harries & Reeve (2009:611), Kim et al. (2013:709) and Stiles et 
al. (2017:1855), running has a positive association with BMD due to the mechanical load that 
is placed on the body. A study by Pollock et al. (2010:422) found a decrease in BMD in areas 
that were not exposed to mechanical loading. Wilkin et al. (2010:204), Andreoli, Celi, Volpe, 
Sorge and Tarantino (2012:69) and Selingerova et al. (2015:273) also noted that those who 
are physically active have elevated BMD levels.  
Physical activity has been found to stimulate bone formation, which enables the maintenance 
of BMD, limits bone loss and prevents or delays the onset of osteoporosis (Pollock et al., 
2010:424; Korsten-Reck, 2011:156; Kruger et al., 2011:749; de Almeida Carvalho et al., 
2014:2). According to Smith (2012:275) and Stiles et al. (2017:2), physical activity is the only 
non-pharmacological means to enable and maintain bone formation. Without physical activity 
BMD can decrease, resulting in the occurrence of osteoporosis and an increased risk of 
fractures (Andreoli et al., 2012:69). 
According to Pollock et al. (2010:423), Morseth et al. (2011:175), Abd El Mohsen et al. 
(2016:2577) and Kim et al. (2016:2), high impact sports such as strength-based activities and 
contact sports have been found to have a positive influence with regard to bone mineralization, 
and bone density, especially in premenopausal females. The load that is placed on the bone 
occurs via ground reaction forces and the contraction of muscles, which, alongside the 
exposure to oestrogen within the body, elevates and maintains BMD (Gibson et al., 2000:612; 
Morseth et al., 2011:175). The areas of the body that are exposed to the greatest amount of 
stress will have a higher BMD (Tomkinson, Gibson, Lunt, Harries & Reeve, 2003:463; Andreoli 
et al., 2012:70). Morseth et al. (2011) noted that female endurance athletes, especially 
runners, have a greater BMD of the femoral neck.  
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Resistance exercise training has been found to stimulate the osteogenic activities of bone, 
thereby increasing BMD in the youth and the elderly (Halpert, 2004:80; Marques, Wanderley, 
Machado, Sousa, Viana, Moreira-Goncalves, Moreira, Mots & Carvalho, 2011:525; Morseth 
et al., 2011:175; Andreoli et al., 2012:70; Stunes et al., 2017:13). Individuals who engage in 
long distance running should incorporate resistance exercises of the upper body in order to 
maintain BMD by providing an adequate load on the spine (Bemben et al., 2004:220). 
According to the study conducted by Marques et al. (2011:529), implementing resistance 
training for 8 months can stimulate bone formation, especially of the hip, whereas aerobic 
exercise can cause bone mass to increase.  
As one ages, the osteogenic activities of the bone stimulated by mechanical loading becomes 
less active, which results in ineffective bone sensitivity (Marques et al., 2011:529). The 
findings of Baheiraei et al. (2005:2) indicate that older, post-menopausal females have a lower 
BMD of the lumbar spine and the femoral neck compared to younger, pre-menopausal 
females. Pollock et al. (2010:421) found that BMD begins to decrease from the age of 30 years 
and once menopause occurs, the mineral content of the bone declines more rapidly. Females 
older than the age of 60 years were found to have osteoporosis of the lumbar spine (Chan et 
al., 2004:61). It is vital to incorporate physical activity into one’s lifestyle to maintain BMD and 
prevent or delay the onset of osteoporosis (Bacelar et al., 2015:102). As found in a study by 
Silva et al. (2014:227), osteopenia and osteoporosis are more prevalent as one ages, which 
increases the risk of a fracture occurrence.  
Vorster et al. (2001:21) and Wentz et al. (2012:381) found that intense or strenuous training 
over a prolonged period may result in elevated bone turnover, bone resorption is increased 
causing a decline in BMD with the potential risk for stress fractures. Pollock et al. (2010:422) 
hold that a low BMD occurs in female athletes who participate in endurance running.  
According to Henning (2014:122), when bone is exposed to excessive forces repeatedly, there 
may be an increased amount of traction present on the bone. This traction may be related to 
the inability of the muscles to absorb the shock and stresses that are placed on the bone 
(Henning, 2014:122). It is advised to incorporate cross training into the training regime to 
expose the body to different running surfaces and exercises to reduce the overload factor 
placed on bones (Henning, 2014:122).  
When engaging in weight bearing activities, the load exposes the body to internal forces of 
stress, which may result in deformation and strain that could ultimately result in the 
development of micro-cracks (Andreoli et al., 2012:70). Without adequate recovery, sound 
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nutrition and proper accumulation of muscle strength and endurance, the damage can lead to 
macro-cracks resulting in a bone stress injury or stress fracture, mainly of the lower-
extremities (Barrack et al., 2014). 
The research presented indicated that physical activity has an influence on BMD which can 
either be positive or negative. The latter seems to be associated with excessive exposure. 
Long distance runners for example, are exposed to excessive running exposure which 
potentially can affect their BMD negatively particularly that of females who participate in such 
activities. It is therefore imperative to explore the influence of physical activity on BMD in 
female long distance runners. 
2.10.2  Running 
According to Hespanhol Jnr, Costa and Lopes (2013:1456), running is a widely practised form 
of physical activity enjoyed by individuals of different ages, from different backgrounds as well 
as of different fitness levels. The rate at which running has gained exposure amongst females 
is increasing rapidly. This has been attributed to running being relatively inexpensive, easy to 
learn and providing a variety of benefits, including self-confidence, improved well-being, 
weight loss and enjoyment (Byrd et al., 2016:54).  
Running takes place within a variety of disciplines, namely ultra-marathons, marathons, half 
marathons and shorter distance running on various terrains such as on the road, trails, an 
athletics track, on a treadmill and so forth (Wentz et al., 2012:375; Jenkins, 2014; Geo, 2015). 
According to Wentz et al. (2012:375), running that occurs on a treadmill or on an athletics 
track can provide a greater protective benefit from the development of stress fractures when 
compared to running on a road or on a trail.  
The ultra-marathon is defined as a distance that exceeds the marathon length of 42.2km 
(Blaikie, 2016). Distances usually occur from 50km and over and can be on a road or trail 
(Blaikie, 2016). According to Hanekom and Kluyts (2003:15), Pollock (2010:423) and Farlex 
(2015), marathon running is considered as a long distance running event of 42.2km that 
usually occurs as a road race but may also be a trail run. Half marathon running is over a 
distance of 21.1km, which is half of a full marathon event (Farlex, 2015). Shorter distance 
competitive running events are over 10km, 5km and 3km respectively. Ultra-marathon and 
marathon events are classified as long distance or endurance running, which is defined as 
engaging in running for more than one hour per day for five days within the week (Hanekom 
& Kluyts, 2003:15). 
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An increase in running distance, frequency and intensity may influence one’s BMD rating 
(Tomkinson et al., 2003:463; Pollock et al., 2010:420; Benca et al., 2013:351). There is an 
increase in the mechanical load that is placed on the body during endurance running that may 
act as a protective mechanism against bone loss (Pollock et al., 2010:422; Selingerova et al., 
2015:271; Williamson, 2016:7). Based on their research, Duncan et al. (2002:288) and 
Hanekom and Kluyts (2003:16) indicated that runners have a greater BMD of their legs 
compared to other body sites due to the mechanical loading that is placed on the body.  
However, this repetitive mechanical loading can cause a disturbance in the balance between 
bone resorption and bone formation, which can lead to an injury and more commonly a stress 
fracture (Wentz et al., 2012:375). Female athletes, and more so runners, who have a low BMD 
rating have an increased likelihood of a stress fracture, which can hinder athletic performance 
(Hind, 2008:416). According to Wentz et al. (2012:380), the incidence of a stress fracture can 
occur due to factors such as an increase in training intensity and frequency, menstrual 
abnormalities or an inadequate nutrient intake, which can all influence a decreased BMD.   
According to studies by Pollock et al. (2010:422) and Wentz et al. (2012:380), an increase in 
bone loss and ultimately a lowered BMD is related to the duration of time spent exercising in 
terms of hours per week. Implementing intense or a prolonged duration of exercise that places 
extreme loads onto the bone can cause bone formation irregularities (Burrows & Bird, 
2000:283; Vorster et al., 2001: 21). The findings of the study by Barrack et al. (2014:955), hold 
that endurance athletes such as long distance runners are more likely to develop a bone injury, 
which may be due to having a low BF% and BMI as well as having a low BMD of the femoral 
neck and lumbar spine. Burrows & Bird (2000:289) hold that implementing a moderate amount 
of exercise is more beneficial than vigorous and strenuous activity and have recommended 
that weekly running should consist of 20 to 30km over two to three days for 20 to 30 minutes 
a day. 
According to Knechtle et al. (2012:247), running performance decreases from age 40 years 
and onwards but marathon runners reach their peak running pace between the ages of 25 
and 35 years of age and ultra-marathoners reach their peak at 30 to 49 years of age. 
According to Dusek (2004:38), there is a higher rate of amenorrhoea amongst female long 
distance runners. Without adequate levels of oestrogen within the body, the activity of the 
osteoblasts and osteoclasts becomes unbalanced. This imbalance can affect BMD due to 
elevated bone resorption (Tomkinson et al., 2003:463; Dusek, 2004:40). A study conducted 
by Gibson et al. (2000:612) indicates that long distance running may be beneficial for BMD in 
 39 
females, but this beneficial aspect will only suffice if the females are known to be eumenorrheic 
and have had no history of menstrual abnormalities. 
Henning (2014:124) recommends that running shoes should be replaced after they have been 
used for 300-500 miles (480-800km). The type of running style can vary between individuals 
and there are three types of running styles based on the pattern of where the foot strikes the 
ground (Hamill and Gruber, 2017:146). These styles include fore foot, rear foot and mid foot 
strike patterns (Hamill & Gruber, 2017:146).  Fore foot strike is when the foot contacts the 
ground with the metatarsal heads but there is no contact from the heel. Rear foot strike is 
when the foot contacts the ground by first landing on the heel on the lateral side, with the final 
contact point being the toes. The mid foot strike running style is when the foot contacts the 
ground with the metatarsal heads and the heel simultaneously (Hamill & Gruber, 2017:146). 
Williams, Green and Wurzinger (2012:531) found that fore foot running, and barefoot running 
styles reduce the amount of power that is absorbed by the lower-extremity, especially at the 
knee. This absorption of power then moves to the ankle segment, which may potentially pose 
a risk of injury (Williams et al., 2012:531). 
There are a number of contradictory findings regarding the influence that long distance running 
has on BMD. The influence of long distance running on BMD is not a singular occurrence, as 
BMD is related to a multi-factorial influence and can differ between individuals. The present 
study with the main focus being to determine the BMD status of female long distance runners 
therefore seems relevant and justified.  
2.11 SUMMARY 
In summary this chapter provided background information pertaining to the concept of BMD, 
how it develops, how and when it declines in quality, how it is measured and how the latter 
measurements are interpreted. It also reviewed literature that highlighted the relationship 
between BMD and a variety of variables that subsequently influenced the focus of the present 
study as well as provided valuable research against which to compare the present study’s 
findings. 
Chapter 3 describes the methods and procedures that were used to address the objectives of 
this study. 
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CHAPTER 3 
RESEARCH METHODS AND PROCEDURES 
3.1  INTRODUCTION 
This chapter comprises a description of the elements of the research process that were 
applied in order to achieve the aim of the study. A full description of the research design, the 
participants, the sampling method and the data collection and analysis of the results is 
presented. The chapter concludes with the ethical issues that were considered and the 
relevant approval that was sought to conduct the study.  
3.2  RESEARCH DESIGN 
A research design can be considered as the blue print of the study, where the procedures are 
laid out in order for an effective and efficient study to be conducted (Fouché, Delport & de Vos 
et al., 2011:142). There are two types of macro research design, namely quantitative and 
qualitative and a quantitative design was chosen for this study (Fouché et al., 2011:142). 
Quantitative research designs are administered in order to explore the research problem via 
data capturing and analysis by means of statistical methods (Fouché et al., 2011:142).  The 
specific classification of the study design used for this study was a non-experimental, 
descriptive, quantitative, correlational research study design.  
Incorporating a non-experimental, correlational research study design indicates that there is 
no control or experimental group present. Non-experimental research designs correspond to 
the use of descriptive statistics, whereby questionnaires and surveys are commonly used 
(Maree and Pietersen, 2007:152; Fouché et al., 2011:155). Correlational research study 
designs involve no intervention plan and no pre- or post- testing. The purpose of using the 
descriptive, quantitative, correlation research design is to quantify the BMD status of the 
female long distance runners and to determine the possible correlation that exists between 
BMD and the relevant variables with the use of descriptive and correlation statistical 
techniques. 
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3.3  SAMPLING METHOD 
Sampling method refers to the selection of participants from the relevant population that will 
be analysed within the study (Kerlinger & Lee, 2000:163hologic; Unrau, Gabor & Grinnell, 
2007:224). The sampling method incorporated in this study was non-probability, convenience 
sampling (Gravetter & Forzano, 2003:118; Unrau et al., 2007:231). This involved a non-
randomized sample of individuals from selected running clubs who volunteered to participate 
in the study.  
The convenience sampling technique allows an easily obtainable sample group, all of whom 
meet the criteria of the study but there will be a greater potential for bias (Bailey, 1994:94; 
McBurney, 2001:246; Alston & Bowles, 2003:87-88; Monette, Sullivan & DeJong, 2005:145-
146; Grinnell & Unrau, 2008:355; Laerd, 2013). Every effort was made to maintain consistency 
and accuracy throughout the study for each individual. 
The participants were recruited through diverse means. Firstly, all running clubs were 
contacted telephonically and via email regarding the study and requested to assist by 
informing and encouraging their club members to participate. The runners who were interested 
in the study were then contacted individually. The participants were also recruited at various 
running events where informative flyers were distributed. ‘Word of mouth’ advertising of the 
study assisted in recruiting participants.  
3.4  PARTICIPANTS 
Participants included in the study were female long distance runners over the age of 25 years. 
By only including participants over the age of 25 years it was possible to eliminate certain 
physiological growth-related changes, such as epiphyseal growth plates not yet being closed 
and further strengthening of bone and the possible growth-related influence on BMD 
(Nemours, 2015). 
The research participants were currently involved in running marathon and ultra-marathon 
events in order to classify as long distance runners. Each female participant had to have 
completed at least two marathon or ultra-marathon events to qualify for the study. The aim 
was to include no fewer than 30 participants in order to determine a more reliable and accurate 
conclusion from the statistical measures obtained. A total of 40 female participants ranging in 
age from 26 to 68 years were finally included in this study. Of the total number of participants, 
32 were registered members of running clubs in NMB and the remaining 8 participants are 
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currently long distance runners who regularly compete in long distance running events but are 
not officially registered members of a club. 
3.5  MEASURING INSTRUMENTS  
The instruments used within a research study enable the collection of data from a selected 
target group which is then analysed and presented as useful and understandable information 
(Wilkinson & Birmingham, 2003:3). The measuring instruments involved in this study included 
a questionnaire, an electronic scale to measure weight, a stadiometer to measure height and 
a bone densitometer with the DXA to measure BMD and BF%. These measuring instruments 
will be explained in more detail, as well as the protocols and procedures that were consistently 
adhered to in order to obtain the required information.  
3.5.1  Questionnaire 
A short questionnaire was administered prior to the densitometry scan in order to obtain 
demographic and biographic information. The questionnaire included dichotomous questions, 
multiple choice questions, contingency questions and open-ended questions. There were 
questions regarding age, ethnicity, height, weight, membership of a running club, individual 
menses and their menstrual cycle, history of broken or fractured bones, family history 
regarding osteoporosis and parental hip fractures, training load and running regime, number 
of marathon and ultra-marathon races completed, nutritional and supplemental intake (such 
as calcium, fruits and vegetables, protein, caffeine, carbonated beverages), medication 
usage, consumption of alcoholic beverages, smoking status and whether or not they 
incorporate a strength and conditioning program into their training regime. Please see 
Appendix D for a copy of the questionnaire.  
The questionnaire was distributed via email and each participant completed the questionnaire 
and returned it before the date of their densitometry scan by either submitting it via email or 
returning a printed copy. All questionnaires that were submitted prior to the densitometry scan 
appointment were checked in order to clarify any unanswered questions. Clarity on these 
unanswered questions was obtained from the participant at the testing venue. 
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3.5.2  Anthropometric Assessment 
Prior to the densitometry scan, each participant was required to undergo an anthropometric 
assessment, when their height and weight was measured and recorded. The height and 
weight of each participant was measured according to the International Society for the 
Advancement of Kinanthropometry (ISAK) standards and guidelines (Norton & Olds, 1996).  
The height was measured by using a stadiometer (Seca portable stadiometer, model 213) 
(Figure 3.1) and weight was measured by means of an electronic scale (Micro T7E 
Scalemaster electronic platform scale) (Figure 3.2). The same stadiometer and electronic 
scale were used throughout to ensure reliability and consistency. Each height and weight 
measurement was taken without shoes and while wearing minimal clothing (Norton & Olds, 
1996:37). 
 
Figure 3.1: Stadiometer to measure height 
The height was measured according to a predetermined method whereby the participant stood 
upright with their feet together and their heels, buttocks and upper portion of the back against 
the stadiometer (Norton, Whittingham, Carter, Kerr, Gore & Marfell-Jones, 1996:37). 
The researcher then moved the participant’s head into the Frankfort Plane, which is when the 
tragion of the ear is on the same horizontal plane as the orbitale found at the lower edge of 
the eye socket (Norton et al., 1996:37). The researcher then holds the jaw of the participant 
with their fingers reaching and holding the mastoid processes to correctly position the head, 
after which the headboard of the stadiometer was placed on top of the head of the participant 
as firmly as possible. The participant then inhaled deeply and the height measurement was 
recorded to the nearest 0.1cm (Norton et al., 1996:37). 
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Figure 3.2: Electronic scale to measure weight 
Weight was measured by the participant standing on a calibrated, electronic scale. The 
participants were instructed to remove any excess layers of clothing as well as any items in 
their pockets, such as their cell phones or keys. The participant then stood in the centre of the 
scale with their weight equally distributed over both feet and their head and eyes facing the 
wall in front of them (Norton et al., 1996:37-38). 
Height and weight measurements were used to calculate BMI by applying the following 
formula of weight (kg) ÷ height² (m²). The bone densitometer software calculates BMI 
automatically if height and weight are entered into the system correctly. The ACSM (2014:63) 
reference data was subsequently used to interpret the values obtained from the female long 
distance runners involved in the study. The relevant table reflecting the reference data was 
presented in Chapter 2 (see Table 2.1).  
3.5.3  Bone Densitometer  
The bone densitometer utilizing DXA is the most accurate means to measure BMD and can 
be used to identify and diagnose osteoporosis (Maghraoui, 2012:4; National Health Service, 
2014; Farlex, 2016). It was also used to determine the BF% of the participants. The DXA scan 
is considered to be the gold standard (Maghraoui, 2012:4; Kim & Yang, 2014:2; Silva et al., 
2014:227; Tonuk, 2015:150) for determining BF%, which was recorded in this study. The 
participants underwent the DXA scan in order to retrieve the relevant data required for the 
study. The bone densitometer used to conduct the testing was the Hologic Discovery W with 
the APEX System Software Version 4.0.2 (Figure 3.3). The same bone densitometer was 
utilized throughout in order to maintain reliability. 
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Figure 3.3: Hologic Discovery W bone densitometer 
Prior to the DXA scan and before each participant entered the room, calibration was 
conducted via a quality check (QC) test (Marques et al., 2011:525; Hologic, 2014:7). The test 
was conducted to ensure the bone densitometer was calibrated correctly (Maghraoui, 2012:6). 
To conduct the QC test, a spine phantom was used for calibration (Figure 3.4) (Marques et 
al., 2011:525; Hologic, 2014:7; Kim & Yang, 2014:3). The laser projected a cross onto the bed 
of the densitometer and the spine phantom with a cross marking was placed into a position 
aligned with the laser.  The QC test is performed to analyse the radiation quality and the 
absorption coefficient of the bone densitometer to ensure precise, reliable and consistent 
measurements are taken during a scan (Kim & Yang, 2014:3).  
 
Figure 3.4: Spine Phantom 
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To obtain the correct images from each scan, the positioning of the body had to be specific 
and all relevant information had to be provided. For example, it was important to include the 
identity of the patient, their age and birthdate, their height and weight as well as their gender 
and ethnicity (Maghraoui, 2012:6; Hologic, 2014:8; Doroudinia & Colletti, 2015:649).  
All participants were informed prior to their appointment to not wear jewellery or any items of 
clothing containing metal elements such as zippers, buttons or wired brassieres or metallic 
printing (Kim et al., 2016:3). Without the removal of jewellery and metal items such as zippers, 
the DXA software may mistake these items for bone, which will have an effect on the final 
result of BMD and the total weight value of the individual (Giangregorio & Webber, 2003:306; 
Richardson, Zack & Beiseigel, 2004:114). Participants were also told to remove their shoes 
prior to the scan (Hologic, 2014:14).  
The DXA scan was performed by a qualified radiographer, with the participant lying flat on 
their back on an open X-ray table within the specified position boundaries (National Health 
Service, 2014). Emphasis was placed on the importance of the correct positioning of each 
participant to ensure posture was accurate as well as that the correct area was scanned via 
the placement of the scanning arm of the bone densitometer (Hologic, 2014:20; Kim & Yang, 
2014:5; Doroudinia & Colletti, 2015:649). The participants were to remain still throughout the 
test, while breathing normally. Two radiographers performed the scans for each participant 
throughout the course of the study (Marques et al., 2011:526). Throughout the scanning 
procedure the radiographer remained behind a lead X-ray shield in order to limit exposure to 
radiation.  
The scanning arm of the bone densitometer then moved over the body while a beam 
consisting of a low dose X-ray passed through the body to measure BMD (DXA Scan, 2014). 
Three scans were taken, namely the lumbar spine, the hip and then the total body scan 
(Maghraoui, 2012:7). All scans were conducted on the same bone densitometer, following the 
same sequence, specifically the lumbar spine, the hip and then the full body. Prior to 
conducting each individual scan, the radiographer had to select the scan that was to be 
conducted.  
The lumbar spine scan (Figure 3.5) was conducted with the participants lying straight and 
supine while resting their legs on a foam block at a 90 ̊ angle with their arms across their chest 
(Maghraoui, 2012:6; Hologic, 2014:20). The reasoning for resting their legs on a foam block 
was to ensure their back was flat against the bed in order to obtain an accurate result 
(Maghraoui, 2012:6). The lumbar spine scan consisted of the L1 to L4 vertebrae so as to not 
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include the lower ribs or the pelvis and the duration was approximately 3 minutes. The results 
were displayed after the completion of the auto-analysis (Hologic, 2014:20; Doroudinia & 
Colletti, 2015:648). 
 
Figure 3.5: Positioning for the lumbar spine scan 
The hip scan (Figure 3.6 and Figure 3.7) was taken with the participants lying supine with both 
femurs in a straight position (Maghraoui, 2012:6). The scan of the hip was taken on the side 
that the participant referred to as their non-dominant side (Marques et al., 2011:525). The non-
dominant side is considered to be the side that is exposed to the least amount of force and 
contains a lower amount of BMD when compared to the dominant side (Min et al., 2016). The 
participants then rested their non-dominant foot against a box/positioning device whereby the 
hip and leg to be scanned were internally rotated at 15 ̊-25 ̊ with the foot flexed towards the 
ceiling and held in place with a foot strap (Maghraoui, 2012:6; Hologic, 2014:24). For this study 
the inclination of the positioning device was 15 ̊ to enable internal hip rotation. The arm of the 
participant on the side of the hip to be scanned, was placed on the chest to not influence the 
scan. The hip scan was completed once the lesser and greater trochanter were identified, as 
well as the femoral neck of the total hip on the side that was scanned (New et al., 2000:143; 
Doroudinia & Colletti, 2015:648). The duration of the scan was approximately 3 minutes and 
the results were displayed after the completion of the auto-analysis (Hologic, 2014: 30). 
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Figure 3.6: Positioning for the hip scan 
 
Figure 3.7: Positioning device to maintain the internally rotated hip and leg 
The full body scan was taken with the participant lying completely still in a supine position 
(Hologic, 2014:40). The feet were brought together at the toes and held in position by an 
elastic band for stability during the scan. The participant’s entire body had to remain within the 
black border marked on the bed of the scanning table to ensure correct and precise alignment 
and positioning (Hologic, 2014:40). The full body scan consisted of 7 up and down movements 
with the bed and scanning arm moving simultaneously, which totalled approximately 7 
minutes. The results were displayed once the auto-analysis was completed (Hologic, 
2014:40).  
The BF% of each participant was taken and analysed simultaneously during the full body scan, 
when the amount of lean mass and fat mass was observed. In this study the BF% is dependent 
upon age and gender. The relevant table featuring the normative data for BF% in relation to 
age is reflected in Chapter 2 (see Table 2.2).  
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The data obtained from the bone densitometer after the DXA scan consisted of the Z-scores, 
the T-scores and the BMD, which consists of the BMC and the area of bone that was 
measured as well as the BMD expressed in g/cm2. The BMD was then interpreted according 
to the WHO T-score measurement, which is classified as normal being greater than 1 SD 
below the mean value (also referred to as above -1 SD), whereas decreased BMD resulting 
in osteopenia is identified when the T-score is between 1 and 2.5 SD below the mean value 
(also referred to as between -1 and -2.5 SD), with osteoporosis defined as a T- value of more 
than 2.5 SD below the mean (also referred to as below -2.5 SD) (Blake & Fogelman, 2007:509; 
Wilkin et al., 2010:200; Heidari, 2014:5; National Health Service, 2014; Abd El Mohsen et al., 
2016:2576; Lespessailles et al., 2017:1). According to the National Health Service (2014); 
Tonuk et al. (2015:151), Lespessailles et al. (2017:1), The National Osteoporosis Foundation 
(2017) and the International Society for Clinical Densitometry (2013), a Z-score that is greater 
than or equal to 2 SD below the mean (also referred to as less than -2.0 SD), is a low BMD.  
As previously mentioned, three scans were taken to determine BMD, the lumbar spine, the 
hip and full body. The latter included BF% measurements (see Figures 3.8, 3.9, 3.10 as well 
as 3.11 for examples of the relevant images and corresponding example reference graphs 
obtained respectively).  
 
 
Figure 3.8: Lumbar spine scan with the corresponding example reference 
graph 
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Figure 3.9: Hip scan with the corresponding example reference graph 
  
Figure 3.10: Full body scan with the corresponding example reference graph 
  
 
Figure 3.11: BF% scan with the corresponding BF% rating 
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After each individual scan a number value was provided, stating the amount of radiation the 
participant was exposed to, which is known as the Dose Area Product (DAP) (Raubenheimer, 
Spangenberg, van Jaarsveld, Koller, de Vries, Herbst, Willemse & Joubert, 2004:24). The 
DAP meter is situated on the X-ray tube in order to measure the radiation emitted to the air in 
relation to the area of the X-ray taken (Raubenheimer et al., 2004:24). The DAP recording is 
to identify the amount of exposure to carcinogens and the risk of cancer and this reading 
should remain as low as possible (Raubenheimer et al., 2004:24). The DAP measurement 
can vary between individuals, as there is no specific DAP value. Each DAP measurement is 
recorded in a file that is kept on the premises at the centre where the scan took place. The 
updating and safe storage of this record file is a legal requirement that researchers and 
technicians need to abide by. In total, the duration of all three scans was between 30 and 45 
minutes. 
3.6  PILOT STUDY 
Prior to the commencement of the study a pilot-study was conducted to refine the testing 
procedures. A pilot study can be defined as “A small study conducted prior to a larger piece 
of research to determine whether the methodology, sampling, instruments and analysis are 
adequate and appropriate” (Bless, Higson-Smith and Kagee, 2006:184; Strydom, 2011:237). 
The pilot-study enabled the correction of any errors and the opportunity to make relevant 
adjustments in order to conduct a sound and accurate study (Strydom, 2011:236, in de Vos 
et al., 2011). A pilot study is conducted to ensure face and content validity as well as to provide 
an estimate on the length of time needed to complete the testing procedures (McBurney, 
2001:228; Strydom, 2011:236, in de Vos et al., 2011).  
The pilot study for the questionnaire was completed by an avid runner with the knowledge 
necessary to provide advice and recommendations for the study but who did not meet the 
requirements to participate in the study. The questionnaire was also reviewed by the 
researcher’s supervisor as well as a statistician to ensure that ethical procedures were met 
and to ensure that it would meet the requirements needed to formulate adequate statistics 
once testing was completed.  
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3.7  DATA COLLECTION 
The proposal for the study was submitted for approval to the Health Sciences Faculty 
Postgraduate Studies Committee and to the Research Ethics Committee Human (REC-H) of 
the Nelson Mandela University for authorization prior to the commencement of the research 
study.  
Data collection commenced in March 2017 and concluded in October 2017. Female runners 
who were current participants in marathon and ultra-marathon events were selected to 
participate in the study. The questionnaire was sent via email with a letter to the managers of 
the respective running clubs as well as information about the study (see Appendix B) with the 
consent form (see Appendix C). The questionnaire was completed prior to the DXA scan 
appointment. The completion of the questionnaire by the participant acknowledged their 
consent to participate in the study. Once each questionnaire was received, the information 
was transcribed into an Excel document. Testing commenced at the Biokinetics and Sports 
Science Unit (BSSU) of the High-Performance Complex of Nelson Mandela University.  
On arrival, participants presented the completed (dated and signed) consent form. Each 
participant then had to answer a limited number of questions regarding their current pregnancy 
status, whether they have any metal pins or rods in their body, the side they consider to be 
the dominant side, the type of running shoe they wear as well as their running style. The 
anthropometric measurement assessment was then conducted, whereby height and weight 
were taken to determine the BMI.  
The participant subsequently underwent the DXA scan performed by a qualified radiographer 
to determine BMD as well as BF%. As mentioned before, three scans were taken to determine 
BMD, which consisted of the lumbar spine, the hip and full body, including BF% 
measurements.  
3.8  DATA ANALYSIS 
All data obtained from the questionnaire, the BMI as well as that which was obtained from the 
bone densitometer DXA scans were entered onto a coded Excel document enabling data 
analysis to be conducted with the use of Microsoft Excel®. An application to use on Excel with 
the coded data to analyse the results was formulated with the assistance of a consulting 
statistician. For the purpose of this study descriptive and inferential statistical analyses were 
subsequently conducted. 
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Descriptive statistics is defined as the analysis of data that describes, summarizes and 
simplifies data effectively but does not allow conclusions to be drawn (Gravetter & Wallnau, 
2008:6). There are two ways in which to utilize descriptive statistics, namely measures of 
central tendency and measures of spread (Gravetter & Wallnau, 2008:6; Fouché & Bartley, 
2011:254-265; Laerd, 2013). Measures of central tendency (mean and median) and spread 
(range, quartiles, minimum and maximum and standard deviation) were used to describe the 
BMD, BF% and BMI data obtained. Frequency distributions were used to describe the 
participants in terms of age and ethnicity as well as to describe BMD, BF% and BMI 
respectively in terms of the relevant categories of various variables measured.  Descriptive 
statistics were represented by means of tables and graphs.  
According to researchers, inferential statistics are administered to determine conclusions 
based on a set of data, usually the sample that has been selected from the population 
(Gravetter & Wallnau, 2008:7; Laerd, 2013). They can be used to develop overviews of the 
population being tested from the sample that is provided (Gravetter & Wallnau, 2008:7). It can 
be used to correlate between sets of descriptive data and denote whether there is the 
probability of any differences occurring between the sample sets of data (Fouché & Bartley, 
2011:274-275; Laerd, 2013). The inferential statistics used in this study included Pearson-
Product Moment Correlation Coefficients to determine the relationships between BMD, BMI 
and BF% respectively as well as independent t-tests to compare BMD, BMI and BF% 
respectively in relation to selected categories of variables assessed. Both statistical and 
practical significance were determined. Statistical significance was set at p < .05.  
In the case where the Pearson-Product Moment Correlation Coefficient was implemented, 
statistical significance set at p < .05 level for 40 participants resulted in r ≥ 0.312. Practical 
significance within the study was considered when r ≥ 0.300 and overall significance for the 
correlational analysis was set at r ≥ 0.312. 
In the case where independent t-tests were applied, Cohen’s d statistic was used to determine 
the practical significance of differences between means. Cohen’s d depicts an effect size that 
enables the determination of significant relationships (Gravetter & Wallnau, 2008:233). The 
effect size is small when d ≥ 0.2, medium when d ≥ 0.5 and large when d ≥ 0.8 (Gravetter & 
Wallnau, 2008:233). Overall significance was identified when the difference between two 
means revealed an outcome of p < .05 and d > 0.2. The results were analysed with the 
assistance of a consulting statistician at the Nelson Mandela University. 
 
 54 
3.9  ETHICAL CONSIDERATIONS  
Ethics is defined as the philosophy involving the ideas about behaviour in terms of what is 
morally right or wrong (Merriam-Webster, 2017). Ethics revolves around human conduct 
involving the values of men and women, such as obeying the law, abiding by human rights 
and maintaining a safe and healthy environment for research participants (The Business 
Dictionary, 2015). Ethics as summarised by Strydom (2011:114) in the following definition:  
“…a set of moral principles which is suggested by an individual or group, is subsequently 
widely accepted, and which offers rules and behavioural expectations about the most 
correct conduct towards experimental subjects and respondents, employers, sponsors, 
other researchers, assistants and students.” 
For the purpose of this study, ethical considerations were taken into account through firstly 
gaining approval for the research proposal from the University Faculty Postgraduate Studies 
Committee (FPGSC) and subsequently gaining ethics clearance for the study from the 
University Research Ethics Committee-(Human) (see Appendix A for approval letter and 
ethics approval number).   
The researcher ensured that each potential participant was under no obligation to participate 
in the study and ethical conduct was adhered to in terms of gaining voluntary consent from 
the participants to take part in the study (see Appendix C for a copy of the Consent Form). 
Additionally, assurance was given to the participants that their identity would remain 
confidential. This was ensured by using a unique identity code for each participant when their 
data was entered into the Excel spreadsheet for further analysis. Only the researchers had 
the link between the code and the names of the participants and that has been locked away 
securely.  
The participants all received a preamble letter and an informed consent letter along with the 
questionnaire that was emailed to them individually. On arrival the participants returned the 
completed consent form (signed and dated), and again signed a statement to emphasise that 
their participation was completely voluntary and that they were informed of the potential risks 
involved (See Appendix E) and that they were willing to provide information in addition to that 
gathered via the emailed questionnaire. Each participant was briefed, prior to the 
commencement of the testing, about the study and the requirements of completing the study.  
Densitometry assessment utilizing DXA is known for having a low dose of radiation during a 
scan and there is little to no risk of physiological or psychological harm. As informed consent 
was provided, participants were aware of the aims and objectives of this study and were not 
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misled in any way. Each participant was provided with a thorough explanation once in the 
designated lab, about the scans that were to be performed and what the procedures entailed. 
If at any time a participant felt embarrassed, disrespected or had a sense of discomfort, they 
had the opportunity and right to discontinue and to withdraw from the study. No participants 
chose to withdraw from the testing procedures. 
All information obtained from the questionnaire and the DXA scans was kept private and 
remained confidential. Participants remained anonymous throughout the study as codes were 
provided for each participant. Once the scans were completed, the participants were informed 
about their results by the radiographer, based on the auto-analysis run on the bone 
densitometer software. If any concerns were raised from the observations of the scans, the 
participant was informed to seek sound medical advice from a qualified medical practitioner. 
All data was then archived on the system as well as stored safely on an external hard-drive. 
The benefit to the participant was to gain a greater insight on the topic of BMD and the risks 
involved when BMD is not of a recommended standard. Participants received knowledge and 
became more aware of how to prevent or reduce the risks associated with decreased BMD.  
In summary, this chapter focused on the research methodology that was used for the study. 
The research design, the inclusion criteria for the participants involved, the sampling method 
that was incorporated, and how the data collection and analysis of the results was performed, 
were provided. The chapter concluded with ethical considerations and the relevant approval 
that was sought to conduct the study. 
Chapter 4 presents the results of the study that were obtained from the data analysis. The 
results reflect the outcome of both the descriptive and inferential statistical analyses.   
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CHAPTER 4 
RESULTS 
4.1 INTRODUCTION 
This chapter focuses on the results obtained from the study. The focus is on the analysis of 
the results obtained from the questionnaire as well as from the densitometry scans.  
The order in which the results are presented is in line with the objectives of the study. 
Descriptive information pertaining to the sample as well as their BMD, BF% and BMI are 
provided before indicating the relationships with BMD, BF% and BMI respectively. Lastly, the 
relationship of BMD, BF% and BMI respectively with selected variables are reflected.  
4.2 DEMOGRAPHIC PROFILE OF THE POPULATION 
This section on demographics was based on the age and ethnicity of the study participants. A 
total of 40 female long distance runners participated in the study and ranged between the 
ages of 26 to 68. Of the sample population, 10% of the participants were 42 years old, making 
it the largest group of females of the same age.  
Table 4.1 represents the frequency distribution of the different age categories involved in the 
study. From Table 4.1 it is clear that the majority of the participants were between the ages of 
31 and 50 (73%, n = 29). 
Table 4.1: Descriptive Statistics: Frequency distribution of age category 
Age (Years) Number Percentage 
20-30 3 8% 
31-40 12 30% 
41-50 17 43% 
51-60 6 15% 
61-70 2 5% 
Total 40 100% 
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Table 4.2 identifies the representation of ethnicity within the sample.  
Table 4.2: Descriptive Statistics: Frequency distribution for ethnicity 
From Table 4.2 it is clear that almost the entire sample (n = 38; 95%) was white.  
4.3 BMD, BF% AND BMI OF FEMALE LONG DISTANCE RUNNERS 
The first objective of the study was to describe the BMD, BF% and BMI of female long distance 
runners. Descriptive statistical analysis was used for this purpose and incorporated measures 
of central tendency and dispersion as well as frequency distributions. 
4.3.1  Results from the Bone Densitometer utilising the DXA scan 
Table 4.3 depicts the descriptive statistics for the results obtained from the densitometer scans 
of the 40 participants. The table includes the values for the BMD (g/cm²), which comprises the 
BMC (g) per unit of bone area (cm²). The table also presents the Z-scores for all participants, 
but for those participants over the age of 50, the T-scores of the femoral neck, the hip total, 
the lumbar spine and the full body respectively are also given. The results also reflect the 
descriptive statistics for BF% and BMI. 
 
 
 
 
 
 
 
 
Ethnicity Number Percentage 
White 38 95% 
Black 1 3% 
Other 1 3% 
Total 40 100% 
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Table 4.3: Descriptive Statistics: Densitometry data 
  n Mean SD Min 
Quartile 
1 
Median 
Quartile 
3 
Max 
Femoral Neck Area 
(cm²) 
40 4.89 0.45 3.78 4.73 4.89 5.14 5.91 
Femoral Neck BMC (g) 40 4.10 0.65 2.78 3.67 4.14 4.44 5.77 
Femoral Neck BMD 
(g/cm²) 
40 0.84 0.12 0.60 0.75 0.84 0.88 1.23 
Femoral Neck Z-score 40 0.39 0.98 -1.50 -0.45 0.50 0.90 2.40 
Femoral Neck T-score 9 -0.68 0.90 -2.30 -0.80 -0.30 0.00 0.20 
Hip Total Area (cm²) 40 33.52 3.06 27.48 31.61 33.49 35.69 39.48 
Hip Total BMC (g) 40 32.26 4.71 19.90 29.82 32.15 34.52 44.10 
Hip Total BMD (g/cm²) 40 0.96 0.12 0.69 0.87 0.97 1.04 1.26 
Hip Total Z-Score 40 0.48 0.88 -1.30 -0.23 0.60 1.10 2.70 
Hip Total T-score 9 -0.36 0.86 -2.10 -0.80 -0.10 0.20 0.80 
Lumbar Bone Area 
(cm²) 
40 60.52 6.31 41.76 55.73 61.02 65.51 70.63 
Lumbar BMC (g) 40 62.75 12.81 34.54 56.43 61.10 68.45 92.77 
Lumbar BMD (g/cm²) 40 1.03 0.13 0.72 0.94 1.02 1.11 1.34 
Lumbar Z-Score 40 0.31 1.09 -1.80 -0.55 0.35 0.93 2.90 
Lumbar T-score 9 -1.11 0.92 -3.00 -1.50 -1.10 -0.50 0.00 
Total Bone Area (cm²) 40 1965.26 143.10 1532.54 1893.50 1944.18 2021.01 2344.13 
Total BMC (g) 40 2319.32 346.65 1390.27 2108.49 2284.90 2474.12 3582.31 
Total BMD (g/cm²) 40 1.18 0.11 0.91 1.12 1.17 1.22 1.53 
Total Z-Score 40 0.69 1.03 -1.80 0.10 0.55 1.20 4.20 
Total T-score 9 -0.19 1.33 -2.60 -1.00 0.10 0.50 1.70 
Body Fat % 40 26.71 6.33 13.10 22.13 28.00 29.95 39.80 
BMI (kg/m2) 40 22.80 2.58 18.91 20.39 22.95 24.33 29.68 
From the descriptive statistics of the bone densitometry results depicted in Table 4.3, the 
mean score for BMD was found to be largest for the total body and the lowest for the femoral 
neck. The mean values for the Z-scores were found to be largest for the total body and lowest 
for the lumbar spine. The mean values for the T-scores were found to be greatest in the total 
body and lowest in the lumbar spine. The mean Z-scores and the mean T-scores were similar 
in that they presented the same order of strength. The total body was found to be the greatest, 
followed by the hip total, then the femoral neck and lastly the lumbar spine, which was found 
to be the lowest for both the Z-scores and T-scores. Overall, the mean Z-scores were all 
positive and were greater than the mean T-scores. 
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4.3.2 Body Mass Index (BMI) 
The BMI data obtained was categorised and interpreted according to the ACSM (2014:63) 
normative data referred to in Chapter 2 and reflected in Table 4.4 as either normal or 
overweight.  
Table 4.4: Descriptive Statistics: Frequency distribution of the BMI category 
BMI Rating Number Percentage 
Normal 34 85% 
Overweight 6 15% 
Total 40 100% 
From Table 4.4 it is evident that most (n = 34, 85%) of the participants were categorized as 
normal. The overall mean BMI of 22.81 ± 2.58 kg/m² (reflected in Table 4.3) was also rated 
as normal. 
4.3.3 Body Fat Percentage (BF%) 
As part of the whole-body scan, a mean BF% of 26.71 ± 6.33% (Table 4.3) was recorded from 
the analysis by the bone densitometer. The BF% ratings were then interpreted according to 
the ACSM (2008:59) general population classification criteria referred to in Chapter 2 (Table 
2.2) and reflected in Table 4.5. 
Table 4.5: Descriptive Statistics: Frequency distribution of the BF% categories 
BF% Ratings Number Percentage 
Excellent 7 18% 
Good 7 18% 
Average 6 15% 
Below Average 12 30% 
Poor 8 20% 
Total 40 100% 
Table 4.5 indicates that a total of 50% of the participants fell in the below average to poor 
category in respect to their BF% even though the mean BF% was rated as average. The BF% 
categories are according to pre-determined normative data in relation to age. 
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4.4 RELATIONSHIP OF BMD WITH BF% AND BMI RESPECTIVELY 
The second objective of the study was to determine the relationship between the BMD of 
female long distance runners in relation to BF% and BMI respectively. The statistical analysis 
was conducted with the use of the Pearson-Product Moment Correlation Coefficients to reflect 
the relationships that occurred. Table 4.6 indicates the relationship between BMD and BF% 
and BMI respectively. 
Table 4.6: Inferential Statistics: Correlation of BMD variables with BF% and BMI 
respectively 
  BF % BMI 
Femoral Neck BMD (g/cm²) .049 .300 
Femoral Neck Z-score .163 .415 
Hip Total BMD (g/cm²) -.014 .271 
Hip Total Z-Score .085 .370 
Lumbar BMD (g/cm²) .105 .339 
Lumbar Z-Score .263 .444 
Total BMD (g/cm²) -.072 .258 
Total Z-Score -.007 .334 
From Table 4.6, it is evident that there were no significant correlations (r < 0.312) between 
BMD variables and BF%. However, the femoral neck, the hip total, the lumbar spine and the 
total body Z-scores as well as the lumbar spine BMD (g/cm²), which are indicated in bold red, 
presented with both statistical and practical significant correlations with BMI. 
4.5 RELATIONSHIPS OF BMD, BF% AND BMI RESPECTIVELY WITH SELECTED 
VARIABLES  
The third objective of the study was to determine the relationship of BMD, BF% and BMI 
respectively with each of the following variables: age, anthropometric measurements, female 
reproductive variables, bone health indicators, disease history, medication, lifestyle factors, 
training load, running shoe and running style. The statistical analysis was conducted via the 
use of t-tests to determine if there were any statistically significant differences between the 
relevant sample mean scores.  
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4.5.1 The Relationship of BMD, BF% and BMI respectively with Age 
Table 4.7 indicates the differences between younger (aged 20-40 years) and older (aged 41-
70 years) runners in respect of BMD variables, BF% and BMI respectively. 
Table 4.7: Inferential Statistics: Comparisons between categories of age in respect of   
BMD variables, BF% and BMI 
Variable 
Age 
Category 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Younger  15 0.87 0.15 
0.05 1.25 .220 n/a 
Older  25 0.82 0.10 
Femoral neck Z-score 
Younger  15 0.27 1.12 
-0.20 -0.61 .543 n/a 
Older 25 0.46 0.89 
Hip Total BMD (g/cm²) 
Younger  15 0.99 0.14 
0.04 1.05 .302 n/a 
Older 25 0.95 0.10 
Hip Total Z-Score 
Younger  15 0.38 1.03 
-0.16 -0.57 .574 n/a 
Older 25 0.54 0.79 
Lumbar BMD (g/cm²) 
Younger 15 1.03 0.11 
0.00 0.11 .916 n/a 
Older 25 1.03 0.14 
Lumbar Z-Score 
Younger 15 -0.11 0.93 
-0.68 -1.98 .055 n/a 
Older 25 0.57 1.12 
Total BMD (g/cm²) 
Younger 15 1.18 0.11 
0.01 0.26 .795 n/a 
Older 25 1.17 0.11 
Total Z-Score 
Younger 15 0.61 1.14 
-0.13 -0.37 .715 n/a 
Older 25 0.73 0.98 
Body Fat % 
Younger 15 26.69 5.07 
-0.03 -0.01 .988 n/a 
Older 25 26.72 7.08 
BMI (kg/m²) 
Younger 15 23.25 2.39 
0.71 0.84 .406 n/a 
Older 25 22.54 2.70 
Table 4.7 reflects no statistically significant differences between the younger and older age 
categories for either BMD variables, BF% or BMI. The mean density values for the femoral 
neck, the hip total, the lumbar spine and total body BMD were non-significantly greater in the 
younger runners (20-40 years) than in the older runners (41-70 years). However, the Z-scores 
of the femoral neck, the hip total, the lumbar spine and total body were greater in the older 
age category (41 to 70 years) compared to the younger age category (20 to 40 years). 
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4.5.2 The Relationship of BMD and BF% respectively with BMI  
Table 4.8 indicates the differences between runners classified as having a normal BMI (< 
25.99 kg/m2) and those classified as being overweight (BMI > 30kg/m2) in respect of BMD and 
BF% respectively.  
Table 4.8: Inferential Statistics: Comparisons between categories of BMI in respect of 
BMD variables and BF% 
Variable BMI Category n Mean SD Diff t p(df =38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Normal 34 0.83 0.12 
-0.07 -1.23 .226 n/a 
Overweight 6 0.90 0.12 
Femoral neck Z-score 
Normal 34 0.25 0.95 
-0.91 -2.22 .033 0.98*** 
Overweight 6 1.17 0.75 
Hip Total BMD (g/cm²) 
Normal 34 0.95 0.11 
-0.06 -1.24 .221 n/a 
Overweight 6 1.02 0.14 
Hip Total Z-Score 
Normal 34 0.36 0.84 
-0.80 -2.16 .037 0.96*** 
Overweight 6 1.17 0.82 
Lumbar BMD (g/cm²) 
Normal 34 1.02 0.13 
-0.06 -1.00 .323 n/a 
Overweight 6 1.08 0.14 
Lumbar Z-Score 
Normal 34 0.19 1.10 
-0.85 -1.81 .079 n/a 
Overweight 6 1.03 0.70 
Total BMD (g/cm²) 
Normal 34 1.17 0.09 
-0.05 -1.07 .292 n/a 
Overweight 6 1.22 0.17 
Total Z-Score 
Normal 34 0.58 0.91 
-0.72 -1.62 .114 n/a 
Overweight 6 1.30 1.53 
Body Fat % 
Normal 34 25.57 6.02 
-7.63 -2.99 .005 1.32*** 
Overweight 6 33.20 3.77 
Small *, Medium**, Large***  
From Table 4.8 it can be seen that the femoral neck and hip total Z-scores were significantly 
higher in runners classified as overweight than those identified as being of normal weight.  As 
to be expected, BF% was also significantly higher in overweight runners.  All three of these 
statistical differences had large effect sizes (p = .033; d = 0.98 for femoral neck; p = .037; d = 
0.96 for hip total and p = .005; d = 1.32 for BF%).  
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The mean values of BMD and the Z-scores for the femoral neck, the hip total, the lumbar spine 
and the total body were non-significantly greater in those classified as overweight (n = 6) 
compared to those who were classified as having a normal weight (n = 34).  
Table 4.9 indicates the difference between the two BF% categories in respect of the various 
BMD variables and BMI respectively. The two categories are Above Average, which refers to 
those who were classified as having an average or a good BF% and Below Average, which 
refers to those who were considered as having a poor BF%.  
Table 4.9: Inferential Statistics: Comparisons between categories of BF% in respect of 
BMD variables and BMI 
Variable 
Body Fat% 
Categories 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Above Average  20 0.83 0.09 
-0.02 -0.54 .595 n/a 
Below Average  20 0.85 0.15 
Femoral neck Z-score 
Above Average  20 0.32 0.85 
-0.14 -0.45 .656 n/a 
Below Average  20 0.46 1.11 
Hip Total BMD (g/cm²) 
Above Average 20 0.96 0.10 
-0.01 -0.33 .747 n/a 
Below Average  20 0.97 0.13 
Hip Total Z-Score 
Above Average 20 0.45 0.81 
-0.08 -0.27 .791 n/a 
Below Average  20 0.52 0.96 
Lumbar BMD (g/cm²) 
Above Average 20 1.01 0.12 
-0.04 -1.03 .311 n/a 
Below Average  20 1.05 0.13 
Lumbar Z-Score 
Above Average 20 0.14 1.09 
-0.36 -1.03 .309 n/a 
Below Average  20 0.49 1.09 
Total BMD (g/cm²) 
Above Average 20 1.17 0.11 
0.00 -0.14 .892 n/a 
Below Average  20 1.18 0.11 
Total Z-Score 
Above Average 20 0.65 1.01 
-0.08 -0.24 .810 n/a 
Below Average  20 0.73 1.08 
BMI (kg/m²) 
Above Average 20 21.16 1.64 
-3.28 -5.19 <.0005 1.64*** 
Below Average  20 24.45 2.30 
Small *, Medium**, Large***  
From Table 4.9 it can be deduced that only the mean BMI differed significantly between the 
two BF% categories (p < .0005; d = 1.64) with the higher mean value of 24.45 kg/m² being 
associated with the Below Average category, whereas the lower mean value of 21.16 kg/m² 
represents the Above Average category. The Below Average BF% category was associated 
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with the higher BMD and Z-score values in the case of all the BMD variables, but these 
differences were insignificant.  
4.5.3 The Relationship of BMD, BF% and BMI respectively with Female 
Reproductive Variables 
Table 4.10 indicates the relationships of BMD, BF% and BMI respectively with menarche. For 
the analysis, the participants were classified as “early” starters if menarche occurred between 
10 and 12 years of age, or “late” starters if menarche occurred when they were 13 years or 
older.  
Table 4.10: Inferential Statistics: Comparisons between categories of menarche in 
respect of BMD variables, BF% and BMI 
Variable Menarche n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Early 11 0.85 0.14 
0.01 0.22 .825 n/a 
Late 29 0.84 0.12 
Femoral neck Z-score 
Early 11 0.55 1.17 
0.21 0.62 .542 n/a 
Late 29 0.33 0.91 
Hip Total BMD (g/cm²) 
Early 11 0.98 0.12 0.03 
 
0.70 
 
.491 
 
n/a 
 Late 29 0.95 0.12 
Hip Total Z-Score 
Early 11 0.70 0.97 
0.30 0.96 .341 n/a 
Late 29 0.40 0.85 
Lumbar BMD (g/cm²) 
Early 11 1.01 0.12 
-0.03 -0.60 .554 n/a 
Late 29 1.04 0.13 
Lumbar Z-Score 
Early 11 0.23 1.04 
-0.12 -0.30 .765 n/a 
Late 29 0.34 1.13 
Total BMD (g/cm²) 
Early 11 1.19 0.13 
0.02 0.53 .599 n/a 
Late 29 1.17 0.10 
Total Z-Score 
Early 11 0.89 1.28 
0.28 0.77 .444 n/a 
Late 29 0.61 0.93 
Body Fat % 
Early 11 26.93 5.89 
0.30 0.13 .897 n/a 
Late 29 26.63 6.59 
BMI (kg/m²) 
Early 11 23.48 2.98 
0.93 1.02 .313 n/a 
Late 29 22.55 2.42 
From Table 4.10 it is clear that whether the runner experienced menarche early (10-12 years) 
or late (13 years and older) it did not affect BMD, BF% or BMI significantly differently. It can 
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be noted that BF% and BMI are higher in the younger compared to the older age category. 
These differences were not significant. 
Table 4.11 reflects the comparison between the two categories of full-term pregnancies (none 
versus one or more) in relation to BMD variables, BF% and BMI respectively.  
Table 4.11: Inferential Statistics: Comparison between categories of full-term 
pregnancies in respect of BMD variables, BF% and BMI 
Variable 
Pregnancy 
grouped 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
None 12 0.90 0.11 
0.09 2.10 .043 0.72** 
One or more 28 0.81 0.12 
Femoral neck Z-score 
None 12 0.72 1.06 
0.47 1.40 .169 n/a 
One or more 28 0.25 0.92 
Hip Total BMD (g/cm²) 
None 12 1.01 0.13 
0.07 1.86 .071 n/a 
One or more 28 0.94 0.11 
Hip Total Z-Score 
None 12 0.73 1.10 
0.36 1.19 .242 n/a 
One or more 28 0.38 0.76 
Lumbar BMD (g/cm²) 
None 12 1.05 0.15 
0.03 0.65 .518 n/a 
One or more 28 1.02 0.12 
Lumbar Z-Score 
None 12 0.23 1.33 
-0.13 -0.33 .744 n/a 
One or more 28 0.35 1.00 
Total BMD (g/cm²) 
None 12 1.19 0.12 
0.03 0.74 .463 n/a 
One or more 28 1.17 0.10 
Total Z-Score 
None 12 0.83 1.24 
0.21 0.59 .558 n/a 
One or more 28 0.62 0.94 
Body Fat % 
None 12 26.83 5.04 
0.17 0.08 .938 n/a 
One or more 28 26.66 6.89 
BMI (kg/m²) 
None 12 23.89 2.74 
1.55 1.79 .082 n/a 
One or more 28 22.34 2.41 
Small *, Medium**, Large***  
Table 4.11 indicates that the mean femoral neck BMD differed significantly between the two 
pregnancy categories. Participants who had no children had a significantly higher mean 
femoral neck BMD (0.90 g/cm²) than those who had one or more children (0.81 g/cm²) (p = 
.043; d = 0.72). None of the other variables were significantly different between those who 
had, and who did not have full-term pregnancies. 
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Table 4.12 indicates the difference between mean values of BMD, BF% and BMI respectively 
in relation to the use of contraception. 
Table 4.12: Inferential Statistics: Comparisons between use and non-use of 
contraceptives in respect of BMD variables, BF% and BMI 
Variable 
Contraceptive 
medication 
n Mean SD Diff t p(df=38) Cohen’s d 
Femoral neck BMD (g/cm²) 
Yes 33 0.84 0.12 
0.02 0.36 .719 n/a 
No 7 0.82 0.14 
Femoral neck Z-score 
Yes 33 0.42 0.94 
0.20 0.48 .636 n/a 
No 7 0.23 1.19 
Hip Total BMD (g/cm²) 
Yes 33 0.96 0.12 
-0.01 -0.21 .837 n/a 
No 7 0.97 0.13 
Hip Total Z-Score 
Yes 33 0.48 0.87 
-0.04 -0.10 .918 n/a 
No 7 0.51 1.01 
Lumbar BMD (g/cm²) 
Yes 33 1.02 0.12 
-0.05 -0.96 .342 n/a 
No 7 1.07 0.16 
Lumbar Z-Score 
Yes 33 0.23 1.04 
-0.45 -1.00 .325 n/a 
No 7 0.69 1.32 
Total BMD (g/cm²) 
Yes 33 1.17 0.11 
-0.01 -0.25 .803 n/a 
No 7 1.18 0.09 
Total Z-Score 
Yes 33 0.68 1.08 
-0.04 -0.08 .935 n/a 
No 7 0.71 0.80 
Body Fat % 
Yes 33 26.59 6.40 
-0.69 -0.26 .796 n/a 
No 7 27.29 6.45 
BMI (kg/m²) 
Yes 33 22.92 2.58 0.65 
 
0.60 
 
.550 
 
n/a 
No 7 22.27 2.71 
The BMD, BF% and BMI values as depicted in Table 4.12 were not significantly different 
between those who used contraception and those who did not use contraception. However, 
the majority of the participants did or are still using contraception (n = 33).  
Table 4.13 reflects the difference between two categories of contraception and the BMD 
variables, BF% and BMI values respectively. The types of contraception have been grouped 
into two categories, namely hormonal contraception such as the pill, the patch and the 
injection and barrier methods such as the copper T IUD and the diaphragm. The categories 
of contraception used are based on the participants’ answers provided in the questionnaire. 
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Table 4.13: Inferential Statistics: Comparison between contraceptive types in respect 
of BMD variables, BF% and BMI 
Variable Contraceptive Type n 
Mea
n 
SD Diff t p(df=19) 
Cohen's 
d 
Femoral neck 
BMD (g/cm²) 
Hormonal 12 0.85 0.11 
-0.02 -0.29 .774 n/a 
Barrier Methods 9 0.87 0.17 
Femoral neck Z-
score 
Hormonal 12 0.38 1.00 
-0.24 -0.52 .606 n/a 
Barrier Methods 9 0.62 1.08 
Hip Total BMD 
(g/cm²) 
Hormonal 12 0.99 0.12 
0.04 0.61 .547 n/a 
Barrier Methods 9 0.95 0.16 
Hip Total Z-Score 
Hormonal 12 0.63 1.03 
0.24 0.53 .600 n/a 
Barrier Methods 9 0.39 0.97 
Lumbar BMD 
(g/cm²) 
Hormonal 12 1.03 0.14 
0.03 0.50 .625 n/a 
Barrier Methods 9 1.00 0.14 
Lumbar Z-Score 
Hormonal 12 0.20 1.19 
0.09 0.17 .864 n/a 
Barrier Methods 9 0.11 1.12 
Total BMD 
(g/cm²) 
Hormonal 12 1.20 0.13 
0.05 1.02 .322 n/a 
Barrier Methods 9 1.14 0.10 
Total Z-Score 
Hormonal 12 0.90 1.29 
0.53 1.05 .305 n/a 
Barrier Methods 9 0.37 0.92 
Body Fat % 
Hormonal 12 
27.1
5 
4.58 
0.22 0.08 .940 n/a 
Barrier Methods 9 
26.9
3 
8.32 
BMI (kg/m²) 
Hormonal 12 
23.6
0 
2.87 
1.47 1.27 .221 n/a 
Barrier Methods 9 
22.1
3 
2.26 
There were no significant differences in the mean scores of the BMD variables, BF% and BMI 
respectively, between the types of contraception used as reflected in Table 4.13. A trend can 
be noted where the mean values for BF% (27.15%) and BMI (23.60 kg/m²) respectively are 
greater in those who use hormonal contraception than the mean value for BF% (26.93%) and 
BMI (22.13 kg/m²) of the barrier method category but these differences were insignificant. 
Table 4.14 indicates the relationship of BMD, BF% and BMI respectively between whether or 
not the participants are menopausal. The two categories reflected were ‘yes’ and ‘no’. Those 
who are currently menopausal said ‘yes’ and those who said ‘no’ were not experiencing any 
symptoms of menopause. Two participants were excluded from the analysis as they were 
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unsure about their status as they were not officially menopausal but were experiencing certain 
symptoms relative to menopause. 
Table 4.14: Inferential Statistics: Comparison between menopausal and non-
menopausal women in respect of BMD variables, BF% and BMI 
Variable Menopausal n Mean SD Diff t p(df=36) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Yes 8 0.76 0.11 
-0.09 -2.24 .031 0.89*** 
No 30 0.85 0.10 
Femoral neck Z-score 
Yes 8 0.26 1.13 
-0.11 -0.30 .768 n/a 
No 30 0.38 0.92 
Hip Total BMD (g/cm²) 
Yes 8 0.90 0.11 
-0.08 -1.73 .092 n/a 
No 30 0.97 0.11 
Hip Total Z-Score 
Yes 8 0.39 0.98 
-0.09 -0.24 .812 n/a 
No 30 0.47 0.88 
Lumbar BMD (g/cm²) 
Yes 8 0.92 0.11 
-0.13 -2.71 .010 1.08*** 
No 30 1.05 0.12 
Lumbar Z-Score 
Yes 8 0.04 1.14 
-0.31 -0.70 .487 n/a 
No 30 0.35 1.11 
Total BMD (g/cm²) 
Yes 8 1.10 0.11 
-0.09 -2.21 .034 0.88*** 
No 30 1.20 0.11 
Total Z-Score 
Yes 8 0.24 1.12 
-0.61 -1.47 .149 n/a 
No 30 0.84 1.01 
Body Fat % 
Yes 8 31.28 5.35 
6.24 2.75 .009 1.09*** 
No 30 25.03 5.79 
BMI (kg/m²) 
Yes 8 23.14 2.63 
0.52 0.49 .629 n/a 
No 30 22.63 2.67 
Small *, Medium**, Large***  
Table 4.14 indicates that menopausal runners had significantly lower femoral neck BMD (p = 
.031; d = 0.89), lumbar BMD (p = .010; d = 1.08) and total BMD (p = .034; d = 0.88) scores 
than their non-menopausal counterparts but they had a significantly higher BF% (p = .009; d 
= 1.09) than non-menopausal runners.   
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4.5.4 The Relationship of BMD, BF% and BMI respectively with Bone Health 
Indicators 
Table 4.15 indicates the differences of BMD, BF% and BMI in relation to the incidence of 
broken bones due to a traumatic event. The two categories consisted of ‘yes’ if any bone was 
broken due to a traumatic event such as a motor vehicle accident and ‘no’ if no bones were 
broken due to a traumatic event. 
Table 4.15: Inferential Statistics: Comparison between trauma related incidence and 
non-incidence of broken bones in respect of BMD variables, BF% and BMI 
Variable 
Broken Bone(s) 
(trauma) 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Yes 6 0.84 0.14 
0.00 0.06 .955 n/a 
No 34 0.84 0.12 
Femoral neck Z-score 
Yes 6 0.35 1.00 
-0.05 -0.11 .915 n/a 
No 34 0.40 0.99 
Hip Total BMD (g/cm²) 
Yes 6 0.96 0.16 
-0.01 -0.14 .890 n/a 
No 34 0.96 0.11 
Hip Total Z-Score 
Yes 6 0.38 1.06 
-0.12 -0.30 .769 n/a 
No 34 0.50 0.86 
Lumbar BMD (g/cm²) 
Yes 6 0.95 0.13 
-0.09 -1.61 .115 n/a 
No 34 1.04 0.13 
Lumbar Z-Score 
Yes 6 -0.47 0.94 
-0.92 -1.97 .057 n/a 
No 34 0.45 1.07 
Total BMD (g/cm²) 
Yes 6 1.14 0.12 
-0.04 -0.76 .452 n/a 
No 34 1.18 0.11 
Total Z-Score 
Yes 6 0.35 1.06 
-0.39 -0.86 .395 n/a 
No 34 0.74 1.03 
Body Fat % 
Yes 6 22.48 5.31 
-4.98 -1.83 .076 n/a 
No 34 27.46 6.27 
BMI (kg/m²) 
Yes 6 20.67 1.41 
-2.51 -2.32 .026 1.03*** 
No 34 23.18 2.57 
Small *, Medium**, Large***  
In Table 4.15 only the mean BMI differed significantly between the two categories of having 
broken a bone due to a traumatic event. Participants who had not broken a bone due to a 
traumatic event had a significantly higher mean BMI compared to those who had broken a 
bone due to a traumatic event (p = .026; d = 1.03). It should also be noted that the mean BMD 
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Z-score values of the femoral neck, the hip total, the lumbar spine and the total body as well 
as the mean values for BF% were lower in those who had broken a bone in their lifetime (n = 
6) due to a traumatic event compared to those who had not (n = 34). These differences were 
not significant. 
Table 4.16 indicates the differences of BMD, BF% and BMI respectively in relation to broken 
bones not due to a traumatic event.  The two categories compared consisted of ‘yes’ if a bone 
was broken due to a non-traumatic event such as a genetic disorder or bone disease, namely 
osteoporosis and ‘no’ if no bone(s) were broken due to a non-traumatic event. 
Table 4.16: Inferential Statistics: Comparison between non-traumatic related 
incidence and non-incidence of broken bones in respect of BMD variables, 
BF% and BMI 
Variable 
Broken Bone(s) 
(no trauma) 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Yes 9 0.82 0.09 
-0.03 -0.54 .589 n/a 
No 31 0.84 0.13 
Femoral neck Z-score 
Yes 9 0.37 0.89 
-0.03 -0.08 .936 n/a 
No 31 0.40 1.01 
Hip Total BMD (g/cm²) 
Yes 9 0.93 0.07 
-0.04 -0.99 .329 n/a 
No 31 0.97 0.13 
Hip Total Z-Score 
Yes 9 0.32 0.77 
-0.21 -0.62 .541 n/a 
No 31 0.53 0.91 
Lumbar BMD (g/cm²) 
Yes 9 1.00 0.07 
-0.03 -0.67 .504 n/a 
No 31 1.04 0.14 
Lumbar Z-Score 
Yes 9 0.22 0.62 
-0.12 -0.28 .782 n/a 
No 31 0.34 1.20 
Total BMD (g/cm²) 
Yes 9 1.15 0.05 
-0.03 -0.83 .410 n/a 
No 31 1.18 0.12 
Total Z-Score 
Yes 9 0.50 0.44 
-0.24 -0.61 .548 n/a 
No 31 0.74 1.15 
Body Fat % 
Yes 9 27.06 6.28 
0.44 0.18 .856 n/a 
No 31 26.61 6.44 
BMI (kg/m²) 
Yes 9 23.19 2.33 
0.50 0.51 .615 n/a 
No 31 22.69 2.67 
Table 4.16 indicates that the mean scores for runners who had suffered a non-traumatic break 
of a bone was lower across all variables, except for BF% and BMI, where their mean scores 
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were higher than those who had not sustained a non-traumatic break. These differences were 
not significant. 
Table 4.17 indicates the relationship of BMD, BF% and BMI respectively in relation to a family 
history of osteoporosis. The two categories consisted of ‘yes’ for those who do have a family 
history and a genetic predisposition to osteoporosis and ‘no’ for those who do not have any 
genetic influences for osteoporosis. 
Table 4.17: Inferential Statistics: Comparison between a positive and negative 
osteoporosis family history in respect of BMD variables, BF% and BMI 
Variable 
Osteoporos
is History 
n 
Mea
n 
SD Diff t p(df=32) 
Cohen’s 
d 
Femoral neck BMD 
(g/cm²) 
Yes 8 0.85 0.08 
-0.02 -0.40 .693 n/a 
No 26 0.87 0.13 
Femoral neck Z-score 
Yes 8 0.25 0.70 
-0.40 -1.07 .291 n/a 
No 26 0.65 0.98 
Hip Total BMD (g/cm²) 
Yes 8 0.99 0.07 
0.01 0.18 .855 n/a 
No 26 0.98 0.12 
Hip Total Z-Score 
Yes 8 0.56 0.54 
-0.10 -0.30 .769 n/a 
No 26 0.66 0.89 
Lumbar BMD (g/cm²) 
Yes 8 1.01 0.07 
-0.05 -1.06 .296 n/a 
No 26 1.06 0.13 
Lumbar Z-Score 
Yes 8 -0.11 0.68 
-0.74 -1.88 .069 n/a 
No 26 0.63 1.05 
Total BMD (g/cm²) 
Yes 8 1.21 0.07 
0.03 0.62 .539 n/a 
No 26 1.19 0.11 
Total Z-Score 
Yes 8 0.96 0.67 
0.17 0.43 .670 n/a 
No 26 0.79 1.05 
Body Fat % 
Yes 8 22.84 4.97 
-4.60 -1.89 .068 n/a 
No 26 27.44 6.30 
BMI (kg/m²) 
Yes 8 21.63 2.07 
-1.67 -1.58 .124 n/a 
No 26 23.30 2.75 
Table 4.17 reflects no significant differences between mean scores for BMD, BF% and BMI 
respectively in relation to a family history of osteoporosis.  
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The occurrence of a hip fracture in parents can be indicative of a family history of osteoporosis. 
Figure 4.1 provides an indication of those participants who have a family history of 
osteoporosis and/or having one or both parents presenting with a hip fracture.  
 
Figure 4.1: Family History of Osteoporosis in relation to parental hip fracture 
Due to the small incidence of family history of osteoporosis and parental hip fracture, no further 
analysis of this factor was justified.  
4.5.5 Health Disorders and Daily Medication 
The prevalence of chronic diseases in the sample was assessed. Of the 40 participants, 
22.5% (n = 9) were living with a chronic disease. Table 4.18 indicates the distribution of chronic 
diseases among the research participants. 
Table 4.18: Descriptive Statistics: Frequency distribution of the incidence of identified 
health disorders 
Health Disorders Number Percentage 
Ankylosing Spondylitis 2 22% 
HIV + 1 11% 
Hypertension 1 11% 
Stage 3 Melanoma 2 22% 
Under Active Thyroid 1 11% 
Cancer 1 11% 
Arthritis 1 11% 
Total 9 100% 
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According to Table 4.18, the most prevalent health disorders among the 9 participants was 
Ankylosing Spondylitis (22%, n = 2) and stage 3 melanoma (22%, n = 2). Only 9 of the 
participants were living with a health disorder. This is a small number in comparison to the 
sample size of 40 participants. As the number was so low it was not possible to determine the 
effect of any of these health disorders on BMD, BMI and BF% respectively.  
The prevalence of medical conditions in the sample was also assessed and the following were 
predetermined conditions from which the participants could select. Of the 40 participants, 15% 
(n = 6) were living with a medical condition. Table 4.19 indicates the distribution of medical 
conditions among the research participants.  
Table 4.19: Descriptive Statistics: Frequency distribution of the types of medical 
conditions 
Medical Conditions Number Percentage 
None 34 85% 
Asthma or Emphysema 2 5% 
Cancer 1 3% 
Polycystic ovaries 1 3% 
Hypogonadotropic Hypogonadism 1 3% 
Anorexia or Bulimia 1 3% 
Total 40 100% 
According to Table 4.19, the most prevalent medical conditions among the 6 participants were 
asthma and emphysema (5%, n = 2). As only 6 of the participants were living with a medical 
condition it was not possible to determine the effect of any of these predetermined medical 
conditions on BMD, BMI and BF% respectively. 
Table 4.20 indicates the mean scores of BMD, BF% and BMI respectively in relation to those 
who take medication daily. The two categories consisted of ‘yes’ for those who consume any 
medication on a daily basis regardless of the type, and ‘no’ for those who do not consume any 
medication daily. 
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Table 4.20: Inferential Statistics: Comparisons between daily and non-daily intake of 
medication in respect of BMD variables, BF% and BMI 
Variable 
Daily 
medication 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Yes 25 0.83 0.11 
-0.02 -0.49 .625 n/a 
No 15 0.85 0.14 
Femoral neck Z-score 
Yes 25 0.37 1.00 
-0.05 -0.15 .883 n/a 
No 15 0.42 0.97 
Hip Total BMD (g/cm²) 
Yes 25 0.96 0.11 
-0.01 -0.35 .731 n/a 
No 15 0.97 0.13 
Hip Total Z-Score 
Yes 25 0.46 0.91 
-0.05 -0.17 .866 n/a 
No 15 0.51 0.86 
Lumbar BMD (g/cm²) 
Yes 25 1.01 0.12 
-0.04 -0.92 .363 n/a 
No 15 1.05 0.14 
Lumbar Z-Score 
Yes 25 0.21 0.97 
-0.27 -0.75 .459 n/a 
No 15 0.48 1.29 
Total BMD (g/cm²) 
Yes 25 1.16 0.11 
-0.03 -0.94 .355 n/a 
No 15 1.20 0.10 
Total Z-Score 
Yes 25 0.58 1.11 
-0.29 -0.86 .395 n/a 
No 15 0.87 0.90 
Body Fat % 
Yes 25 26.82 5.53 
0.30 0.14 .888 n/a 
No 15 26.53 7.69 
BMI (kg/m²) 
Yes 25 23.20 2.51 
1.05 1.26 .215 n/a 
No 15 22.15 2.64 
As reflected in Table 4.20, there were no significant differences found between the mean 
scores for BMD, BF% and BMI respectively in relation to the intake of medication on a daily 
basis. A trend can be noted in that the mean values for the BMD and the relevant Z-scores of 
the femoral neck, hip total, lumbar spine and total body are lower in those who do take 
medication daily (n = 25) than in those who do not take daily medication (n = 15). The 
differences were insignificant.  
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4.5.6 The Relationship between BMD, BF% and BMI respectively and Lifestyle 
Factors 
Table 4.21 indicates the differences in mean values for BMD, BF% and BMI respectively in 
relation to smoking cigarettes. The categories include ‘yes’ for those who currently smoke or 
who have smoked in the past, and ‘no’ for those who have never smoked cigarettes.  
Table 4.21: Inferential Statistics: Comparisons between cigarette smokers and non-
cigarette smokers in respect of BMD variables, BF% and BMI 
Variable Smoking n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Yes 9 0.84 0.08 
0.00 0.00 .998 n/a 
No 31 0.84 0.13 
Femoral neck Z-score 
Yes 9 0.34 0.88 
-0.06 -0.16 .876 n/a 
No 31 0.40 1.01 
Hip Total BMD (g/cm²) 
Yes 9 0.93 0.08 
-0.04 -0.88 .386 n/a 
No 31 0.97 0.13 
Hip Total Z-Score 
Yes 9 0.20 0.73 
-0.36 -1.10 .279 n/a 
No 31 0.56 0.91 
Lumbar BMD (g/cm²) 
Yes 9 1.07 0.08 
0.05 1.00 .323 n/a 
No 31 1.02 0.14 
Lumbar Z-Score 
Yes 9 0.58 0.73 
0.34 0.83 .414 n/a 
No 31 0.24 1.17 
Total BMD (g/cm²) 
Yes 9 1.19 0.09 
0.02 0.57 .575 n/a 
No 31 1.17 0.11 
Total Z-Score 
Yes 9 0.83 0.84 
0.19 0.49 .630 n/a 
No 31 0.64 1.09 
Body Fat % 
Yes 9 27.26 5.65 
0.70 0.29 .774 n/a 
No 31 26.55 6.59 
BMI (kg/m²) 
Yes 9 23.49 2.19 
0.88 0.90 .373 n/a 
No 31 22.61 2.68 
There were no significant differences depicted in Table 4.21 between mean scores for BMD, 
BF% and BMI respectively of those who have smoked or are currently smoking and those who 
have not and do not smoke. 
Table 4.22 indicates the differences in mean values of BMD, BF% and BMI respectively in 
relation to drinking alcoholic beverages. The two categories consisted of ‘yes’ for those who 
do drink alcoholic beverages and ‘no’ for those who do not drink alcoholic beverages. 
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Table 4.22: Inferential Statistics: Comparisons between alcohol consumption and 
non-alcohol consumption in respect of BMD variables, BF% and BMI 
Variable Alcohol n Mean SD Difference t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Yes 34 0.84 0.12 
0.01 0.15 .879 n/a 
No 6 0.83 0.13 
Femoral neck Z-score 
Yes 34 0.35 1.00 
-0.29 -0.66 .515 n/a 
No 6 0.63 0.89 
Hip Total BMD (g/cm²) 
Yes 34 0.97 0.12 
0.03 0.59 .556 
n/a 
 No 6 0.94 0.14 
Hip Total Z-Score 
Yes 34 0.48 0.88 
-0.02 -0.05 .959 n/a 
No 6 0.50 0.95 
Lumbar BMD (g/cm²) 
Yes 34 1.05 0.12 
0.12 2.16 .037 0.96*** 
No 6 0.93 0.11 
Lumbar Z-Score 
Yes 34 0.42 1.10 
0.70 1.47 .149 n/a 
No 6 -0.28 0.91 
Total BMD (g/cm²) 
Yes 34 1.18 0.11 
0.04 0.73 .470 n/a 
No 6 1.15 0.13 
Total Z-Score 
Yes 34 0.72 1.01 
0.24 0.51 .610 n/a 
No 6 0.48 1.22 
Body Fat % 
Yes 34 27.20 5.81 
3.27 1.17 .249 n/a 
No 6 23.93 8.88 
BMI (kg/m²) 
Yes 34 22.92 2.48 
0.74 0.64 .524 n/a 
No 6 22.18 3.29 
Small *, Medium**, Large***  
The mean lumbar BMD value differed significantly between those participants who drink 
alcoholic beverages and those who do not, as indicated in Table 4.22. Participants who do 
consume alcoholic beverages had a significantly higher mean lumbar BMD compared to those 
who do not consume alcoholic beverages (p = .037; d = 0.96). 
Although not significant, the mean values for the BMD of the femoral neck, hip total, lumbar 
spine and total body are also higher in those who do drink alcoholic beverages (n = 34) 
compared to those who do not. The mean values for the BMI and BF% is higher in those who 
drink alcoholic beverages compared to those who do not but the differences were not 
significant. 
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Table 4.23 indicates the differences in mean values of BMD, BF% and BMI respectively in 
relation to the number of alcoholic beverages consumed in a week. The two categories are 
classified as ≤5 (between 1 and 5 alcoholic beverages) and >5 (more than 5 alcoholic 
beverages) consumed per week. 
Table 4.23: Inferential Statistics: Comparison between the categories of the weekly 
intake of alcoholic beverages in respect to BMD variables, BF% and BMI 
Variable 
Alcohol 
Number 
n Mean SD Diff t p(df=32) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
≤5 25 0.86 0.13 
0.09 2.00 .054 n/a 
>5 9 0.77 0.09 
Femoral neck Z-score 
≤5 25 0.58 0.98 
0.86 2.39 .023 0.93*** 
>5 9 -0.29 0.78 
Hip Total BMD (g/cm²) 
≤5 25 0.99 0.12 
0.07 1.71 .098 n/a 
>5 9 0.91 0.08 
Hip Total Z-Score 
≤5 25 0.65 0.90 
0.65 1.99 .055 n/a 
>5 9 0.00 0.65 
Lumbar BMD (g/cm²) 
≤5 25 1.07 0.12 
0.08 1.76 .087 n/a 
>5 9 0.99 0.12 
Lumbar Z-Score 
≤5 25 0.62 1.05 
0.78 1.90 .067 n/a 
>5 9 -0.16 1.07 
Total BMD (g/cm²) 
≤5 25 1.19 0.11 
0.05 1.13 .265 n/a 
>5 9 1.15 0.08 
Total Z-Score 
≤5 25 0.87 1.06 
0.56 1.44 .160 n/a 
>5 9 0.31 0.79 
Body Fat % 
≤5 25 28.21 5.50 
3.81 1.74 .092 n/a 
>5 9 24.40 6.05 
BMI (kg/m²) 
≤5 25 23.29 2.46 
1.41 1.49 .147 n/a 
>5 9 21.88 2.35 
Small *, Medium**, Large*** 
As reflected in Table 4.23, only the mean femoral neck Z-score differed significantly between 
the two categories of drinking ≤5 and drinking ˃5 alcoholic beverages per week. Participants 
who consume ≤5 alcoholic beverages per week had a significantly higher mean femoral neck 
Z-score compared to those who consume ˃5 alcoholic beverages per week (p = .023; d = 
0.93). 
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The mean values for the BMD of the femoral neck, hip total, lumbar spine and total body as 
well as the Z-scores for hip total, lumbar spine and total body are greater in those who 
consume ≤5 alcoholic beverages per week (n = 25) compared to those who consume ˃5 
alcoholic beverages per week (n=9). The mean values for the BF% and BMI followed the 
same tendency of being lower in those who consume ˃5 alcoholic beverages per week and 
no significant differences were found in the afore-mentioned BMD and body composition 
variables.  
Diet and nutritional intake was another lifestyle factor that was assessed to determine its 
association with BMD variables, BF% and BMI respectively. Figure 4.2 provides a graphical 
representation of a weekly dietary intake of calcium, calcium supplements, protein, fruits and 
vegetables, caffeine and carbonated beverages. The participants were asked about their daily 
intake of each of these food items per day (daily intake), week (weekly intake), less often 
consumption or never consuming the product. Figure 4.2 provides a graphical representation 
of the number of participants who consumed the relevant food items in the following frequency 
categories: daily, weekly, less often and never. 
 
Figure 4.2: Number of participants per category of time and selected food item intake 
Figure 4.2 illustrates that the majority of the participants consume calcium, protein, fruits and 
vegetables and caffeine daily. Carbonated beverages are found to be consumed less often 
and the majority of the participants (n = 24) do not ever consume calcium supplements.  
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4.5.7 The Relationship of BMD, BF% and BMI respectively with Training Load 
The inclusion criteria for this study were female runners who participate in long distance 
events, namely marathon and/or ultra-marathon events.  
Table 4.24 indicates the difference between the mean values for BMD, BF% and BMI 
respectively in relation to the total number of social and competitive long distance running 
years completed. There are a number of runners who participated competitively in long 
distance running, whereas others have participated in these events for social reasons. The 
two categories of runners that are compared in respect of BMD, BF% and BMI in Table 4.24 
were those who have run for 10 or fewer (˂11) long distance (marathon and/or ultra-marathon) 
running years and those who have run for more than 10 (>10) long distance running years, 
either socially or competitively. 
Table 4.24: Inferential Statistics: Comparison between the two categories of number 
of long distance running years completed  
(˂11 versus ˃10) in respect of BMD variables, BF% and BMI 
Variable 
Total long 
distance 
running years 
n Mean SD Diff t p(df=38) 
Cohen’s 
d 
Femoral neck BMD (g/cm²) 
<11 27 0.84 0.13 
-0.01 -0.16 .876 n/a 
>10 13 0.84 0.10 
Femoral neck Z-score 
<11 27 0.31 0.99 
-0.24 -0.73 .468 n/a 
>10 13 0.55 0.97 
Hip Total BMD (g/cm²) 
<11 27 0.97 0.13 
0.01 0.20 .841 n/a 
>10 13 0.96 0.09 
Hip Total Z-Score 
<11 27 0.45 0.92 
-0.09 -0.31 .755 n/a 
>10 13 0.55 0.81 
Lumbar BMD (g/cm²) 
<11 27 1.03 0.14 
0.02 0.40 .691 n/a 
>10 13 1.02 0.09 
Lumbar Z-Score 
<11 27 0.30 1.17 
-0.03 -0.07 .943 n/a 
>10 13 0.33 0.96 
Total BMD (g/cm²) 
<11 27 1.17 0.12 
-0.02 -0.46 .645 n/a 
>10 13 1.19 0.09 
Total Z-Score 
<11 27 0.61 1.11 
-0.22 -0.62 .542 n/a 
>10 13 0.83 0.86 
Body Fat % 
<11 27 27.94 5.69 
3.77 1.81 .078 n/a 
>10 13 24.17 7.05 
BMI (kg/m²) 
<11 27 23.09 2.64 
0.88 1.01 .318 n/a 
>10 13 22.21 2.45 
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Table 4.24 reflects no significant differences between the mean scores for BMD variables, 
BF% and BMI respectively of those who have been doing long distance running for ˂11 years 
compared to those who have being doing long distance running for ˃10 years.  
The mean Z-scores for femoral neck, hip total, lumbar spine and total body were lower for 
those who have participated in ˂11 years of long distance running. The mean scores for BF% 
and BMI were larger for those who have been involved in long distance running for ˂11 years. 
These differences (as reflected in Table 4.24), are not significantly different. 
Table 4.25 indicates the relationship between BMD variables, BF% and BMI respectively and 
the total number of marathons that have been completed. The least number of marathons that 
were completed from the sample was two, with the highest number belonging to a 60-year-
old participant. This indicates that there is a wide range of completed marathon events among 
the participants and categories were formulated to accommodate the range. The two 
categories subsequently identified are for those who have completed 10 or fewer (≤10) 
marathon events and for those who have completed 11 or more (≥11) marathon events.  
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Table 4.25: Inferential Statistics: Comparison between the categories of total number 
of completed marathon events (≤10 versus ≥11) in respect to BMD 
variables, BF% and BMI 
Variable 
Total 
marathons 
completed 
n Mean SD Difference t p(df=38) 
Cohen’s 
d 
Femoral neck BMD (g/cm²) 
≤10 24 0.84 0.14 
0.01 0.22 .830 n/a 
≥11 16 0.83 0.09 
Femoral neck Z-score 
≤10 24 0.33 1.00 
-0.16 -0.51 .612 n/a 
≥11 16 0.49 0.97 
Hip Total BMD (g/cm²) 
≤10 24 0.96 0.13 
0.00 -0.04 .968 n/a 
≥11 16 0.96 0.10 
Hip Total Z-Score 
≤10 24 0.40 0.86 
-0.22 -0.76 .452 n/a 
≥11 16 0.61 0.91 
Lumbar BMD (g/cm²) 
≤10 24 1.04 0.14 
0.02 0.44 .663 n/a 
≥11 16 1.02 0.11 
Lumbar Z-Score 
≤10 24 0.28 1.11 
-0.08 -0.23 .816 n/a 
≥11 16 0.36 1.09 
Total BMD (g/cm²) 
≤10 24 1.17 0.12 
0.00 -0.11 .913 n/a 
≥11 16 1.18 0.09 
Total Z-Score 
≤10 24 0.65 1.15 
-0.10 -0.29 .773 n/a 
≥11 16 0.74 0.86 
Body Fat % 
≤10 24 27.46 6.37 
1.86 0.91 .368 n/a 
≥11 16 25.59 6.31 
BMI (kg/m2) 
≤10 24 23.17 2.65 
0.90 1.09 .284 n/a 
≥11 16 22.26 2.46 
According to Table 4.25, there were no significant differences between the mean scores for 
BMD, BF% and BMI respectively of those who have competed in ≤10 marathon events 
compared to those who have competed in ≥11 marathon events.  
The mean values for the Z-scores for the femoral neck, hip total, lumbar spine and total body 
are greater in those who have completed ≥11 marathons (n = 16) than in those who have 
participated in ≤10 (n=24). The mean values for BF% and BMI are greater for those who have 
completed ≤10 marathon events compared to those who have participated in ≥11 marathon 
events. None of the differences identified in Table 4.25 are significant. 
Table 4.26 indicates the differences between BMD, BF% and BMI respectively in relation to 
the total number of ultra-marathons that have been completed.  
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Six participants out of the sample of 40 had not completed an ultra-marathon event. The least 
number of ultra-marathons completed, excluding those who have not competed, is one. The 
most ultra-marathons that were completed by a participant was 58. Due to the wide range of 
completed ultra-marathon events among the participants, categories were formulated. The 
two categories consisted of those who have completed 5 or fewer (≤5) ultra-marathon events 
(and included the 6 participants who had not completed any ultra-marathon events) and the 
other was for those who have completed 6 or more (≥6) ultra-marathon events. The categories 
were formulated to have an equal number of participants per category in order to determine 
potentially significant differences. 
Table 4.26: Inferential Statistics: Comparison between the categories of the total 
number of completed ultra-marathon events (≤5 versus ≥6) in respect of 
BMD variables, BF% and BMI 
Variable 
Total ultra-
marathons 
completed 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
≤5 20 0.85 0.14 
0.02 0.42 .674 n/a 
≥6 20 0.83 0.10 
Femoral neck Z-score 
≤5 20 0.39 1.05 
0.00 0.00 1.000 n/a 
≥6 20 0.39 0.93 
Hip Total BMD (g/cm²) 
≤5 20 0.97 0.12 
0.02 0.59 .557 n/a 
≥6 20 0.95 0.12 
Hip Total Z-Score 
≤5 20 0.51 0.87 
0.06 0.20 .846 n/a 
≥6 20 0.46 0.91 
Lumbar BMD (g/cm²) 
≤5 20 1.04 0.13 
0.03 0.79 .436 n/a 
≥6 20 1.01 0.13 
Lumbar Z-Score 
≤5 20 0.39 1.08 
0.16 0.44 .659 n/a 
≥6 20 0.24 1.13 
Total BMD (g/cm²) 
≤5 20 1.19 0.12 
0.02 0.62 .539 n/a 
≥6 20 1.16 0.10 
Total Z-Score 
≤5 20 0.79 1.12 
0.20 0.61 .547 n/a 
≥6 20 0.59 0.95 
Body Fat % 
≤5 20 28.76 5.21 4.09 
 
2.13 
 
.040 0.67** 
≥6 20 24.67 6.81 
BMI (kg/m²) 
≤5 20 23.75 2.38 
1.88 2.45 .019 0.78** 
≥6 20 21.86 2.48 
Small *, Medium**, Large***  
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The results reflected in Table 4.26 indicate that the mean BF% and BMI differed significantly 
between the two categories of having completed ≤5 ultra-marathon events versus having 
completed ≥6 ultra-marathon events. Runners who have competed in up to five ultra-marathon 
events had significantly higher BF% (p = .040, d = 0.67) and BMI values (p = .019, d = 0.78) 
than those who competed in more than six ultra-marathons.  
The mean values for BMD and Z-score variables are slightly higher in those who have 
participated in five or fewer ultra-marathon events (n = 20) compared to those who have 
participated in more than six such events (n = 20) but these differences are small and not 
significant.  
Table 4.27 indicates the differences between the mean values of BMD, BF% and BMI 
respectively for each of the two categories of total number of long distance running events 
(marathon plus ultra-marathons) completed. The categories consisted of ˂11 long distance 
running events and ˃10 long distance running events.  
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Table 4.27: Inferential Statistics: Comparison between the categories of total long 
distance running events completed (˂11 versus ˃10) in respect of BMD 
variables, BF% and BMI 
Variable 
Total Long 
distance 
events 
n Mean SD Difference t p(df=38) 
Cohen’s 
d 
Femoral neck BMD (g/cm²) 
< 11 17 0.86 0.16 
0.04 1.03 .312 n/a 
> 10 23 0.82 0.09 
Femoral neck Z-score 
< 11 17 0.38 1.12 
-0.01 -0.04 .967 n/a 
> 10 23 0.40 0.88 
Hip Total BMD (g/cm²) 
< 11 17 0.99 0.13 
0.05 1.37 .178 n/a 
> 10 23 0.94 0.11 
Hip Total Z-Score 
< 11 17 0.54 0.88 
0.09 0.32 .748 n/a 
> 10 23 0.44 0.89 
Lumbar BMD (g/cm²) 
< 11 17 1.05 0.14 
0.03 0.71 .483 n/a 
> 10 23 1.02 0.12 
Lumbar Z-Score 
< 11 17 0.24 1.16 
-0.13 -0.38 .706 n/a 
> 10 23 0.37 1.06 
Total BMD (g/cm²) 
< 11 17 1.20 0.12 
0.04 1.16 .252 n/a 
> 10 23 1.16 0.10 
Total Z-Score 
< 11 17 0.82 1.19 
0.24 0.73 .472 n/a 
> 10 23 0.58 0.91 
Body Fat % 
< 11 17 27.19 5.31 
0.83 0.40 .688 n/a 
> 10 23 26.36 7.09 
BMI (kg/m²) 
< 11 17 23.08 2.02 
0.47 0.57 .572 n/a 
> 10 23 22.60 2.96 
There were no significant differences noted in Table 4.27 but certain trends were observed. 
Table 4.27 indicates that the mean values for femoral neck, hip total, lumbar spine and total 
body BMD are greater in those who have participated in fewer than 11 long distance running 
events compared to those who have participated in more than 10 long distance running 
events. These differences were not significant. The mean values for BF% and BMI are greater 
in those who have participated in fewer than 11 long distance running events. These 
differences are insignificant. 
Table 4.28 indicates the differences between the mean values of BMD, BF% and BMI 
respectively for the two categories of best marathon completion times. The categories are 
equal to or less than 3 hours and 50 minutes (≤3:50:00) and more than 3 hours and 50 minutes 
(>3:50:00).  
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Table 4.28: Inferential Statistics: Comparison between the categories for best 
marathon completion times (≤3:50:00 versus >3:50:00) in respect of BMD 
variables, BF% and BMI 
Variable 
Best Marathon 
time categories 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
≤ 03:50:00 13 0.83 0.11 
-0.01 -0.35 .728 n/a 
>03:50:00 27 0.84 0.13 
Femoral neck Z-score 
≤ 03:50:00 13 0.46 1.02 
0.11 0.32 .752 n/a 
>03:50:00 27 0.36 0.97 
Hip Total BMD (g/cm²) 
≤ 03:50:00 13 0.95 0.12 
-0.01 -0.31 .761 n/a 
>03:50:00 27 0.97 0.12 
Hip Total Z-Score 
≤ 03:50:00 13 0.56 0.92 
0.12 0.39 .698 n/a 
>03:50:00 27 0.44 0.87 
Lumbar BMD (g/cm²) 
≤ 03:50:00 13 1.01 0.12 
-0.02 -0.49 .627 n/a 
>03:50:00 27 1.04 0.14 
Lumbar Z-Score 
≤ 03:50:00 13 0.36 1.15 
0.07 0.19 .847 n/a 
>03:50:00 27 0.29 1.08 
Total BMD (g/cm²) 
≤ 03:50:00 13 1.16 0.10 
-0.02 -0.63 .532 n/a 
>03:50:00 27 1.18 0.11 
Total Z-Score 
≤ 03:50:00 13 0.61 0.87 
-0.11 -0.33 .747 n/a 
>03:50:00 27 0.72 1.12 
Body Fat % 
≤ 03:50:00 13 23.41 8.03 
-4.90 -2.43 .020 0.82*** 
>03:50:00 27 28.30 4.72 
BMI (kg/m²) 
≤ 03:50:00 13 21.77 2.57 
-1.53 
-1.81 
 
.078 
 
n/a 
 >03:50:00 27 23.30 2.48 
Small *, Medium**, Large***  
BF% as reflected in Table 4.28 was significantly higher for runners with slower best marathon 
times than for runners with faster best marathon times (p = .020; d = 0.82) with the mean 
values of 23.41% for completing a marathon 3 hours and 50 minutes or less and the mean 
value of 28.30% for those completing a marathon in more than 3 hours and 50 minutes.  
The mean values for the BMD of the femoral neck, hip total, lumbar spine and total body are 
greater in those who completed the marathon in more than 3 hours 50 minutes, but these 
differences are not significant. The mean value for BMI is also greater for those who took 
longer to complete the marathon, which was more than 3 hours 50 minutes, but this difference 
was also insignificant.  
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Table 4.29 indicates the comparison between the mean values of BMD, BF% and BMI 
respectively and the two categories of average weekly running distance covered per year. The 
relevant categories compared are 30 to 50 km/week versus 51 to 100 km/week.  
Table 4.29: Inferential Statistics: Comparison between the categories of average 
weekly running distance per year (30-50 km/week versus 51-100 km/week) 
in respect of BMD variables, BF% and BMI 
Variable 
Average weekly 
distance per year 
(km/week) 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
30-50 17 0.85 0.15 
0.02 0.63 .535 n/a 
51-100 23 0.83 0.10 
Femoral neck Z-score 
30-50 17 0.64 1.03 
0.44 1.42 .165 n/a 
51-100 23 0.20 0.91 
Hip Total BMD (g/cm²) 
30-50 17 0.99 0.12 
0.05 1.31 .197 n/a 
51-100 23 0.94 0.11 
Hip Total Z-Score 
30-50 17 0.81 0.77 
0.57 2.13 .040 0.68** 
51-100 23 0.24 0.89 
Lumbar BMD (g/cm²) 
30-50 17 1.03 0.14 
0.00 -0.02 .986 n/a 
51-100 23 1.03 0.12 
Lumbar Z-Score 
30-50 17 0.50 1.14 
0.33 0.93 .357 n/a 
51-100 23 0.17 1.05 
Total BMD (g/cm²) 
30-50 17 1.16 0.12 
-0.03 -0.79 .437 n/a 
51-100 23 1.19 0.10 
Total Z-Score 
30-50 17 0.62 1.14 
-0.11 -0.32 .750 n/a 
51-100 23 0.73 0.97 
Body Fat % 
30-50 17 29.97 6.27 
5.67 3.09 .004 0.99*** 
51-100 23 24.30 5.31 
BMI (kg/m²) 
30-50 17 24.10 2.79 
2.25 2.99 .005 0.95*** 
51-100 23 21.85 1.97 
Small *, Medium**, Large***  
Table 4.29 depicts that there are significantly higher mean hip total Z-scores (p = .040; d = 
0.68), BF% (p = .004; d = 0.99) and BMI (p = .005; d = 0.95) identified for runners who had a 
lower average weekly distance (30-50 km/week) per year compared with those who had a 
higher average weekly distance (51-100 km/week) per year. Runners who covered less 
distance weekly had higher mean scores for all three variables.  
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Table 4.30 indicates the differences between the mean values of BMD, BF% and BMI 
respectively for the two categories of participants, those engaged in and those not engaged 
in a strength and conditioning program as part of their weekly training regime. A strength and 
conditioning program is incorporated to improve overall body strength and comprises 
resistance exercises performed in addition to the running program aimed at providing benefits 
to performance. The two categories consisted of those who did incorporate a strength and 
conditioning program into their weekly training regime and those who did not. 
Table 4.30: Inferential Statistics: Comparison between the implementation and the 
non-implementation of a weekly strength and conditioning program with 
respect to BMD variables, BF% and BMI 
Variable 
Strength and 
conditioning 
program 
n Mean SD Difference t p(df=38) 
Cohen’s 
d 
Femoral neck BMD (g/cm²) 
Yes 21 0.85 0.16 
0.02 0.47 .643 n/a 
No 19 0.83 0.07 
Femoral neck Z-score 
Yes 21 0.30 1.20 
-0.18 -0.58 .568 n/a 
No 19 0.48 0.68 
Hip Total BMD (g/cm²) 
Yes 21 0.97 0.15 
0.02 0.53 .598 n/a 
No 19 0.95 0.08 
Hip Total Z-Score 
Yes 21 0.42 1.07 
-0.13 -0.48 .637 n/a 
No 19 0.55 0.62 
Lumbar BMD (g/cm²) 
Yes 21 1.03 0.15 
0.01 0.31 .759 n/a 
No 19 1.02 0.10 
Lumbar Z-Score 
Yes 21 0.17 1.18 
-0.30 -0.86 .397 n/a 
No 19 0.47 0.98 
Total BMD (g/cm²) 
Yes 21 1.18 0.13 
0.01 0.24 .809 n/a 
No 19 1.17 0.08 
Total Z-Score 
Yes 21 0.63 1.26 
-0.12 -0.36 .721 n/a 
No 19 0.75 0.72 
Body Fat % 
Yes 21 25.87 5.85 
-1.77 -0.88 .384 n/a 
No 19 27.64 6.86 
BMI (kg/m²) 
Yes 21 22.51 2.42 
-0.62 -0.76 .455 n/a 
No 19 23.13 2.78 
According to Table 4.30, there were no significant differences for the BMD, BF% and BMI 
respectively for those who implemented a strength and conditioning program and those who 
did not. The mean values of BMD for the femoral neck, hip total, lumbar spine and total body 
are greater for those who did implement a strength and conditioning program during the week 
(n = 21), compared to those who did not (n = 19). The mean values for the Z-scores of the 
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femoral neck, hip total, lumbar spine and total body are lower in those who engaged in a 
strength and conditioning program compared to those who did not. The mean values for the 
BF% and BMI were greater for those who did not implement a strength and conditioning 
program versus those who did. These differences are not significant. 
4.5.8 Running Shoe and Running Style 
The type of running shoes used is based solely on individual preference, comfort, affordability 
and injury prevention. As a result, there is not necessarily only one type of shoe considered 
to be the ‘best’ option. The results of the latter analysis are reflected in Table 4.31. 
Table 4.31: Descriptive Statistics: Frequency distribution of the type of running shoes 
used by the runners 
Type of Running Shoe Number Percentage 
Over Pronator Shoes 2 5% 
Neutral Shoes 35 88% 
Unsure 3 8% 
Total 40 100% 
Table 4.31, depicts that the majority of the participants (n = 35, 88%) used a neutral shoe, 
according to self-identification.  
Table 4.32 depicts the type of running style utilized by the runners. Three types of running 
style were presented and the results are reflected in Table 4.3.2.  
Table 4.32: Descriptive Statistics: Frequency distribution of the type of running style 
used by the runners 
Running Style Number Percentage 
Rear-foot strike 10 25% 
Mid-foot Strike 8 20% 
Forefoot strike 13 33% 
Unsure 9 23% 
Total 40 100% 
According to Table 4.32, 33% (n = 13) of the participants self-identified using a forefoot running 
style in the questionnaires they completed. This style had the highest frequency of occurrence 
followed by rear-foot strike (n = 10, 25%).  
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The participants were also requested to disclose the duration of wear of their running shoes. 
A number of them reported the duration in months, as reflected in Table 4.33, whereas others 
reflected their duration in kilometres, as reflected in Table 4.34.  
Table 4.33: Descriptive Statistics: Frequency distribution of shoe wear duration in 
months 
Months Number Percentage 
4 2 8% 
5 1 4% 
6 6 23% 
8 1 4% 
9 2 8% 
12 11 42% 
18 2 8% 
24 1 4% 
Total 26 100% 
 
Table 4.34: Descriptive Statistics: Frequency distribution of shoe wear duration in 
kilometers 
Distance (km) Number Percentage 
600 1 8% 
700 1 8% 
800 5 38% 
900 2 15% 
1000 2 15% 
1200 1 8% 
1600 1 8% 
Total 13 100% 
According to Table 4.33, the highest frequency (n = 11, 42%) of the participants wore their 
shoes for a duration of 12 months, while Table 4.34 that the highest frequency (n = 5; 38%) 
of the other runners wore their shoes for a total distance of 800km. Shoe wear duration was 
established via self-identification and from the answers derived from the questionnaire 
completed by the participants. 
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Due to the relative large number of categories and subsequent small numbers involved per 
category, the effect of type of running shoe, type of running style and the duration of shoe 
wear respectively on BMD, BMI and BF% could not be determined. 
Chapter 5 discusses the results presented in Chapter 4. The discussion is to explain the 
results in more detail and in relation to relevant literature findings before providing a summary 
of the findings of the study.  
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CHAPTER 5 
DISCUSSION, SUMMARY, CONCLUSION, LIMITATIONS, AND 
RECOMMENDATIONS 
5.1 INTRODUCTION 
This final chapter presents a discussion of the results listed in Chapter 4. The discussion 
portrays the findings from this study in relation to related research reviewed, focusing 
specifically on the BMD, BF% and BMI profile of the female long distance runners, the 
relationships between BMD, and BMI and BF%, respectively, as well as how BMD, BMI and 
BF% relate to other relevant factors such as age, anthropometric measurements (BMI), 
female reproductive variables, bone health indicators, disease history, medication, lifestyle 
factors, training load, running shoe type and running style. This chapter concludes with a 
summary of the key findings of the research study, after which the limitations of the study are 
highlighted, and recommendations are put forward for future research.  
5.2 SAMPLE PROFILE IN RESPECT OF AGE, GENDER AND ETHNICITY  
This study included only female participants and the discussions concerning gender focus on 
the female population. It has been found that females are more prone to the risk of an 
osteoporotic fracture than males, as females generally have a lower BMD and a lower level of 
collagen elasticity than males (Henry & Eastell, 2000:513; Benca et al., 2013:346). Females’ 
lower BMD rating, especially during and after menopause, is due to the decreased levels of 
sex hormones such as oestrogen that is needed for the production and maintenance of bone 
growth (Wilkin et al., 2010:198; Folscher et al., 2015:6; Runolfsdottir et al., 2015:24). These 
are the reasons for focusing on female long distance runners. 
Literature regarding the relationship between age and BMD is limited, according to Benca et 
al. (2013:346). However, it has been found that with increasing age, one is more prone to the 
risk of lowered BMD and an increase in BF% (Runolfsdottir et al., 2015:24). The highest age 
frequency of the females included in this study fell within the 41 to 50 years of age range (see 
Table 4.1). According to Vorster (2001:20), Chan et al. (2004:61), Wilkin et al. (2010:198) and 
Selingerova et al. (2015:271), peak bone mineralisation is reached between the ages of 25 
and 30, after which it begins to decline, particularly from the age of 35 to 40 (Greydanus & 
Patel, 2004:16; NIH, 2016). The majority of the female participants included in this study had 
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already passed the age of peak bone mineralisation and were on the lower end of the 
spectrum for BMD levels.  
Ethnicity has also been indicated in the literature to affect BMD differentially (Micklesfield et 
al., 2011:257). With regard to the present study, the majority of the participants were white 
females, barring two individuals who were black and Asian (see Table 4.2). Black females 
have been found to have a higher BMD and are less prone to osteoporotic fractures compared 
to white females, who are said to have weaker bones (Wallace et al., 2005:357; Wilkin et al., 
2010:204; Micklesfield et al., 2011:258). The present study’s mean BMD of 1.18 ± 0.11 g/cm2 
and mean Z-score of 0.69 ± 1.03 reflect the mostly white female runners’ BMD ratings. 
5.3 SAMPLE PROFILE IN RESPECT OF BONE MINERAL DENSITY (BMD)  
The results obtained from the densitometer scans included the BMC (grams), the area of the 
bone that was observed (cm²), the BMD (g/cm²), the Z-score and the T-score. A T-score was 
only provided if the subject was 50 years of age or older, whereas all participants were 
provided with a Z-score (Hologic, 2014:8). The T-score represents the difference between the 
measured BMD of the subject in relation to the BMD of a younger adult population of the same 
gender at peak bone mass. The Z-score represents the difference between the measured 
BMD of the subject in relation to the BMD of a population of the same age, gender and ethnicity 
(Wilkin et al., 2010:199; George et al., 2011:51; Heidari et al., 2014:2; Hologic, 2014:83; 
Doroudinia & Colletti, 2015:648; Tonuk et al., 2015:151). The present sample’s BMD profile 
and further comparisons only reflect BMD ratings (g/cm2) and the associated Z-scores and T-
scores (where applicable). 
Three scans were conducted for this study, the hip, the lumbar spine and the total body 
respectively. The hip scan consisted of results for the hip total as well as the femoral neck 
comprising the specific hip area. The lumbar spine results consisted of the BMD results for 
the mean of the four vertebrae, L1 to L4. Lastly, the whole-body results included the total body 
values and the overall BF%.  
According to the World Health Organization, BMD is interpreted according to the relevant 
associated T-score and Z-score values. A T-score (only available for people 50 years and 
older), is considered normal when it is greater than 1 SD below the mean (also referred to as 
above -1 SD); osteopenia, which is a decreased BMD, is identified when the T-value is 
between 1 and 2.5 SD below the mean (also referred to as between -1 and -2.5 SD) and a 
further decrease in BMD is categorised as osteoporosis and is considered when a BMD of 
more than 2.5 SD below the mean (also referred to as less than -2.5 SD) is registered (Blake 
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& Fogelman, 2007:510; Wilkin et al., 2010:200; George et al., 2011:51; Abd El Mohsen et al., 
2016:2576; DXA Scan, 2014; Lespessailles et al., 2017:12; Maghraoui, 2012:3). A Z-score is 
considered normal for a BMD value that is equal to or above -2.0 SD (Tonuk et al., 2015:151; 
The National Osteoporosis Foundation, 2017). 
The results of the present study, as reflected in Table 4.3, indicate that the mean Z-score for 
the hip total, the femoral neck, the lumbar spine and the whole body were all above -2.0, thus 
classifying the average Z-scores of the sample of female runners involved in this study as 
normal. The average T-score values for the hip total, the femoral neck and the whole body 
were above -1 SD, confirming that the BMD of the female runners of 50 years and older had 
a normal classification. The mean T-score value for the lumbar spine was -1.11 ± 0.92, 
categorising the female runners of 50 years and older as osteopenic for this region.  
BMD is used to indicate the strength of the bones and a decreased BMD in the spine may be 
due to several factors, such as a deficiency of oestrogen, menstrual irregularities, low caloric 
intake, an increase in the volume and frequency of training and the use of glucocorticoids 
(Hanekom & Kluyts, 2003:15; Gibson et al., 2004:612; Leslie, 2008; Pollock et al., 2010:418; 
Wakamatsu, 2013:150). According to Micklesfield et al. (2011:257), decreased BMD of the 
lumbar spine, which can result in osteoporosis, is more common amongst white individuals 
than black individuals. 
5.4 SAMPLE PROFILE IN RESPECT OF BODY MASS INDEX (BMI) 
BMI was calculated based on participants’ measured weight and height and reflected in kg/m2. 
BMI was subsequently classified according to normative data (Kim et al., 2013:709; Silva et 
al., 2014:224; Nuttall, 2015). BMI can indicate body fatness and can be used as a guide to 
identify risk factors for disease. The classification for BMI was provided in Table 2.1 of Chapter 
2 and comprises the following categories: underweight, normal weight, overweight, obesity 
class 1, obesity class 2 and obesity class 3 (ACSM, 2014:63).  
Table 4.3 indicates that the mean BMI rating for all the participants was 22.80 ± 2.58 kg/m², 
which falls within the category of “normal”, that is between 18.5 and 24.9 kg/m² (ACSM, 
2014:63; Nuttall, 2015). With regard to the sample population of the present study and 
according to Table 4.4, 34 individuals were classified as having a normal BMI (18.5 to 24.9 
kg/m²). The remaining 6 participants were classified as overweight, as their mean BMI of 27.26 
± 1.67 kg/m2 fell between 25.0 and 29.9 kg/m².  
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A normal BMI rating is considered ‘safe’, as with an increased body weight, runners are more 
exposed to injuries due to the increased load placed on the body (Manore, 2004:49; Benca et 
al., 2013; Kim et al., 2013:710; Newman et al., 2013:229; Silva et al., 2014:227; van der Worp, 
et al., 2015:7). A low BMI can result in a low bone mass, which would impair the quality of 
bone and affect physical performance due to the lack of support for the body and the joints 
(Vorster et al., 2001:21; Pollock et al., 2010:420; Benca et al., 2013; Thralls et al., 2016:22).  
Individuals with a BMI greater than 25 kg/m² are considered to be at greater risk of injury due 
to the increased amount of stress and impact placed on the joints (Douglas, 2013; Kim et al., 
2013:710; Newman et al., 2013:230; Silva et al., 2014:226; van der Worp et al., 2015:7). 
According to Silva et al. (2014:224) and Cavkaytar et al. (2015:691), a higher BMI can provide 
protective benefits and delay the onset of osteoporosis. Marwaha et al. (2013:355) hold that 
obesity increases BMD due to the load placed on the musculoskeletal system (da Silva et al., 
2007:946). Fat mass has been found to have a positive influence on BMD as it performs a 
role in the mechanical loading on bone (Kim et al., 2013:710; Doroudinia & Colletti, 2015:648; 
Isanejad et al., 2017:624).  
During the postmenopausal years females are generally more prone to having increased BF% 
and BMI than younger individuals who have not yet undergone menopause (Kim et al., 
2013:714). 
5.5 SAMPLE PROFILE IN RESPECT OF BODY FAT PERCENTAGE (BF%) 
BF% indicates the percentage of one’s body composition that consists of fat (ACSM, 2014). 
Females are more likely to have a higher BF% compared to males (Gloria-Bottini et al., 
2007:377) and there are different cut-off values (normative values) for BF% to classify 
essential fat, namely: excellent, good, average, below average and poor categories for the 
respective genders as well as for the different age groups. Each participant was categorised 
according to their BF% value within their respective age category. The mean BF% for the total 
sample was 26.71 ± 6.33% (see Table 4.3) and is interpreted as ‘average’ based on the ACSM 
rating for the average age of the sample. The highest frequency of participants was classified 
as below average (n = 12, 30%) according to Table 4.5, thus indicating that their BF% was on 
the higher side of the spectrum. 
Table 4.9 indicates that 50% (n=20) of the participants were rated as having an ‘above 
average’ BF% which is representative of an ‘average’ or ‘good’ BF%. BF% differs between 
males and females, as males have more fat-free mass (Gloria-Bottini et al., 2007:378), as well 
as between the different age groups, especially as ageing is associated with increased fat 
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mass (Gloria-Bottini et al., 2007:378). The larger percentage of female long distance runners 
are representative of a low body weight and BF%. There is a need to be lean when engaging 
in endurance sport to increase performance (Pollock et al., 2010:420; George et al., 2011:50). 
Those who are classified as having a low BF% are more likely to have a decreased BMD 
(Vorster et al., 2001:21). 
5.6 RELATIONSHIP BETWEEN BMD AND BMI AND BF% RESPECTIVELY 
Statistical analyses were conducted with the use of the Pearson-Product Moment Correlation 
Coefficients to reflect the relationships that occurred between BMD and BMI and BF% 
respectively.  
Table 4.6 indicates the practical and statistically significant correlations of BMD, BF% and BMI 
respectively. The Z-scores for the femoral neck, hip total, lumbar spine and the total body as 
well as the BMD of the lumbar spine, presented practical and statistically significant 
correlations with BMI. The findings of the present study coincide with those of Silva et al. 
(2014:227), whereby there is a positive correlation between BMD at the spine, femur and 
femoral neck with BMI. The results of the study conducted by da Silva et al. (2007:946) 
indicated that there is a positive correlation between BMI and BMD at all the relevant sites. 
5.7 ASSOCIATED IMPACT OF SELECTED VARIABLES ON BMD, BMI AND BF% 
RESPECTIVELY 
The section that follows discusses the impact of certain variables on BMD, BMI and BF% 
respectively. The variables to be discussed are age, BMI, female reproductive variables, bone 
health indicators, disease history and medication usage, lifestyle factors, training load as well 
as running shoe type and running style. 
5.7.1 Age 
As one ages the bone remodelling process slows and the accumulation of bone decreases 
(George et al., 2011:51). A decrease in bone accumulation results in a lowered BMD and can 
lead to the onset of osteoporosis and an increased risk of bone fractures (George et al., 
2011:53; Pentyala et al., 2013:7). Table 4.7 in Chapter 4 indicates the inferential statistics for 
the comparison between the categories of age in respect of BMD variables, BF% and BMI. 
Table 4.7 indicates this study’s results in respect of the comparison between the mean BMD 
of the younger females aged 20 to 40 years (1.18 ± 0.11 g/cm2) and the older female group 
aged 41 to 70 years (1.17 ± 0.11 g/cm2). No significant difference (p > .05) between the two 
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groups was found, implying that a decrease in bone accumulation was not prevalent among 
the female runners in this study. 
5.7.2 BMI 
Table 4.8 presents the inferential statistics for the comparison of the categories of BMI in 
respect of BMD variables and BF%. When considering the present study’s findings as 
reflected in Table 4.8, these results indicate that runners classified (according to BMI) as 
overweight, had significantly larger femoral neck Z-scores, hip total Z-scores and BF% than 
those classified as being of normal weight. The present study’s findings support those of 
Marwaha et al. (2013:355), Silva et al. (2014:224) and Cavkaytar et al. (2015:691). The results 
imply that the added weight carried by the runners in this study was associated with higher 
BMD ratings. 
5.7.3 Female Reproductive Variables  
The female reproductive variables comprised age of menarche, menstrual cycle regularity, 
the number of full term pregnancies, contraception usage and type and menopausal status.  
5.7.3.1 Menarche 
Menarche usually occurs between the ages of 11 and 14 but this can vary due to a variety of 
factors, among which are certain lifestyle factors and nutritional intake (Hanekom & Kluyts, 
2003:15; Mishra et al., 2009:178; Korsten-Reck, 2011:157; Karp, 2015). The present study 
found that the larger proportion (frequency) of the participants reached menarche between 
the ages of 13 and 14 (n = 19, 48%), followed by the ages of 10 to 12 (n = 11, 28%) as per 
Table F.3 (Appendix F). These findings coincide with the literature by Hanekom and Kluyts 
(2003:15), Mishra et al. (2009:178) and Karp (2015), indicating that menarche occurs between 
the ages of 11 and 14. Participation in high performance training at a young age may also 
lead to delayed menarche, according to findings by Hanekom and Kluyts (2003:16) and 
Folscher et al. (2015:5), thereby increasing the risk of a lowered BMD and the onset of 
osteoporosis later in life (Burrows & Bird, 2000:281; Korsten-Reck, 2011:157). 
In an attempt to determine the association of menarche with BMD, participants in the present 
study were divided into two groups according to their age of menarche, the “early” group 
(menarche reached between 10 and 12 years of age) and the “late” group (menarche reached 
at the age of 13 and older). Table 4.10 presents the inferential statistics for the comparison of 
the categories of menarche in respect of BMD variables, BF% and BMI. No significant 
differences were found between the “early” and the “late” groups for any of the BMD variables 
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or for BMI and BF%. According to Table F.35 (Appendix F), 68% of the participants have been 
running socially and or competitively for only 5 to 10 years, and given that 92% of the 
participants in this study were older than 31 (Table 4.1), it is unlikely that these runners’ age 
of menarche could have been affected by a high training load prior to reaching menarche.   
5.7.3.2 Menstrual Cycle 
The majority of the participants (n = 22, 55%) disclosed that they had a regular menstrual 
cycle after reaching menarche (see Table F.5, Appendix F) but a greater number of 
participants (53%) revealed that they had missed a period (n = 21) at some stage during their 
menstrual years that was not indicative of pregnancy (Table F.7 Appendix F). No significant 
differences were found between the regular and irregular menstrual cycle groups for any of 
the BMD variables, BF% and BMI respectively though (Table F.7 Appendix F). 
The risk for developing osteoporosis increases when there is a deficiency or low level of 
oestrogen and hormonal imbalances, the cessation of menstruation as well as menstrual 
dysfunction, which may be due to strenuous exercise, poor nutritional habits, losing excessive 
weight and stress (Burrows & Bird, 2000:282; Vorster et al., 2001:21; Pollock et al., 2010:421; 
ACSM, 2011; Korsten-Reck, 2011:158; Karp, 2015).  
Long distance running often requires the athletes to be lean and of a low body weight in order 
to perform optimally (Pollock et al., 2010:419; George et al., 2011:54). Due to the nature of 
the sport and specifically ultra-marathons, there is at times a caloric or energy deficit due to 
disordered eating or from too high a training load (ACSM, 2011; Mountjoy et al., 2014:4; Rauh 
et al., 2014:949; Ba & Matzkin, 2015:1868; Folscher, 2015:6; Slater et al., 2016:421; Thralls 
et al., 2016:18). 
5.7.3.3 Full-term Pregnancies 
The most populated category of the number of full-term pregnancies that the present study’s 
participants had were 2 to 3 (n = 21, 53%; Table F.8 Appendix F). As indicated in Table 4.11, 
the majority of the female runners have had one or more full-term pregnancies (n = 28). 
Findings by Shao et al. (2012:572) and Derakhshan et al. (2016:45) indicated that BMD 
decreases during pregnancy and with lactation due to the foetus utilizing the maternal calcium 
for its own skeletal formation. According to Derakhshan et al. (2016:45), BMD can return to 
normal pre-pregnancy levels after 12 months but there have not been enough longitudinal 
studies to determine the long-term effects that pregnancy may have on BMD. 
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Table 4.11 presents the inferential statistics for the comparison of the categories of full-term 
pregnancies in respect of the BMD variables, BF% and BMI. The results in Table 4.11 
indicated that it was only the mean femoral neck BMD that was significantly (p < .05; d > 0.2) 
lower (0.81 ± 0.12 g/cm2 versus 0.90 ± 0.11 g/cm2) among the participants who had one or 
more (70%) full-term pregnancies versus none (30%), for those who had not been pregnant, 
although a similar tendency was observed for all the other BMD ratings except for the lumbar 
Z-score.  
The effect of pregnancy on the femoral neck BMD is in line with what literature has recently 
indicated, as according to a study conducted by Kasahara et al.  (2017:1069), pregnancy can 
cause transient osteoporosis of the hip (TOH), resulting in pregnancy-associated 
osteoporosis. Previously noted in the study by Derakhshan et al. (2016:45), BMD decreases 
during pregnancy due to the foetus requiring maternal calcium for bone growth. This loss of 
calcium decreases BMD and increases weight due to the pregnancy and places the bones 
under extreme loads, which can result in the increased incidence of fractures, especially of 
the femoral neck (Kasahara et al., 2017:1069).  
5.7.3.4 Contraception Use and Type 
Contraception use could have a positive influence on BMD as it releases the oestrogen that 
is needed for bone growth and maintenance, thus decreasing the risk of fractures and 
osteoporosis (Chantler et al., 2012:533; Karp, 2015). Findings from this study (Table F.9 
Appendix F) indicate that 33 of the participants (83%) use or have used some form of 
contraception. The majority of the female runners in this study use or have used the pill (n = 
22, 67%), followed by the IUD (n = 18, 55%) (Table F.11 Appendix F). The majority of the 
participants have been using contraception for more than five years (n = 27, 82%) (Table F.10 
Appendix F).  
Table 4.12 depicts the inferential statistics for the comparison between use and non-use of 
contraceptives in respect of the BMD variables, BF% and BMI. According to Table 4.12, the 
BMD, BF% and BMI values were not significantly different among those who use 
contraception and those who do not use contraception. The use of oral contraception is 
presumed to increase body weight and BF% in a number of instances and to influence BMD 
(Proctor-Gray et al., 2008:1209; Karp, 2015). According to Bemben et al. (2004:220), and in 
relation to the findings of this study, there has been no significant difference found between 
BMD values of those who do and those who do not use oral contraception. 
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5.7.3.5 Menopausal Status 
Menopause occurs in later life, usually between the ages of 40 and 60 but the age at which it 
begins can vary (Mishra et al., 2009:179; Korsten-Reck, 2011:156; Karp, 2015). Menopause 
is the time when the female reproductive phase has ended and can be related to BMD (da 
Silva et al., 2007:946; Mishra et al., 2009:179; Karp, 2015). In this study only 8 runners (20%) 
reported to be menopausal with two stating that they were unsure whether they were 
menopausal or not (see Table F.12 Appendix F). Those who were uncertain were omitted 
from the inferential statistical analysis in Table 4.14. 
Table 4.14 reports on the inferential statistics of the comparison of menopausal and non-
menopausal women in respect of the BMD variables, BF% and BMI. The menopausal runners 
reflected significantly lower (p < .05; d > 0.2) BMD ratings than their non-menopausal peers 
in respect of femoral neck (0.76 ± 0.11 versus 0.85 ± 0.10 g/cm2), the lumbar spine (0.92 ± 
0.11 versus 1.05 ± 0.12 g/cm2) and their total body BMD (1.10 ± 0.11 versus 1.20 ± 0.11 
g/cm2). The menopausal runners on the other hand, presented with significantly higher (p < 
.05; d > 0.2) BF% than the non-menopausal runners (31.28 ± 5.35 versus 25.03 ± 5.79%).  
Of those who were said to be menopausal, the majority had been in that stage for three or 
more years (3-4 years: n = 4, 40%; 5 + years: n = 3, 30%). BMD has been found to decrease 
after menopause due to the reduced amount of oestrogen present within the body, thereby 
decreasing the BMD of the hip, the lumbar spine and the body overall (Chan et al., 2004:59; 
da Silva et al., 2007:944; Wakamatsu et al., 2013:149; de Almeida Carvalho et al., 2014; 
Bacelar et al., 2015:95; Folscher et al., 2015:6; Karp, 2015). The present study supports the 
relevant literature findings. 
5.7.4 Bone Health Indicators  
Bone constantly undergoes remodelling via bone breakdown initiated by osteoclasts and bone 
formation initiated by osteoblasts (Morseth et al., 2011:1230; Jenkins & Tortora, 2013:167-
168; Mayo Clinic, 2016). When an imbalance occurs during this remodelling process, BMD 
can begin to decrease, which can result in the onset of osteopenia or osteoporosis (Burrows 
& Bird, 2000:282; Vorster et al., 2001;21; Maghraoui, 2012:14; Hammad, 2015:559; Abd El 
Mohsen et al., 2016:2577; Kim et al., 2016:8; Brozgol et al., 2017:175). Osteoporosis can be 
related to one’s genetic make-up. According to the findings reflected in Table 4.17 and Figure 
4.1, the majority of the sample involved in this study (n = 26) do not have a family history of 
osteoporosis.  
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Osteoporosis can result in weak and brittle bones, increasing the fragility of bone and thus 
increasing the risk for the occurrence of fractures (Burrows & Bird, 2000:282; Pentyala et al., 
2013:7; Hammad, 2015:559; Mayo Clinic, 2016). Fractures can result in those participants 
with compromised bone density when exposed to minimal trauma, such as falling or sneezing 
(Hammad, 2015; Mayo Clinic, 2016). It is recommended that physical activity and strength-
based training such as resistance training be incorporated into one’s lifestyle to increase BMD 
and reduce the risk of fractures (Andreoli et al., 2012:72; Smith, 2012:270; Stiles et al., 
2017:8). 
Tables 4.15 and 4.16 indicate the inferential statistics regarding the comparison of traumatic 
and non-traumatic related incidence respectively and non-incidence of broken bones with 
regard to the BMD variables, BF% and BMI. Broken bones may occur as a result of a traumatic 
event such as a motor vehicle accident or a non-traumatic event, such as from a bone disease, 
from sneezing, or from falling. In the present sample there were 6 runners who had broken a 
bone due to a traumatic event, while 9 runners had broken a bone due to a non-traumatic 
event, thus indicating that only the minority of the sample had broken a bone.  
The mean scores for runners who had suffered a broken bone, irrespective of whether trauma 
was involved, were lower across all BMD variables but these differences were not significant. 
However, a significant difference (p < .05; d > 0.2) between the BMI of those who had broken 
bones due to trauma (20.6 ± 1.41 kg/m²) and those who had not (23.18 ± 2.57 kg/m²) was 
observed (see Table 4.15). An increased BMI rating can increase the risk of injury, according 
to Benca et al. (2013) and Douglas (2013), but as per the study conducted by Barrack et al. 
(2014:955), a low BF% and a low BMI can be associated with the onset of a bone injury. The 
present study’s findings support those of Barrack et al. (2014:955). 
5.7.5 Disease History and Medication Usage  
Within the present sample there were a limited number of participants (n = 9) who revealed 
that they are living with a health disorder. Amongst these, the most prevalent health disorders 
are Ankylosing Spondylitis (n = 2, 22%) and stage 3 melanoma (n = 2, 22%), as presented in 
Table 4.18. While the majority of the runners did not have a medical condition, the most 
prevalent medical conditions amongst the others were asthma or emphysema (n = 2, 5%) as 
depicted in Table 4.19. 
The medication commonly used to treat asthma is corticosteroids, such as glucocorticoids 
(Krapf et al., 2008:1669; Harding, 2015; Zaykoski, 2016). According to Canalis and Delany 
(2002:75), Krapf et al., (2008:1669); Harding (2015) and Zaykoski (2016), glucocorticoid use 
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has been found to decrease BMD, resulting in the onset or increased risk of osteoporosis and 
fractures. The use of this medication causes the bone-building function of the osteoblasts to 
slow and inhibits the absorption of calcium from the gastrointestinal tract while increasing bone 
resorption by osteoclasts, thus preventing bone formation (Canalis & Delany, 2002:75; 
Pentyala et al., 2013:8). 
Whether or not the participants had any health disorders or medical conditions, they were 
asked about their intake of daily medication. Table 4.20 depicts the inferential statistics of the 
comparison of daily and non-daily intake of medication with regard to the BMD variables, BF% 
and BMI. The findings presented in Table 4.20 indicate that most of the participants use a 
form of daily medication (n = 25), with calcium being the most common (Table F.25 Appendix 
F). According to this study, there were no significant differences found between the mean 
scores for BMD, BF% and BMI respectively in relation to the intake of medication on a daily 
basis (Table 4.20). As the sample size was too small, there were no inferential statistics 
conducted for the types of daily medication used. 
Tai et al. (2015:1) recommend a calcium intake of 1000-1200 mg/day to treat and potentially 
prevent or delay the onset of osteoporosis. Researchers have recommended, and information 
has been provided for the general public, to increase the intake of calcium via dietary sources 
and supplementation to positively influence or maintain BMD (Greydanus & Patel, 2004:15-
17; Henning, 2014:124; Lamy & Burckhardt, 2014:1; Tai et al., 2015:1; Williamson, 2016:11).  
Calcium is responsible for bone remodelling, bone tissue repair, nerve conduction, muscular 
contraction and blood clotting (Smith, 2012:270; Williamson, 2016:11). The participants were 
asked about their weekly nutritional intake based on whether they consume the product every 
day, every week, only a limited number of times or never. According to the findings reflected 
in Figure 4.2, it can be deduced that the larger frequency of participants consume an adequate 
daily intake of calcium through their diet. The majority of the participants do not include calcium 
supplements in their weekly diet, but according to Greydanus and Patel (2004:15) Lamy and 
Burckhardt (2014:2) and Tai et al. (2015:1), it is advised to increase the daily intake of calcium 
through both diet and calcium supplementation.  
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5.7.6 Lifestyle Factors  
In order to limit the decrease in BMD and to delay the onset of osteoporosis, changes can be 
made to diet and nutritional intake, cigarette smoking and alcohol consumption (de Almeida 
Carvalho et al., 2014).  
5.7.6.1 Diet 
Protein is also responsible for the repair and synthesis of muscle tissue and can reduce the 
amount of muscle that is lost due to muscle fibre breakdown (Potgieter, 2013:1). The majority 
of the participants include protein in their daily diet (n = 34, 85%) as per Figure 4.2 and Table 
F.28 (Appendix F). The ingestion of protein in conjunction with calcium and vitamin D may 
potentially reduce the incidence of a stress fracture (Potgieter, 2013:14). The incorporation of 
protein into the diet has been recommended as it has the ability to increase bone mass and 
BMD (Heaney & Layman, 2008:1568).  
The ingestion of alkalinizing fruits and vegetables has a positive influence of BMD (New et al., 
2000:143; Heaney & Layman, 2008:1568S). As per the findings of this study, the majority of 
the participants include fruits and vegetables into their daily diet (n = 37, 93%), as indicated in 
Figure 4.2 and Table F.29 (Appendix F). No further analyses were conducted in this study 
regarding diet. 
5.7.6.2 Calcium 
It is recommended to include calcium into one’s diet to treat and prevent osteoporosis (Tai et 
al., 2015:1). The intake of calcium regulates bone metabolism and remodelling to ensure 
adequate BMD levels (Vorster et al., 2001:21; da Silva et al., 2012:204; Wentz et al., 
2012:375; Jenkins & Tortora, 2013:77; Ohta et al., 2016:208). An inadequate intake of calcium 
can result in the increased incidence of stress fractures, especially in endurance athletes 
(Kalkwarf et al., 2003:257; Baheiraei et al., 2005:2; Smith, 2012:270; Wentz et al., 2012:375; 
Kim et al., 2016:8).  
5.7.6.3 Cigarette Smoking 
It has been noted that according to Table F.32, the majority of the participants in this study (n 
= 31, 78%) do not smoke cigarettes, but 8 of the runners smoked cigarettes in the past (20%) 
and 1 runner still smokes. Table 4.21 depicts the inferential statistics of the comparison 
between cigarette smokers and non-cigarette smokers with regard to the BMD variables, BF% 
and BMI. Cigarette smoking correlates negatively with BMD, as it can cause osteoporosis and 
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increase the rate of bone resorption, which affects females more than males (Kruger et al., 
2011:749; Runolfsdottir et al., 2015:26).  
The findings of the study by Baheiraei et al. (2005:8) were that the BMD of the lumbar spine 
and femoral neck are lower in those who smoke cigarettes than those who do not smoke. 
Cigarette smoking also negatively influences the production of oestrogen, which limits the 
absorption of calcium from the gastrointestinal tract and affects the production and 
maintenance of bone (Kruger et al., 2011:749). Baheiraei et al. (2005:10) found a correlation 
between the cessation of cigarette smoking and the increase in BMD of the lumbar spine and 
the femoral neck. Table 4.21 indicates that there were no significant differences in the mean 
scores for BMD, BF% and BMI respectively for those who have smoked or currently smoke 
cigarettes and non-cigarette smokers in this study. 
5.7.6.4 Alcoholic Beverages 
Alcohol consumption has been linked to the increase in bone resorption and the onset of 
osteoporosis, resulting in the potential risk of fractures (Jang et al., 2017:9; Kruger et al., 
2011:749). The consumption of more than two alcoholic beverages a day can increase the 
risk of an osteoporotic fracture, especially in white females (Kruger et al., 2011:749) but 
according to Mukamal et al. (2007:594), a moderate intake of alcohol can affect BMD 
positively and has no influence over the onset of osteoporosis.  
Table 4.22 indicates the inferential statistics of the comparison between alcohol consumption 
and non-alcohol consumption with regard to the BMD variables, BF% and BMI. According to 
the findings of the study (Table 4.22), the majority of the participants consume alcoholic 
beverages (n = 34) at a rate of between one and five alcoholic beverages per week (n = 25) 
as indicated in Table 4.23. A significantly higher (p < .50; d > 0.2) BMD of the lumbar spine 
was found for those runners who consumed alcohol (1.05 ± 0.12) versus those who did not 
consume alcohol (0.93 ± 0.11) (see Table 4.22). Table 4.23 indicates the large significant 
difference in the Z-score of the femoral neck that was found between those who drank five or 
fewer alcoholic beverages (0.58 ± 0.98 beverages) and those who drank more than five 
alcoholic beverages (-0.29 ± 0.78 beverages) per week.   
Consuming more than 14 alcoholic beverages per week was found to have a positive influence 
on BMD, according to the study findings by Mukamal et al. (2007:597). Findings by Jang et 
al. (2017:5) posit that BMD of the femoral neck may increase with the consumption of alcohol, 
but alcohol consumption on more than four days per week can cause a decline BMD in. The 
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findings of the present study seem to support the positive effect of a moderate intake of alcohol 
on BMD ratings. 
5.7.6.5 Carbonated Beverages and Caffeine 
In relation to this study, the greater number of runners (n = 19, 48%) incorporate carbonated 
beverages into their diet minimally each week as per Figure 4.2 and Table F.31 (Appendix F). 
The consumption of carbonated beverages can lead to a decline in BMD, according to a study 
conducted by Bukhar et al. (2012:686). BMD declines due to the decrease in blood calcium 
levels caused by the elevated levels of phosphorus in carbonated beverages and can 
ultimately lead to osteoporosis (Ogur et al., 2007:334; Bukhar et al., 2012:686), leading to a 
further decrease in calcium levels within the blood (Ogur et al., 2007:334; Bukhar et al., 
2012:679). According to a study by Kim et al. (1997:281), no association was found between 
BMD and the consumption of carbonated beverages. 
Caffeine intake, such as in coffee, has been found to influence BMD negatively, as consuming 
large amounts of caffeine can affect the body’s ability to absorb calcium (Bukhar et al., 
2012:684). Findings by Smith (2012:270), who determined the impact of both low to moderate, 
as well as high intake of caffeine, indicate that only consuming large amounts of caffeine can 
cause the urinary excretion of calcium, which can then lower BMD. The results of the present 
study, as reflected in Figure 4.2 and Table F.30 (Appendix F), indicate that caffeine intake 
occurs daily by almost all the participants (n = 39, 98%). No further analyses for the intake of 
carbonated beverages and caffeine were conducted. 
5.7.6.6 Lactose Intolerance  
Table F.22 (Appendix F) indicates that the larger proportion of the participants (n = 32, 80%) 
are not lactose intolerant, while 18% (n = 7) of the sample were unsure as to whether or not 
they are lactose intolerant. The remaining participant is lactose intolerant. As the majority 
claimed that they are not lactose intolerant, no inferential statistical analyses could be 
conducted to determine association of lactose intolerance on the BMD of the participants.  
In line with the above-mentioned discussion and relevant research that was reviewed, the 
runners in this study seem to have followed a lifestyle that did not pose a potential risk for a 
negative effect on BMD. 
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5.7.7 Training Load 
This study was specifically aimed at profiling the BMD, BMI and BF% of female long distance 
runners and determining the impact of their chosen sport on the three aforementioned factors. 
One of the requirements for participation in the study was to have completed at least two 
marathon events and or an ultra-marathon running event, otherwise referred to as long 
distance running. Not all of the participants had completed an ultra-marathon event, but 
everyone had to have completed at least two marathon events in order to qualify to participate 
in the study.  
This section first focuses on participants’ running regime, such as their weekly distances and 
frequencies, the number of marathon and ultra-marathon events they have completed as well 
as the number of running years they have accumulated. It also includes information on 
involvement in strength and conditioning training, for example if they engage in a strength-
based program and if so, the frequency per week of that training. All of the information about 
their training and number of events participated in as well as the quality of their performances 
in these long distance events were used to determine the impact of long distance running on 
particularly BMD but also on their BMI and BF%.  
The findings of this study indicated that the majority of the participants (n = 27) have only been 
running long distance events, both socially and competitively, for fewer than 11 years, 
according to Table 4.24 and Figure 4.3. Table 4.25 depicts that the majority of the participants 
(n = 24) have completed between two and 10 marathon events, (Table 4.25 and Figure 4.4), 
and between one and five ultra-marathon events (Figure 4.4). 
Table 4.24 depicts the inferential statistics of the comparison between the two categories, 
namely the lower versus the higher number of long distance running years completed and 
how the participants in these categories compare with respect to the BMD variables, BF% and 
BMI. The findings depicted in Table 4.24 indicate that there are no significant differences 
between the mean scores for the BMD variables, BF% and BMI respectively of those who 
have completed fewer than 11 long distance running years and those who have completed 
more than 10 long distance running years, both socially and competitively.  
Table 4.25 presents the inferential statistics for the comparison between the two categories of 
total number of completed marathon events in respect of BMD variables, BF% and BMI. The 
results reflected in Table 4.25 indicate that there were no significant differences found in the 
mean scores for BMD, BF% and BMI respectively when comparing those who have competed 
in 10 or fewer marathon events with those who have completed 11 or more marathon events. 
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Those who have participated in more than 11 marathon events have slightly greater mean Z-
score ratings, and thus a better BMD for their age group and also a lower mean BF% and 
BMI, although these differences were not significant. 
When comparing the differences in BMD, BF% and BMI respectively in relation to participation 
in ultra-marathons versus no participation in such events, the results in Table 4.26 indicate 
that there is a significant difference (p < .05; d > 0.2) between the number of completed ultra-
marathons and BF% as well as BMI respectively. The mean values for BF% was significantly 
higher in those who have completed five or fewer ultra-marathon events (28.76 ± 5.21%) 
compared to those who have completed six or more ultra-marathon events (24.67 ± 6.81%). 
The mean value for BMI was also significantly higher in those who have completed five or 
fewer ultra-marathon events (23.75 ± 2.38 kg/m²) compared to those who have completed six 
or more ultra-marathon events (21.86 ± 2.48 kg/m²). The mean values for BMD and Z-score 
variables were found to be slightly higher in those who have participated in five or fewer ultra-
marathon events (n = 20) compared to those who have participated in more than six ultra-
marathon events (n = 20), but these differences are small and not significant. 
Similarly, when comparing BMD, BF% and BMI respectively in relation to the total number of 
long distance events completed (marathons plus ultra-marathons) by the runners involved in 
this study, Table 4.27 indicates that the mean values for the femoral neck, hip total, lumbar 
spine and total body BMD are greater in those who have participated in fewer than 11 long 
distance running events in total compared to those who have participated in more than 10 
long distance running events. These differences are not significant. The mean values for BF% 
and BMI were also greater in those who have participated in fewer than 11 long distance 
running events, but these differences were also insignificant.  
Table 4.28 indicates the inferential statistics for the comparison between the categories for 
best marathon completion times in respect of the BMD variables, BF% and BMI. The findings 
reflected in Table 4.28 indicate that the mean value for BF% was significantly lower (p < .05; 
d > 2) in those who completed a marathon in under three hours and 50 minutes (23.41 ± 
8.03%) compared to those who have completed a marathon in equal to or over three hours 
and 50 minutes (28.30 ± 4.72%). Table 4.28 indicates that those who have completed a 
marathon event in under three hours and 50 minutes have slightly lower mean values for BMD 
and BMI ratings, but these differences were not significant.  
Findings by Knechtle et al. (2012:254) correlate with those of this study as reflected in Tables 
4.26 and 4.28. According to Knechtle et al. (2012:254), ultra-marathon runners have a lower 
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BF%, which coincides with the results presented in Table 4.26, which reflect that those who 
completed five or fewer ultra-marathon events had a higher BF% and BMI than those who 
completed six or more ultra-marathon events. Knechtle et al. (2012:254) posit that an 
association has been found whereby completing a long distance running event in a shorter 
time will result in a lower BF%. The findings of the present study indicated that BF% was lower 
in those who completed a marathon in a shorter time, therefore, correlating to the findings of 
the study conducted by Knechtle et al. (2012:254).  
According to research, physical activity stimulates bone formation to maintain BMD and 
prevent the onset of osteoporosis (Pollock et al., 2010:419; Korsten-Reck, 2011:158; Kruger 
et al., 2011:756; de Almeida Carvalho et al., 2014). It is recommended that load bearing 
exercises and resistance training be incorporated into the training regime (Burrows & Bird, 
2000:282; Gibson et al., 2004:611; Pollock et al., 2010:420; Wilkin et al., 2010:205; de 
Almeida Carvalho et al., 2014; Abd El Mohsen et al., 2016:2579; Kim et al., 2016:2; Stunes et 
al., 2017:13). According to a study conducted by Marques et al. (2011:529), resistance training 
has a positive influence on BMD, especially at the hip.  
Table 4.29 presents the inferential statistics of the comparison between the categories of 
average weekly running distance per year in respect of BMD variables, BF% and BMI. The 
runners’ average weekly running distance per year was divided into two categories, 30-50 (n 
= 17) and 51-100 (n = 23) km/week respectively. The runners in each of these two running 
distance categories were compared with each other with respect to each of the BMD ratings, 
as well as with the mean BMI and BF% values. Table 4.29 indicates that there is a significant 
difference (p < .05; d > 0.2) for the hip total Z-score with the lower average weekly running 
distance per year category presenting the higher value (0.81 ± 0.77 versus 0.24 ± 0.89 g/cm2). 
A significant difference (p < .05; d > 0.2) for both BF% and BMI were found with the lower 
average weekly running distance per year category presenting with the higher BF% (29.97 ± 
6.27 versus 24.30 ± 5.31%) and BMI (24.10 ± 2.79 versus 21.85 ± 1.97 kg/m2).  
Studies conducted by Duncan et al. (2002:294), Andreoli et al. (2012:69) Selingerova et al. 
(2015:273) and Stiles et al. (2017:1851), indicate that physical activity influences BMD 
positively in that BMD is increased. Pollock et al. (2010:421) and Wentz et al. (2012:380) 
found that there is a negative association between the hours that are spent training within the 
week and a lowered BMD of the lumbar spine and the total body. According to Duncan et al. 
(2002:288), a positive correlation has been found between the BMD of the arm and the hours 
of training per week. The results of the present study as reflected in Table 4.29, support 
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Pollock et al. (2010:421) and Wentz et al. (2012:380), as the lumbar spine was found to have 
a lower BMD than the other body segments that were analysed.  
According to Vorster et al. (2001:21) and Wentz et al. (2012:381), intense training over a 
prolonged period can cause an elevated bone turnover due to the increased bone resorption 
by the osteoclasts. The bone formation and resorption cycle is, therefore, affected negatively. 
Endurance running increases the mechanical load that is placed on the body, which protects 
against the loss of bone and the area of the body that is exposed to the greatest amount of 
stress will present the higher BMD rating (Pollock et al., 2010:420; Andreoli et al., 2012:73; 
Williamson, 2016:12). As per Table 4.29, the hip total Z-score was found to be significantly 
higher than the other body segments, which supports Pollock et al. (2010:420), Andreoli et al. 
(2012:73) and Williamson (2016:12) and may indicate that most of the mechanical loading 
occurred in the hip region. 
The running season is divided into a pre-season, in-season and an off-season. Running 
distances and frequency increase from pre-season to in-season and then begins to decline 
during the off-season. The running distance per week during each running season can be 
found in Appendix F (Tables F.41 to F.46).  
It has been found that an increase in running distance, frequency and intensity may influence 
the BMD rating negatively (Pollock et al., 2010:420; Benca et al., 2013:351). This is due to the 
increase of the mechanical loading that is placed on the body during endurance running, which 
can interrupt the balance between bone resorption and bone formation (Williamson, 2016:12; 
Wentz et al., 2012:381; Pollock et al., 2010:420; Kim et al., 2014:716). According to Burrows 
and Bird (2000:282), in order to maintain BMD, it is advised to run between 20 and 30 km per 
week for 2 to 3 for a duration of 20 to 60 minutes. The present study indicates that the higher 
proportion of the sample engage in an average weekly running distance of 51 to 100 km (Table 
4.29) for longer than 60 minutes at a time. The runners in this study all exceeded the 
recommendation by Burrows and Bird (2000:282), which may have affected their BMD 
negatively (Pollock et al., 2010:420; Benca et al., 2013:351).  
It is also recommended to incorporate physical activity such as resistance and load bearing 
exercises into one’s running training regime (Gibson et al., 2004:612; Wilkin et al., 2010:205; 
de Almeida Carvalho et al., 2014; Stunes et al., 2017:13). Physical activity can stimulate bone 
formation, thus enabling the maintenance of BMD to limit bone loss and prevent the onset of 
osteoporosis (Pollock et al., 2010:421; Kruger et al., 2011:756; Andreoli et al., 2012:73; de 
Almeida Carvalho et al., 2014).  
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The results presented in Table 4.30 indicate that most of the participants (n = 21, 53%) include 
strength and conditioning exercises in their training regime twice per week (Table F.49 
Appendix F). Table 4.30 indicates that there were no significant differences for the BMD, BF% 
and BMI respectively for those who implemented a strength and conditioning program and 
those who did not. The mean values for the BMD of the femoral neck, the hip total, the lumbar 
spine and the total body are slightly greater for those who do incorporate a strength and 
conditioning program and the Z-scores are slightly lower in those who implement a strength 
and conditioning program compared to those who do not.  The BMI and BF% are slightly 
greater for those who do not implement a strength and conditioning-based program. None of 
the observed differences reflected in Table 4.30 were significant and the results should be 
interpreted with caution. 
Research appears to recommend that long distance runners incorporate resistance exercises 
into their training regime to maintain BMD (Bemben et al., 2004:222; Bacelar et al., 2015:101). 
According to a study by Marques et al. (2011:529), participating in a resistance exercise 
training program for eight months was found to increase bone mass, especially in the hip 
region, due to the stimulation of bone formation. The implementation of a strength-based 
training regime stimulates the osteogenic activities of bone, which increases the BMD 
(Marques et al., 2011:529; Morseth et al., 2011:1230; Andreoli et al., 2012:74; Stunes et al., 
2017:14). The present study could not find evidence in support of the recommendation by 
Bemben et al. (2004:222) and Bacelar et al. (2015:101). 
5.7.8 Running Shoe Type and Running Style 
The type of running shoe worn by runners is based on individual preferences, comfort and 
affordability. The majority of the participants (n = 35, 88%) involved in this study reported that 
they currently use a neutral shoe (Table 4.31). In terms of the running style, a forefoot strike 
pattern is the most common running style (n = 13, 33%), according to Table 4.32.  According 
to Williams et al. (2012:526), using a forefoot striking pattern can reduce the amount of power 
that is absorbed by the lower extremity, thereby reducing the risk of an injury.  
The decision for the replacement of running shoes is different for each person and may be 
due to the wear and tear on the shoes. Runners may replace their running shoes after a certain 
number of months or after a certain distance. Henning (2014:124) recommends that running 
shoes be replaced after 400 to 800km of use. The runners in this study expressed their 
preferred time for changing their running shoes as being either the total kilometres run or the 
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total number of months in use, resulting in a divide in the already small sample size, thus 
jeopardizing further statistical analysis. 
In this study, the higher frequency of the participants who chose to replace their running shoes 
after a certain number of months (n = 26), would have replaced them after 12 months of use 
(n = 11, 42%) (Table 4.33), whereas the highest frequency of those who chose to replace their 
running shoes after a certain distance (Table 4.34), indicated replacing them after 800km of 
wear (n = 5, 38%). It appears that the runners in this study are following Henning’s (2014:124) 
recommendation.  
5.8 SUMMARY OF FINDINGS 
The purpose of this research study was to investigate the BMD of female long distance runners 
in Nelson Mandela Bay. The study aimed to describe and correlate the BMD, BF% and BMI 
of the sample participants as well as to identify the relationships that occurred between BMD, 
BF% and BMI respectively and each of a number of variables. For the purpose of this 
quantitative research study, a questionnaire as well as anthropometric and densitometry 
assessments were conducted, and appropriate statistical analyses applied in order to achieve 
the relevant objectives that were set.  
The questionnaire, which constituted the first phase of gathering information, was 
implemented to identify demographical information, the female reproductive variables, bone 
health indicators, disease history, medication, lifestyle factors, training load, running shoe 
used and running style of the runners.  
The second phase of assessments included the measuring of height and weight to determine 
BMI and subsequently facilitating the densitometry scans conducted by radiographers to 
determine the various BMD variables and BF%. A total of 40 female long distance runners 
participated in and completed the study. The research study was conducted at the Biokinetics 
and Sports Science Unit of the High Performance Complex at the Nelson Mandela University.  
A final summary of the results obtained are as follows: 
 There was a total of 40 female runners who participated in the research study. The 
ages ranged between 26 years and 68 years of age with the majority being in the 31 to 
50 years (n = 29) age category. The mean age and standard deviation of the 
participants involved were 43.6 ± 9.67 years.  
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 The majority of the participants were members of running clubs (80%) and there was a 
total of 12 different running clubs from which the participants were drawn. The 
remaining participants met the inclusion criteria of the study but were not registered 
members of any club. 
 The BMI of the runners was determined based on the height and weight measurements 
that were taken. The majority of the participants (n = 34, 85%) were found to be within 
the ‘normal’ (22.02 ± 1.79 kg/m²) category for the BMI rating with the others (n = 6; 
15%) being classified as ‘overweight (27.26 ± 1.67 kg/m²). The overall rating for the 
sample was also ‘normal’ based on the overall mean BMI (22.80 ± 2.58 kg/m²). 
 Based on the bone densitometry reports of the BF% of each individual, which were 
expressed in relation to age and interpreted according to normative data, the runners 
were classified as follows: 
o Excellent (n = 7, 18%) (18.39 ± 3.15%) 
o Good (n = 7, 18%) (21.79 ± 2.52%) 
o Average (n = 6, 15%) (26.63 ± 3.13%) 
o Below Average (n = 12, 30%) (29.825 ± 2.76%) 
o Poor (n = 8, 20%) (33.7 ± 4.94%) 
The overall rating for the sample was ‘average’ based on the mean BF% of 26.71 ± 
6.33% which was interpreted according to the mean age of the sample.  
 The runners’ mean Z-scores of the femoral neck, the hip total, the lumbar spine and 
the total body were all considered to be within the normal range. The mean values for 
the T-scores of the femoral neck, the hip total and the total body were also all 
considered to be within the normal range, whereas the lumbar spine was classified as 
osteopenic.  
 The Pearson-Product Moment Correlation analysis indicated a significant correlation (r 
≥ 0.312) between the BMI and the Z-scores of the femoral neck, the hip total, the lumbar 
spine and the total body as well as the lumbar spine BMD respectively. There were no 
significant correlations found between BF% and the Z-scores or BMD values.  
 When comparing the mean values of BMD, BF% and BMI respectively in relation to 
various variables, inferential statistical analyses revealed no significant relationships in 
respect of: 
 The two age categories (Younger, 20-40 years versus Older, 41-70 years); 
 The age at which menarche occurred (Early, 10-12 years of age versus Late, 13+ 
years of age);  
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 The use of contraceptive medication (Yes versus No) and the types of contraceptive 
medication used (Hormonal versus Barrier Methods); 
 Broken a bone due to a non-traumatic event (Yes versus No);  
 A family history of osteoporosis (Yes versus No); 
 The daily intake of medication (Yes versus No); 
 Cigarette smoking (Yes versus No); 
 The total number of long distance running years (<11 years versus >10 years);  
 The total number of marathons completed (≤10 versus ≥11); 
 The total number of completed long distance running events (<11 versus >10);  
 The implementation of a strength and conditioning program (Yes versus No).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 When comparing BMD, BF% and BMI respectively in relation to a number of variables, 
inferential statistical analyses revealed specific significant (p < .05; d > 0.2) differences 
for the following comparisons: 
 Normal versus overweight (according to BMI classification): 
Higher mean femoral neck (1.17 ± 0.75 versus 0.25 ± 0.95) and mean hip total 
(1.17 ± 0.782 versus 0.36 ± 0.84), Z-scores as well as a higher mean BF% (33.20 
± 3.77 versus 25.57 ± 6.02%) associated with an ‘overweight’ classification. 
 None versus one or more full-term pregnancies:                                                                                                                                                                      
Lower mean femoral neck Z-score (0.81 ± 0.12 versus 0.90 ± 0.11) associated with 
one or more full-term pregnancies. 
 Menopausal versus non-menopausal females: 
Higher mean femoral neck BMD (0.85 ± 0.10 versus 0.76 ± 0.11 g/cm²), mean 
lumbar BMD (1.05 ± 0.12 versus 0.92 ± 0.11 g/cm²) and mean total BMD (1.20 ± 
0.11 versus 1.10 ± 0.11 g/cm²) associated with non-menopausal participants. An 
elevated mean BF% (31.28 ± 5.35 versus 25.03 ± 5.79%) was found in menopausal 
participants. 
 Breaking versus not breaking a bone due to a traumatic event: 
A higher mean BMI (23.18 ± 2.57 versus 20.67 ± 1.41 kg/m²) was associated with 
not breaking a bone due to a traumatic event. 
 Consuming versus not consuming alcoholic beverages:  
Higher mean lumbar BMD (1.05 ± 0.12 versus 0.93 ± 0.11 g/cm²) was associated 
with consuming alcoholic beverages. A higher mean femoral neck Z-score (0.58 ± 
0.98 versus -0.29 ± 0.78) associated with consuming five or fewer alcoholic 
beverages per week. 
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 Completing five or fewer versus six or more ultra-marathon running events: 
A lower mean BF% (24.67 ± 6.81 versus 28.76 ± 5.21%) and mean BMI (21.86 ± 
2.48 versus 23.75 ± 2.38 kg/m²) was associated with completing six or more ultra-
marathon running events. 
 Completing a marathon in under three hours and 50 minutes versus more than 
three hours and 50 minutes: 
A lower mean BF% (23.41 ± 8.03 versus 28.30 ± 4.72%) was associated with 
completing a marathon event in less than or equal to three hours and 50 minutes, 
a shorter duration. 
 Average running distance of 30-50 km/week versus 51-100 km/week: 
A higher mean hip total Z-score (0.81 ± 0.77 versus 0.24 ± 0.89) was associated 
with an average weekly running distance of 30-50 km. A lower mean BF% (24.30 
± 5.31 versus 29.97 ± 6.27%) and mean BMI (21.85 ± 1.97 versus 24.10 ± 2.79 
kg/m²) was associated with an average weekly running distance of 51-100 km. 
 In addition to the significant differences found, other non-significant trends were noted. 
The following trends are to be observed with caution as they were merely an 
observation of similarity and not due to any significant differences that were found. The 
trends were determined if all the variables presented a similar finding. Similarities were 
noted when the following sets of variables displayed the same trend:  femoral neck, the 
hip total, the lumbar spine and total body for either the BMD or Z-scores respectively 
and the BF% and BMI. 
 The mean Z-scores for all variables were higher in the older age group (41-70 years 
of age) than in the younger age group (20-40 years of age).  
 The mean BMD and Z-scores for all variables were higher in the group that was 
classified as ‘overweight’ versus those in the ‘normal’ classification with regard to 
BMI classification.  
 The mean BF% and BMI was higher in those who use hormonal contraception as 
opposed to barrier methods.  
 The mean Z-scores for all variables were higher in those who had no incidence of 
breaking a bone due to trauma than in those who had. The BF% was also higher 
in those who had not broken a bone due to a traumatic event than in those who 
had. 
 The mean BMD and Z-scores for all variables were lower in those who take daily 
medication versus those who do not. 
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 The mean BMD for all variables was higher in those who consume alcoholic 
beverages compared to those who do not. The mean BMD and Z-scores for all 
variables were higher in those who consumed five or fewer alcoholic beverages in 
comparison to those who consume more per week. The mean BF% and BMI was 
lower in those who consume more than 5 alcoholic beverages per week than in 
those who consumed 5 or fewer per week. 
 The mean Z-scores for all variables were lower in those who have participated in 
fewer than 11 years of long distance running compared to those who have 
participated in more than 10 years of long distance running. The BF% and BMI was 
higher in those who have participated in fewer than 11 years of long distance 
running compared to those who have participated for more than 10 years. 
 The mean Z-scores for all variables were lower in those who have completed 10 or 
fewer marathon events than in those who completed more. 
 The mean BMD for all variables was higher in those who have completed five or 
fewer ultra-marathon running events, whereas the mean BF% and BMI was lower 
in those who have completed six or more ultra-marathon running events.  
 The mean BMD for all variables was higher in those who have participated in fewer 
than 11 long distance running events, and the mean BF% and BMI was lower in 
those who have participated in more than 10 long distance running events 
 The mean BMD for all variables, as well as the mean BF% and BMI, was lower in 
those who completed a marathon in less than or equal to three hours and 50 
minutes than in those who took longer to complete such events.  
 The mean BMD for all variables was higher in those who incorporate a strength 
and conditioning program during the week, but the mean Z-scores for all variables 
were lower in those who incorporate a strength and conditioning program during 
the week than in those who do not. The mean BF% and BMI was lower for those 
who implement a strength and conditioning program compared to those who did 
not. 
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5.9 CONCLUSION 
From the results of the study of 40 female long distance runners, the following conclusions 
were drawn. 
 The overall Z-score and T-score values of the runners were found to be within the 
normal range, but the T-score value of the lumbar spine component was considered to 
be osteopenic, according to the normative data provided to interpret the Z-scores and 
T-scores. The overall BMD was found to be normal, as BMD is expressed by means of 
Z-scores. 
 The BF% and BMI of the runners overall were classified as ‘average’ and ‘normal’ 
respectively. 
 BMD-related Z-scores correlated significantly with the BMI of the runners, but not with 
their BF%. 
 BMD (one or more ratings and or Z-score), was positively influenced (had higher 
ratings), in runners who:   
 Were overweight. 
 Consumed five or fewer alcoholic beverages per week.   
 Ran less than 51 km/week.  
 BMD (one or more ratings and or Z-score), was negatively influenced (had lower 
ratings), in runners who:  
 Had more full-term pregnancies. 
 Were menopausal. 
 BF% and BMI were both found to be lower in runners who:  
 Were not menopausal. 
 Competed in six or more ultra-marathon events. 
 Completed marathons in under three hours and 50 minutes. 
 Have an incidence of breaking a bone due to a traumatic event. 
 Engaged in an average weekly running distance of more than 50 km.  
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5.10 LIMITATIONS 
Certain limitations were associated with this study and the list below needs to be considered.  
 The relatively small sample size limited the extent and power of the possible statistical 
analyses and the fact that convenience sampling was used also limits the 
generalisability of the results. Nevertheless, the results obtained do provide an insight 
into the BMD status of female long distance runners, an area of research that is 
otherwise sparsely informed.   
 The majority (all except two) of the female participants were Caucasian and the results 
are not reflective of different ethnicities. The study only included female long-distance 
runners, and the findings are limited to one gender.  
 To obtain the BMD results from the relevant scans, a qualified radiographer with the 
expertise to operate the bone densitometer was required. Two radiographers were 
used for this study due to circumstances out of the control of the primary researcher. 
This may have influenced the inter-observer reliability. Both were qualified 
professionals with specific experience in operating the relevant densitometer the 
impact of this limitation may be negligible.  
5.11 RECOMMENDATIONS 
The following are recommendations for future research:  
 The present study should be repeated but with a larger sample of runners and ensuring 
that there is enough representation of runners from each ten-year age band, including 
menopausal runners. 
 The present study should be repeated with other ethnic groups represented. 
 Experimental or intervention strategies should be implemented to identify the impact on 
runners and or other females presenting with lower than the norm for age BMD ratings. 
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Appendix A: Ethics Approval 
 
Copies to:    
Supervisor:       Prof R du Randt  
Co-supervisor:     Ms S-A Kock  
Summerstrand South  
Faculty of Health Sciences  
Tel. +27 (0)41 504 2956     
Fax. +27 (0)41 504 9324  
Marilyn.Afrikaner@nmmu.ac.za  
 3 June 2016  
 
Student number:   212248359  
  
Contact person:  Ms M Afrikaner   
MS C MEIER  
90 GREENACRES VILLAGE  
ASCOT ROAD  
GREENACRES  
PORT ELIZABETH  
6045  
  
RE: OUTCOME OF PROPOSAL SUBMISSION  
  
QUALIFICATION: MA (Human Movement Science: Research)  
FINAL RESEARCH/PROJECT PROPOSAL:    
BONE MINERAL DENSITY OF FEMALE LONG DISTANCE RUNNERS IN NELSON MANDELA BAY         
Please be advised that your final research project was approved by the Faculty Postgraduate Studies 
Committee (FPGSC) subject to the amendments / recommendations being made to the satisfaction 
of your Supervisors:  
FPGSC grants ethics approval.  The ethics clearance reference number is H16-HEA-HMS-004 and is 
valid for three years.  
 We wish you well with the project.  
  
Kind regards,  
  
Marilyn Afrikaner   
FPGSC Secretariat   
Faculty of Health Sciences    
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Appendix B: Request to the NMB Running clubs for permission to involve female 
runners in the research study and to inform them about the study 
 
 
 
 
 
 
PO Box 77000  
Nelson Mandela Metropolitan University 
Port Elizabeth  
6031  
South Africa  
www.nmmu.ac.za 
 
 
Faculty of Health Sciences 
Department of Human Movement Science 
School of Lifestyle Sciences 
Tel: 041 504 4692 
E-mail: cathm17@gmail.com (primary researcher) 
Rosa.DuRandt@nmmu.ac.za (supervisor) 
Date: June 2016Manager of Running Club 
Re: REQUEST TO INVITE REGISTERED RUNNERS TO PARTICIPATE IN A RESEARCH 
STUDY 
My name is Catherine Meier and I am a Biokinetics masters student at the Nelson Mandela 
Metropolitan University (NMMU). I am investigating the Bone Mineral Density and body 
composition of registered runners in Nelson Mandela Bay. This research will be conducted 
under the supervision of Professor Rosa du Randt. 
I have received clearance from the Human Movement Science (HMS) Department’s Research 
Committee and the Faculty of Health Sciences Research Technology, Innovation (FRTI) to 
proceed with the data collection phase of my study. I have also been granted ethics approval 
for the study, reference number: H16-HEA-HMS-004. 
I would like to request permission to invite registered runners over the age of 18 years to 
participate in a study regarding Bone Mineral Density and body composition of female long 
distance runners. I hence need your permission to approach the runners of the various running 
clubs to allow them the ability to be included within this study.  
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Aim and objectives of the research: 
The main research aim of this study is to determine the Bone Mineral Density rating as well 
as its association with body fat and other selected factors among female long distance runners 
in Nelson Mandela Bay using the Dual-Energy X-ray Absorptiometry (DXA). The information 
obtained may facilitate not only runners but additionally health care practitioners in 
implementing preventative measures due to identifying the status and possible stressors 
affecting Bone Mineral Density in selected NMB running clubs. 
The objectives of the study are: 
1. To describe the BMD, BF% and BMI of long distance female runners  
2. To determine the relationship between BMD of long distance female runners and their 
BF% and BMI respectively. 
3. To determine the effect of the following variables on the BMD, BF% and BMI 
respectively of long distance female runners: age, anthropometric measurements, 
female reproductive variables, bone health indicators, disease history, medication, 
lifestyle factors, training load, running shoe and running style 
Significance of the study: 
The rationale of the study will provide fellow researchers as well as health care practitioners 
such as Physiotherapists and Biokineticists with information on the BMD ratings of long 
distance female runners which prevail in selected NMB running clubs. The study may 
additionally provide baseline data for future studies aimed at determining the risk factor for 
osteoporosis in female runners and potential intervention strategies to minimize the onset of 
this condition. The running population in the NMB may benefit from the study by increasing 
their knowledge regarding BMD, body fat percentages and overall health status.  
Your positive consideration of the request to participate in this research study will be much 
appreciated.  
Yours sincerely 
Catherine Meier      Rosa Du Randt 
Researcher       Supervisor  
Tel: 082 754 4641      Tel: 041 504 2499 (Work)
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Faculty of Health Sciences 
NMMU 
Tel: +27 (0)41 504 4692 
E-mail supervisor: Rosa.DuRandt@nmmu.ac.za 
                            Date: 2016 
 
Ref: H16-HEA-HMS-004 
Dear Runner  
You are being asked to participate in a research study. I am currently completing my Master’s 
degree in Human Movement Science at the Nelson Mandela Metropolitan University. The 
research explores the Bone Mineral Density and Body Composition of registered female 
runners in Nelson Mandela Bay who are over the age of 18 years.  
Research procedure 
The study involves female participants who are currently registered as members of various 
running clubs in NMB. The information will be coded to ensure anonymity of participation. Data 
analysis and report writing will maintain anonymity of results. No responses of individual 
participants will be upheld at all times.   
Should you choose to participate, please note that: 
 Your participation in this research is entirely voluntary; you are free to choose to participate 
or not to participate. 
 You may withdraw at any time, since there is no penalty for withdrawing or refusing to 
participate. 
 If you agree to participate it indicates that you understand the purpose of this study, and 
are voluntarily consenting to participate in this research.  
 All information will be treated with the utmost confidentiality. 
 The results will only report group data sets and not those of individuals thereby maintaining 
anonymity and confidentiality within the study.  
 Information gathered through this study will be stored in an Excel data file.  Only the post-
graduate student, Catherine Meier, and her supervisor, Professor Rosa Du Randt, will 
have access to the coded data collected during this study.  Although your identity will 
remain confidential at all times, the results of the research may be presented at a scientific 
conference or in a peer-reviewed publication.  
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This project has received ethical clearance from the university Ethics Committee, Ref: H16-
HEA-HMS-004.  If you have any questions or concerns regarding your rights as a participant 
in this study, you may contact the Chairperson of the Research Ethics Committee (Human): 
Professor Charmain Cilliers by telephone at 041-504 2235, or by email at 
Charmain.Cilliers@nmmu.ac.za 
If you have any questions to be answered and clarified pertaining to this study, please contact 
Catherine Meier at 082 754 4641 or Rosa du Randt 041 504 2499 (Work).  
Thank you for your time and interest. 
Catherine Meier 
Email: cathm17@gmail.com 
Tel:  082 754 4641 
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Appendix C: Consent Form 
NELSON MANDELA METROPOLITAN UNIVERSITY 
 
INFORMATION AND INFORMED CONSENT FORM 
RESEARCHER’S DETAILS 
Title of the research project 
Bone Mineral Density of female long distance runners in the Nelson Mandela 
Bay 
Reference number  
Principal investigator Catherine Meier 
Address 90 Greenacres Village 4, Ascot Road, Greenacres, Port Elizabeth 
Postal Code 6045 
Contact telephone number 
(private numbers not 
advisable) 
082 754 4641 
 
A. DECLARATION BY OR ON BEHALF OF PARTICIPANT  Initial 
I, the participant and the 
undersigned 
(full names) 
  
ID number  
OR  
I, in my capacity as (parent or guardian) 
of the participant (full names) 
ID number  
Address (of participant)  
 
A.1 HEREBY CONFIRM AS FOLLOWS:  Initial 
I, the participant, was invited to participate in the above-mentioned research project   
that is being undertaken by Catherine Meier 
From The department of Human Movement Science 
of the Nelson Mandela Metropolitan University. 
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 THE FOLLOWING ASPECTS HAVE BEEN EXPLAINED TO ME, THE PARTICIPANT:  Initial 
2.1 Aim:   
The main research aim of this study was to determine the Bone 
Mineral Density rating as well as its association with body fat and 
other selected factors among female long distance runners in 
Nelson Mandela Bay. 
  
   
2.2 Procedures:   
I understand that a DXA scan on a bone densitometer will be 
conducted to determine BMD as well as Body Composition. 
  
2.3 Risks: 
Confidentiality breach will be maintained by administering a 
number in terms of coding in order to remove personally 
identifiable information.  The data will only be for the sole viewing 
of the principal researcher Catherine Meier and the supervisor 
Prof Du Randt in order to maintain confidentiality.  A pilot study 
has been conducted to allow feedback in order to for corrections 
to be made efficiently if need be. A consent letter with all the 
relevant information will be attached.  The principal investigator 
Catherine Meier and the supervisor Prof Du Randt will both sign 
a pledge of confidentiality stating they that the results obtained 
from the study will not be discussed with others. Findings will be 
reported and provided back to those who participated in the study 
but only using descriptive statistics. All documents retrieved will 
be stored in a safe at the HMS department.  
  
2.4 Possible benefits:   
As a result of my participation in this study, I will gain a greater 
insight into the topic of Bone Mineral Density and body 
composition of female runners.  A broader state of knowledge will 
be provided in order to prevent or reduce their risk for fracture or 
injury occurrences. 
  
2.5 Confidentiality:   
My identity will not be revealed in any discussion, description or 
scientific publications by the investigators. 
  
2.6 Access to findings: 
Any new information or benefit that develops during the course 
of the study will be shared as follows: the conclusion of the study 
will be distributed to each participant involved in the study in order 
to have a sense of the BMD status amongst the runners of NMB 
and to gain a greater understanding of BMD. 
  
2.6 
Voluntary 
participation / 
refusal / 
discontinuation: 
My participation is voluntary YES NO 
  
My decision whether or not to 
participate will in no way affect my 
present or future care / employment / 
lifestyle 
TRUE FALSE 
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3. THE INFORMATION ABOVE WAS EXPLAINED TO ME/THE PARTICIPANT BY:  Initial 
Catherine Meier   
in Afrikaans  English x Xhosa  Other  
and I am in command of this language, or it was satisfactorily translated to me by 
(name of translator) 
I was given the opportunity to ask questions and all these questions were answered satisfactorily. 
 
4. 
No pressure was exerted on me to consent to participation and I understand that I may 
withdraw at any stage without penalisation. 
  
 
5. Participation in this study will not result in any additional cost to myself. 
  
 
A.2 I HEREBY VOLUNTARILY CONSENT TO PARTICIPATE IN THE ABOVE-
MENTIONED PROJECT: 
Signed/confirmed 
at 
 on  20 
 
 
 
Signature or right thumb print of participant 
Signature of witness: 
Full name of witness: 
 
B. STATEMENT BY OR ON BEHALF OF INVESTIGATOR(S) 
I,  Catherine Meier declare that: 
1.  
I have explained the information given in this document 
to 
(name of patient/participant) 
and / or his / her representative (name of representative) 
2. He / she was encouraged and given ample time to ask me any questions; 
3. 
This conversation was conducted 
in 
Afrikaan
s 
 English X 
Xhos
a 
 Other  
And no translator was used OR this conversation was translated into 
(language)  by (name of translator) 
4. I have detached Section D and handed it to the participant YES NO 
Signed/confirmed 
at 
 
o
n 
 20 
Signature of interviewer 
Signature of witness: 
Full name of witness: 
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C. IMPORTANT MESSAGE TO PATIENT/REPRESENTATIVE OF PARTICIPANT 
 
Dear participant/representative of the participant 
 
Thank you for your/the participant’s participation in this study.  Should, at any time during the study: 
 
- an emergency arise as a result of the research, or 
- you require any further information with regard to the study, or 
- the following occur 
 
 
 
 
 
 
 (indicate any circumstances which should be reported to the investigator) 
 
Kindly contact Catherine Meier 
at telephone number 082 754 4641 
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Appendix D: Questionnaire 
 
Questionnaire for the study: Bone Mineral Density of Long Distance Female Runners in Nelson Mandela Bay 
Researcher: Catherine Meier 
Research Facility: NMMU 
My name is Catherine Meier and I am a Masters student at NMMU under the supervision of Prof. Rosa du Randt.  I am conducting a survey 
with regards to Bone Mineral Density (BMD) of female long distance runners in Nelson Mandela Bay. This survey will accompany the use of 
the densitometry (DXA) scan. The information collected will be used to obtain greater insight and knowledge with regards to BMD and associated 
influential factors.  Information obtained will remain confidential and will only be shared with the primary researcher and supervisor. 
The questionnaire is to be completed voluntarily and it should not take longer than 15 minutes to complete. Please answer questions as honestly 
as possible. Where applicable, please use an ‘X’ (type into the answer box) when selecting the answer(s).        
                                                                                        
Name:  
Surname:  
Date of 
Birth 
(dd/mm/y
yyy)         Age: 
Ethnicity (Please mark all 
applicable options with an ‘X’): 
White  Black Indian Coloured  
Other (specify):  
Running Club: 
Are you pregnant: Yes No Unsure  
Height (cm): 
Weight (kg): 
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Question 1: Medical History 
1.1 
What age did menses (first 
menstruation) occur? 
Before age 10  10-12 years 13-14 years 15-18 years 
19+ 
years 
1.2 
How sure are you with 
regards to question 1.1? 
Unsure Sure Very Sure 
  
  
1.3 
Do/did you have a regular 
menstrual cycle? 
Yes No Sometimes  
1.4 
Have you ever missed a 
period (Excluding 
pregnancy and 
menopause)? 
Yes  No    
1.5 
How many full-term 
pregnancies have you 
had? 
  
1.6 
Were you or are you 
currently on any 
contraceptive medication? 
Yes No Sometimes  
1.7 
If you answered yes to 
question 1.6, how long 
have you used 
contraception? 
<1 year  
  
  
  
1-2 years    
3-4 years    
5+ years    
1.8 
If you answered yes to 
question 1.6, what type of 
contraception method(s) 
do/did you use? (Mark all 
applicable options using 
an ‘X’) 
Pill 
 
Diaphragm 
  
  
Patch 
 
Nuvaring 
  
  
Injection  Implant  
IUD  Other: (Please Specify) 
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1.9 
Are you currently 
menopausal? 
Yes 
 No 
 
  
  
1.10 
If you answered yes to 
question 1.9, how long 
has it been? 
<1 year   
1 year-2 years   
3 years -4 years   
5+ years   
1.11 
If you answered yes to 
question 1.9, are you 
currently on any 
medication for 
menopause? 
Yes  No  
  
  
1.12 
If you answered yes to 
question 1.11, please 
specify what type of 
medication you are using?   
1.13 
Have you ever broken or 
fractured a bone from 
significant trauma (e.g. car 
accident)? 
Yes  No   
  
  
1.14 
Have you ever broken or 
fractured a bone in your 
adult life not from 
significant trauma? 
Yes  No   
  
  
1.15 
If you answered yes to 
question 1.13 and/or 1.14 
please specify which 
bones have been 
broken/fractured? 
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1.16 
Do you have any family 
history of osteoporosis? 
Yes No Unsure 
 
 
1.17 
Are you being treated for 
osteoporosis? 
Yes  No  
  
  
1.18 
Did either of your parents 
ever have a hip fracture? 
Yes  No Unsure 
 
1.19 
Do you have any chronic 
conditions? (e.g. obesity, 
type 2 diabetes, heart 
disease, stroke, cancer, 
arthritis etc.) 
Yes  No 
If yes, please specify: 
1.20 
Do you have any of the 
following medical 
conditions? (Mark all 
applicable options with an 
‘X’) 
Anorexia or Bulimia Seizure disorder 
Asthma or Emphysema Cancer 
End stage renal disease Inflammatory bowel diseases 
Hyperparathyroidism Rheumatoid arthritis 
Other: Please specify 
  
None 
  
1.21 
Have you undergone a 
hysterectomy?  Yes No  
  
  
1.22 
Are you or have you been 
lactose intolerant? 
Yes No Unsure 
  
 
1.23 
Are you currently using 
any form of daily 
medication? 
Yes No 
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1.24 
Which of the following 
types of medication do 
you use (Mark all 
applicable options with an 
‘X’)?  
Type Daily Less often Not 
Bisphosphonates (e.g. Actonel, Fosamax, Reclast, 
Boniva, Risedronate)      
Selective Estrogen Receptor Modulators (e.g. Evista, 
Raloxifene)      
Calcitonin (e.g. Miacalcin, Fortical)     
Parathyroid Hormone (e.g. Forteo, Teriparatide)     
Vitamin D, Metabolites, Analogs (e.g. Calcitriol, 
Cholecalciferol)     
Monoclonal Antibody (e.g. Prolia, Denosumab)     
Protelos (i.e. Strontium Ranelate)     
Steroid Hormones (e.g. Corticosteroids, Glucocorticoids, 
Cortisone, Prednisone)     
Estrogen or Hormone Replacement Therapy     
Calcium (e.g. Caltrate, Os-Cal)     
Antiseizure or anticonvulsant medication     
Other: (Please specify)    
None   
1.25 
Do you currently or have 
you smoked? 
Yes (currently)  Yes (in the past) No 
1.26 
If you answered yes 
(currently) to question 
1.25, please specify how 
many cigarettes you 
smoke per day?   
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1.27 
Do you drink alcoholic 
beverages? 
Yes  No 
 
 
1.28 
If you answered yes to 
question 1.27, please 
specify how many 
alcoholic drinks you 
consume per week?   
Question 2: Nutrition 
 
Please indicate (using an 
‘X’) which of the following 
types of food/supplements 
you consume: 
Daily Weekly Less often 
Ne
ver 
2.1 
Food containing calcium 
(e.g. dairy products, dark 
leafy greens, soy 
products, broccoli etc.)     
2.2 
Any form of calcium 
supplementation other 
than food     
2.3 
Food containing protein 
(e.g. fish, lean beef, 
chicken, eggs, almonds, 
lentils)     
2.4 Fruits and vegetables     
2.5 
Caffeinated beverages 
(e.g. coffee, tea)     
2.6 
Carbonated beverages 
(e.g. cola, sparkling water)     
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Question 3: Running Regime 
  Socially Competitively  
3.1 
How many years have you participated 
in running? 
 
   
3.2 
How many years have you participated 
in marathon and ultra-marathon 
running events?  
  
 
3.3 
What type of running event/s do you 
prefer?                                  Marathon (42.2 km) Ultra-marathon Both 
3.4 
How many marathon and ultra-
marathon events have you completed 
in total? 
Marathon: 
  
Ultra-marathon: 
  
3.5 
What, on average, are your weekly 
running distance and frequency and 
the longest distance per training run?                                             
Distance (km) in total per 
week
Frequency per week 
(days)  
Longest 
distance per 
run (km) 
  
3.5.1 
Pre-season 
      
  
  
3.5.2 
In-season 
      
  
  
3.5.3 
Off-season 
      
  
  
3.6 
What is your best marathon time 
Hours:  Minutes:  
3.7 
What type of surface do you prefer to 
run on?                                     
Hard  
(road) 
Soft (grass) Treadmill 
Mixed 
terrain 
No 
preferenc
e 
3.8 
Which type of discipline do you prefer?                                          
Trail Runs Road Runs Mixed Terrain 
No 
preferenc
e 
 
 
 156 
 
Question 4: Strength and Conditioning Regime 
4.1 
Do you partake in a strength and 
conditioning program? Yes No  
4.2 
If you answered yes to question 4.1, 
please specify where you perform this 
program (Mark all applicable options 
using an ‘X’)   
Gym  
Home  
Outdoors  
Other (please specify  
4.3 
If you answered yes to question 4.1, 
what area do you mainly focus on? 
(Mark all applicable options using an 
‘X’)   
Lower body 
Upper 
body 
Core 
Full Body 
 
4.4 
If you answered yes to question 4.1, 
how often do you partake in a strength 
training program per week?                                                        
Less than 1 day/week 
1 
day/wee
k 
2 days/week 
3 or more 
days/week 
 
Many thanks for your participation in this study. 
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Appendix E: Consent Form with Additional Questions 
 
 
 
PO Box 77000 • Nelson Mandela Metropolitan University 
• Port Elizabeth • 6031 • South Africa •www.nmmu.ac.za 
 
Faculty of Health Sciences 
Department of Human Movement Science 
School of Lifestyle Sciences  
Tel: 041 504 4692 
                     
Bone Mineral Density of Long Distance Female Runners in Nelson Mandela Bay 
 
Researcher: Catherine Meier 
 
Supervisor: Prof Rosa du Randt 
 
My name is Catherine Meier, a Masters student at NMMU under the supervision of Prof. 
Rosa du Randt.  I am conducting a survey with regards to Bone Mineral Density (BMD) of 
female long distance runners in Nelson Mandela Bay. This survey will accompany the use 
of the DXA scan. The information collected will be used to obtain greater insight and 
knowledge with regards to BMD and associated influential factors.  Information obtained 
will remain confidential and will only be shared with the primary researcher and supervisor. 
 
I (Name)                                                                         agree to participate in this study 
voluntarily. I fully understand the risks that are involved with regards to the 
densitometry assessment by means of a Dual-Energy X-ray Absorptiometry (DXA) 
scan. The Biokinetics and Sports Science Unit (BSSU) and the researcher (Catherine 
Meier) will not be held liable for any injury, loss or damages caused 
                                                                                                                              
 Signed Participant                                                                      Date 
                         
                                                                                                                      
Signed primary Researcher                                               Signed Radiographer 
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Additional Questions 
Name: 
Surname: 
Date of Birth: 
Age: 
Height: 
Weight: 
Dominant Hand: 
 
1 Are you Pregnant? Yes  No  
2 Do you have any metal rods or 
pins in your body? 
Yes  No  
3 What brand of running shoes do 
you wear? 
 
4 What type of running shoes do you 
wear? 
Over Pronator 
shoes 
 Supinator 
Shoes 
 
Neutral Shoes  Unsure  
5 Are you concerned about the type 
of running shoe you wear? 
Yes  No  
6 What type of running style do you 
use? 
Rear-foot strike  Mid-foot 
strike 
 
Forefoot strike  Unsure  
7 How long do you wear a pair of 
running shoes? 
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Appendix F: Results 
 
DEMOGRAPHICS 
There was a total of 40 female runners who participated in the study who ranged from the 
ages of 26 years to 68 years. Of the sample population, 10% of the participants were 42 years 
old, making it the largest number of females of the same age group which can be seen in 
Table F.1 
Table F.1: Descriptive Statistics: Frequency distribution of Age 
Age Number Percentage 
26 1 3% 
27 1 3% 
29 1 3% 
33 2 5% 
34 1 3% 
35 2 5% 
36 2 5% 
38 2 5% 
39 3 8% 
41 3 8% 
42 4 10% 
44 2 5% 
46 2 5% 
47 2 5% 
49 3 8% 
50 1 3% 
51 1 3% 
52 1 3% 
56 2 5% 
57 1 3% 
59 1 3% 
66 1 3% 
68 1 3% 
Total 40 100% 
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One of the requirements was to only include female runners who were currently members of 
a running club. Unfortunately, not all the participants were currently members of a club at the 
time of testing but have been club members in the past. According to Table F.2, 20% of the 
participants were not currently members of a running club. There were 12 different running 
clubs that were associated with this study. 
Table F.2: Descriptive Statistics: Frequency distribution of Running Clubs 
Running Club Number Percentage 
None 8 20% 
32GI EP 1 3% 
Achilles Running Club 1 3% 
Bluewater Bay Athletics Club 1 3% 
Body Concept Warriors 7 18% 
Charlo Running Club 5 13% 
Elite Athletics Club 1 3% 
Infinity Athletics Club 1 3% 
My Training Day 1 3% 
Nedbank 5 13% 
NMMU 3 8% 
PE Amateur Athletics Club 5 13% 
Warriors 1 3% 
Total 40 100% 
 
FEMALE REPRODUCTIVE VARIABLES 
The female reproductive variables consisted of the age at which menarche occurred, the 
regularity of the menstrual cycle, the number of full term pregnancies, contraception usage 
and type, if they have undergone a hysterectomy as well as if they are menopausal. 
According to Table F.3, majority of the female participants, at 48%, were between the ages 
of 13 and 14 years when they started menarche. The age group to follow was the ages of 10-
12 years with 28%. 
 
 
 
 
 161 
Table F.3: Descriptive Statistics: Frequency distribution of the Onset of Menarche 
Age Category Number Percentage 
10-12 years 11 28% 
13-14 years 19 48% 
15-18 years 9 23% 
19+ years 1 3% 
Total 40 100% 
 
The regularity of the menstrual cycle is quite an important factor to know as it may have an 
influence on ones BMD. Table F.4 depicts the results of the regularity of the present study 
participants menstrual cycle.  
Table F.4: Descriptive Statistics: Frequency distribution of Regular menstrual cycle 
Regular Menstrual Cycle Number Percentage 
Yes 22 55% 
No 10 25% 
Sometimes 8 20% 
Total 40 100% 
 
Table F.5 indicates the relationship of BMD, BF% and BMI with the regularity of the menstrual 
cycle.  
 
Table F.5: Inferential Statistics: Comparison between regular and irregular menstrual 
cycle in respect of BMD variables, BF% and BMI respectively.  
Variable 
Regular menstrual 
cycle 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD 
(g/cm²) 
Yes 22 0.86 0.12 
0.04 1.10 .278 n/a 
No / Sometimes 18 0.82 0.12 
Femoral neck Z-score 
Yes 22 0.56 0.90 
0.38 1.22 .230 n/a 
No / Sometimes 18 0.18 1.05 
Hip Total BMD 
(g/cm²) 
Yes 22 0.99 0.09 
0.06 1.52 .137 n/a 
No / Sometimes 18 0.93 0.14 
Hip Total Z-Score 
Yes 22 0.69 0.64 
0.45 1.66 .105 n/a 
No / Sometimes 18 0.23 1.07 
Lumbar BMD (g/cm²) 
Yes 22 1.02 0.11 
-0.01 -0.34 .739 n/a 
No / Sometimes 18 1.04 0.15 
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Variable 
Regular menstrual 
cycle 
n Mean SD Diff t p(df=38) 
Cohen's 
d 
Lumbar Z-Score 
Yes 22 0.28 0.98 
-0.08 -0.22 .825 n/a 
No / Sometimes 18 0.36 1.24 
Total BMD (g/cm²) 
Yes 22 1.18 0.07 
0.01 0.19 .852 n/a 
No / Sometimes 18 1.17 0.14 
Total Z-Score 
Yes 22 0.71 0.69 
0.05 0.16 .873 n/a 
No / Sometimes 18 0.66 1.36 
Body Fat % 
Yes 22 26.44 7.25 
-0.60 -0.30 .769 n/a 
No / Sometimes 18 27.04 5.18 
BMI 
Yes 22 22.74 2.43 
-0.15 -0.18 .861 n/a 
No / Sometimes 18 22.89 2.82 
 
There were no significant differences found between the yes and no/sometimes groups for 
any of the BMD variables, BF% and BMI respectively. 
 
Table F.6 indicates the relationship of BMD, BF% and BMI with the categories of missing a 
period.  
 
Table F.6: Inferential Statistics: Comparisons between missing and not missing a 
period in respect to BMD variables, BF% and BMI respectively. 
Variable Missed a period n Mean SD Diff t p(df=38) 
Cohen's 
d 
Femoral neck BMD (g/cm²) 
Yes 21 0.82 0.12 
-0.05 -1.21 .233 n/a 
No 19 0.86 0.13 
Femoral neck Z-score 
Yes 21 0.09 1.05 
-0.63 -2.13 .040 0.67** 
No 19 0.72 0.79 
Hip Total BMD (g/cm²) 
Yes 21 0.94 0.13 
-0.05 -1.40 .169 n/a 
No 19 0.99 0.09 
Hip Total Z-Score 
Yes 21 0.20 1.05 
-0.59 -2.25 .031 0.71** 
No 19 0.79 0.49 
Lumbar BMD (g/cm²) 
Yes 21 1.02 0.14 
-0.01 -0.28 .778 
n/a 
 No 19 1.03 0.12 
Lumbar Z-Score 
Yes 21 0.11 1.21 
-0.43 -1.25 .220 
n/a 
 No 19 0.54 0.92 
Total BMD (g/cm²) Yes 21 1.17 0.13 0.00 -0.08 .936 n/a 
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Variable Missed a period n Mean SD Diff t p(df=38) 
Cohen's 
d 
No 19 1.18 0.09  
Total Z-Score 
Yes 21 0.60 1.26 
-0.17 -0.51 .611 
n/a 
 No 19 0.77 0.73 
Body Fat % 
Yes 21 26.38 4.14 
-0.70 -0.34 .733 
n/a 
 No 19 27.08 8.22 
BMI 
Yes 21 22.54 2.44 -0.55 
 
-0.67 
 
.505 
 
n/a 
 No 19 23.10 2.77 
Small*, medium**, large*** 
Participants who have missed a period had a significantly lower mean femoral neck Z-score 
(p=.040; d=0.67) and total body Z-score (p=.031; d=0.71) compared to those who have not 
missed a period. 
The factor of full term pregnancies with regards to the participants of this study, ranged from 
having no children to having five children. Majority of the participants had two children which 
was followed by those who had no children. Table F.7 indicates the number of full-term 
pregnancies according to categories. 
Table F.7: Descriptive Statistics: Frequency distribution of Number of Full-term 
Pregnancies  
Number of pregnancies Number Percentage 
None 12 30% 
One 6 15% 
Two / Three 21 53% 
Four /Five 1 3% 
Total 40 100% 
 
Contraception is a common form of medication usage. According to table F.8, majority of the 
participants, consisting of 83%, are currently using or have used some form of contraception. 
As per Table F.9, contraception usage has occurred for five or more years for 82% of the 
participants. 
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Table F.8 Descriptive Statistics: Frequency distribution for Contraception Usage 
Use of Contraception Number Percentage 
Yes 33 83% 
No 7 18% 
Total 40 100% 
 
Table F.9: Descriptive Statistics: Frequency distribution of the Duration of 
Contraceptive usage 
Contraception Duration Number Percentage 
<1 year 2 6% 
1-2 years 2 6% 
3-4 years 2 6% 
5+ years 27 82% 
Total 33 100% 
There is a wide variety of the types of contraception one can use. Some participants have 
even used more than one type of contraception during their lifetime. According to table F.10, 
it has been found that majority of the participants use or have used the pill as their chosen 
form of contraception which is then followed by the use of the Intrauterine Device (IUD). 
 
Table F.10 Descriptive Statistics: Frequency Distribution of the Type of Contraceptive 
Contraception Type Number Percentage 
Pill 22 67% 
Patch 1 3% 
Injection 5 15% 
IUD 18 55% 
Diaphragm 1 3% 
Nuvaring 0 0% 
Implant 0 0% 
Other 2 6% 
Total 33 100% 
 
A certain number of the older participants are currently menopausal and according to table 
F.11, there are 20% of the sample population who are currently undergoing menopause, 
however the majority of the participants are not menopausal. As per table F.12, those who 
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are menopausal have been for at least a year with the majority of 40% having menopause for 
3 to 4 years. Those who are menopausal consist of 60% who use medication according to 
table F.13 with the commonly used types of medication listed in table F.14. 
 
Table F.11: Descriptive Statistics: Frequency distribution of Currently being 
Menopausal 
Menopausal Number Percentage 
Yes 8 20% 
No 30 75% 
Unsure 2 5% 
Total 40 100% 
 
Table F.12: Descriptive Statistics: Frequency distribution of Duration of Menopause  
Menopause Duration Number Percentage 
<1 year 2 20% 
1-2 years 1 10% 
3-4 years 4 40% 
5+ years 3 30% 
Total 10 100% 
 
Table F.13: Descriptive Statistics: Frequency distribution of Menopause Medication 
Usage 
Menopause Medication Number Percentage 
Yes 4 40% 
No 6 60% 
Total 10 100% 
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Table F.14: Descriptive Statistics: Frequency distribution of the Name of Menopause 
Medication  
Menopause Medication Type Number Percentage 
Hormone Replacement Patch 1 25% 
Hormone Replacement Therapy 1 25% 
Femigel 1 25% 
Evoral Patch 1 25% 
Total 4 100% 
 
There are 8% of the participants who have undergone a hysterectomy according to table F.15 
 
Table F.15: Descriptive Statistics: Frequency distribution of a Hysterectomy 
Hysterectomy Number Percentage 
Yes 3 8% 
No 37 93% 
Total 40 100% 
 
BONE HEALTH INDICATORS 
Broken bones can influence BMD but it is also important to know if a bone has been broken 
due to trauma such as from a motor vehicle accident or from no trauma such as from 
sneezing. According to table F.16 and F.17, majority of the participants have not broken a 
bone whether it be from trauma or from no trauma. Of the bones that have been broken, it 
has been found that the most common types are of the wrist and stress fractures both of 
which consist of 8% of the sample population according to table F.18. 
 
Table F.16: Descriptive Statistics: Frequency distribution of a Broken Bone due to a 
traumatic event 
Broken Bone (Trauma) Number Percentage 
Yes 6 15% 
No 34 85% 
Total 40 100% 
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Table F.17: Descriptive Statistics: Frequency distribution of a Broken bone due to a 
non-traumatic event 
Broken Bone (No Trauma) Number Percentage 
Yes 9 23% 
No 31 78% 
Total 40 100% 
 
 
Table F.18: Descriptive Statistics: Frequencies distribution of the Names of Broken 
Bones  
Names of Broken Bones Number Percentage 
Ankle 2 5% 
Arm 1 3% 
Collar Bone 2 5% 
Elbow 1 3% 
Femur 1 3% 
Fibula 2 5% 
Hand 1 3% 
Stress fracture 3 8% 
Tibia 2 5% 
Toe 1 3% 
Wrist 3 8% 
Total 40 100% 
 
It has been found that Osteoporosis may be genetically determined. As per table F.19, 
majority of the participants do not have a family history of osteoporosis but there are 20% of 
the participants who do have a family history of osteoporosis. More often than not, a hip 
fracture is often the main type of fracture that occurs in an osteoporotic individual. As per the 
data of this study, we can see that majority of the sample population consisting of 95% have 
not noted a hip fracture occurrence in either of their parents.  
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Table F.19: Descriptive Statistics: Frequency distribution of Family History of 
Osteoporosis and parental hip fractures 
Family History of 
Osteoporosis 
Number Percentage 
Yes 8 20% 
No 26 65% 
Unsure 6 15% 
Total 40 100% 
Parental Hip Fracture Number Percentage 
Yes 1 3% 
No 38 95% 
Unsure 1 3% 
Total 40 100% 
 
An individual who has any metal rods, pins or plates within their body may have slightly 
effected BMD results as the metal will appear denser than compared to the actual bone that 
it has replaced. With regards to the sample population, only one participant stated that she 
has metal pins in her body as per table F.20. 
 
Table F.20: Descriptive Statistics: Frequency distribution of the Presence of Metal rods 
or plates in body 
Metal Rods/Plates in Body Number Percentage 
Yes 1 3% 
No 39 98% 
Total 40 100% 
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DISEASE HISTORY 
There are certain health disorders and medical conditions that can influence BMD. According 
to Table F.21, majority of the participants do not have any chronic diseases.  
 
Table F.21: Descriptive Statistics: Frequency distribution of Health Disorders 
Health Disorders Number Percentage 
Yes 9 23% 
No 31 78% 
Total 40 100% 
 
The inability to consume or digest lactose may negatively influence BMD. According to Table 
F.22, 80% of the sample population are not lactose intolerant. 
 
Table F.22 Descriptive Statistics: Frequency distribution of Lactose intolerance 
Lactose Intolerant Number Percentage 
Yes 1 3% 
No 32 80% 
Unsure 7 18% 
Total 40 100% 
 
MEDICATION 
There are individuals who make use of daily medication and according to Table F.23, there 
is 63% of the individuals who consume daily medication of which calcium, is the most common 
type of medication consumed as per Table F.24. 
 
Table F.23: Descriptive Statistics: Frequency distribution of Daily Intake of medication 
Daily Medication Usage Number Percentage 
Yes 25 63% 
No 15 38% 
Total 40 100% 
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Table F.24: Descriptive Statistics: Frequency Distribution of the Types of Medication  
Medication Type Number Percentage 
Selective Estrogen Receptor Modulators 2 8% 
Vitamin D, Metabolites, Analogs 2 8% 
Steroid Hormones 6 25% 
Estrogen or Hormone Replacement Therapy 6 25% 
Calcium 13 54% 
Total 24 100% 
 
LIFESTYLE FACTORS 
Lifestyle factors include ones’ nutritional intake, cigarette smoking and alcohol consumption. 
Nutritional intake included the consumption per week of calcium, calcium supplementation, 
protein, fruits and vegetables, caffeine as well as carbonated beverages. The categories 
represented daily intake, weekly intake, less often intake or never consuming the nutritional 
product. Graph 2 provides a graphical representation of the consumption of these nutritional 
elements. 
According to Table F.25, calcium intake was mostly a daily occurrence, with 88% of the 
participants including calcium into their daily diet. 
 
Table F.25: Descriptive Statistics: Frequency distribution of Calcium Intake 
Calcium Intake Number Percentage 
Daily 35 88% 
Weekly 5 13% 
Total 40 100% 
 
According to Table F.26, majority of the participants, consisting of 20% never consumed any 
form of calcium supplementation. 
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Table F.26: Descriptive Statistics: Frequency distribution of Calcium Supplementation 
Intake 
Calcium Supplementation 
Intake 
Number Percentage 
Daily 5 13% 
Weekly 3 8% 
Less Often 8 20% 
Never 24 60% 
Total 40 100% 
 
According to Table F.27, protein was consumed daily by 85% of the participants with only 
15% consuming it weekly. 
 
Table F.27: Descriptive Statistics: Frequency distribution of Protein Intake 
Protein Intake Number Percentage 
Daily 34 85% 
Weekly 6 15% 
Total 40 100% 
 
According to Table F.28, majority of the participants, consisting of 93%, consume fruits and 
vegetables daily. 
 
Table F.28: Descriptive Statistics: Frequency distribution of Fruits and vegetables 
Consumption 
Fruit and Vegetable Intake Number Percentage 
Daily 37 93% 
Weekly 2 5% 
Less Often 1 3% 
Total 40 100% 
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According to Table F.29, 98% of the participants consume caffeinated beverages daily. 
 
Table F.29: Descriptive Statistics: Frequency distribution of Caffeine Consumption 
Caffeine Intake Number Percentage 
Daily 39 98% 
Less Often 1 3% 
Total 40 100% 
 
According to Table F.30, 48% of the participants consume carbonated beverages less often 
during the week. 
 
Table F.30: Descriptive Statistics: Frequency distribution of Carbonated Beverages 
Consumption 
Carbonated Beverages Intake Number Percentage 
Daily 7 18% 
Weekly 6 15% 
Less Often 19 48% 
Never 8 20% 
Total 40 100% 
 
According to Table F.31, majority of the participants do not smoke cigarettes. 
 
Table F.31: Descriptive Statistics: Frequency distribution of Cigarette Smoking 
Cigarette Smoking Number Percentage 
Yes (currently) 1 3% 
Yes (in the past) 8 20% 
No 31 78% 
Total 40 100% 
 
According to Table F.32, majority of the participants drink alcoholic beverages with 74% of 
them drinking between 1 and 5 drinks per week as per table F.33. 
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Table F.32: Descriptive Statistics: Frequency distribution of Alcohol Consumption 
Alcohol Consumption Number Percentage 
Yes 34 85% 
No 6 15% 
Total 40 100% 
 
Table F.33: Descriptive Statistics: Frequency distribution of Number of Alcoholic 
Beverages 
Alcohol Consumption per Week Number Percentage 
Between 1 and 5 25 74% 
Between 6 and 10 4 12% 
Over 10 5 15% 
Total 34 100% 
 
TRAINING LOAD 
The following section involves each participant’s running regime such as their weekly 
distances and frequencies, the number of marathon and ultra-marathon events that they have 
completed as well as the duration of running years they have accumulated. It will also include 
their strength and conditioning regime such as if they partake in a strength based program 
and the frequency per week. 
Each participant has a running history involving social running as well as competitive running. 
According to Table F.34, the total number of years of combined social and competitive running 
has been tabulated. A large proportion of the participants have been running for 5 to 10 years 
which consists of 40% of the sample population. When analysing the total number of years 
by separating social and competitive running into individual tables, it is noted that majority of 
the participants have been running for less than 6 years for both social and competitive 
running as per Tables F.35 and F.36. Graph 3 provides a graphical representation of the 
social and competitive running years. 
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Table F.34: Descriptive Statistics: Frequency distribution of the Total Number of Social 
and Competitive long distance running years  
Social and Competitive 
Running Years 
Number Percentage 
<5 11 28% 
5 to 10 16 40% 
11 to 15 8 20% 
16 to 20 4 10% 
21-25 1 3% 
Total 40 100% 
 
Table F.35 Descriptive Statistics: Frequency distribution of the Categories of Social 
long distance years  
Social Long distance Running Years Number Percentage 
<6 years 27 68% 
6-10 years 9 23% 
11-15 years 3 8% 
16-25 years 1 3% 
Total 40 100% 
 
Table F.36: Descriptive Statistics: Frequency distribution of the Categories of 
Competitive long distance run  
Competitive Long distance Running Years Number Percentage 
<6 years 26 65% 
6-10 years 9 23% 
11-15 years 3 8% 
16-25 years 2 5% 
Total 40 100% 
 
As per Table F.37 and F.38, the total number of marathon event categories and ultra-
marathon event categories have been noted. Table F.39 then states that both marathon and 
ultra-marathon events are preferred compared to only the individual events. 
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Table F.37: Descriptive Statistics: Frequency distribution of the Total Number of 
Marathon Events Categories 
Total Marathon Events Number Percentage 
1 to 5 13 33% 
6 to 10 11 28% 
11 to 20 9 23% 
21 to 30 2 5% 
31 to 40 1 3% 
41 to 50 2 5% 
51 to 60 2 5% 
Total 40 100% 
 
Table F.38: Descriptive Statistics: Frequency distribution of the Total Number of Ultra-
marathon Events Categories 
Total Ultra-Marathon Events Number Percentage 
1 to 5 20 50% 
6 to 10 8 20% 
11 to 20 6 15% 
21 to 30 3 8% 
31 to 40 1 3% 
51 to 60 2 5% 
Total 40 100% 
 
Table F.39: Descriptive Statistics: Frequency distribution of Preferred running events 
Preferred Running Events Number Percentage 
Marathon (42.2km) 14 35% 
Ultra-marathon 3 8% 
Both 23 58% 
Total 40 100% 
 
The running year is divided into pre-season, in-season and post/off-season. Each division 
would have a difference in training in terms of the distances covered in each week and the 
distances of the longer runs done during a normal week. Table F.40 tabulates the weekly 
running distances in kilometres and table F.41 tabulates the longest distance in kilometres 
that was run within the week. 
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According to table F.40, majority of the participants run between 11 and 20km per week during 
pre-season 
Table F.40: Descriptive Statistics: Frequency distribution of Pre-season Running 
distance (km) categories 
Pre-season Weekly Running distance (km) Number Percentage 
6 to 10 13 33% 
11 to 20 18 45% 
21 to 30 9 23% 
Total 40 100% 
 
According to table F.41, the longest run completed at one time during the week is between 
11 and 20km during pre-season. 
 
Table F.41: Descriptive Statistics: Frequency distribution of Pre-season Longest run 
(km) categories 
Pre-season Longest Weekly Run (km) Number Percentage 
5 to 10 3 8% 
11 to 20 24 60% 
21 to 30 9 23% 
31 to 40 4 10% 
Total 40 100% 
According to table F.42, the running distance per week for majority of the participants is 40 to 
60 km during in-season training 
Table F.42: Descriptive Statistics: Frequency distribution of In-season Running 
distance (km) categories 
In-season Weekly Running Distance Number Percentage 
40-60 15 38% 
61-80 14 35% 
81-100 10 25% 
121-140 1 3% 
Total 40 100% 
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According to table F.43 the longest run at one time within a week is between 21 and 30 km 
during in-season training 
 
Table F.43: Descriptive Statistics: Frequency distribution of In-season longest run (km) 
categories 
In-season Longest Weekly Run 
(km) 
Number Percentage 
11 to 20 6 15% 
21 to 30 14 35% 
31 to 40 13 33% 
41-50 4 10% 
51-60 3 8% 
Total 40 100% 
 
According to table F.44, the weekly running distance for majority of the participants is between 
31 and 40 km for off-season training. 
Table F.44: Descriptive Statistics: Frequency distribution of Off-season running 
distance (km) categories 
Off-season Weekly Running Distance (km) Number Percentage 
11 to 20 4 10% 
21 to 30 7 18% 
31 to 40 15 38% 
41-50 7 18% 
51-60 5 13% 
61-70 2 5% 
Total 40 100% 
 
According to table F.45, the longest run completed at one time per week is between 11 and 
20 km during off-season training. 
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Table F.45: Descriptive Statistics: Frequency distribution of Off-season Longest run 
(km) categories 
Off-season Longest Weekly Run (km) Number Percentage 
5 to 10 8 20% 
11 to 20 24 60% 
21 to 30 8 20% 
Total 40 100% 
 
Table F.46, tabulates categories of the best marathon times that each participant has 
achieved. Majority have run a marathon between 3.50 hours and 3.99 hours, therefore 
majority have run a sub 4 hour marathon. 
Table F.46: Descriptive Statistics: Frequency distribution of Categories for Best 
Marathon Time 
Best Marathon Time Number Percentage 
< 3 hours 1 3% 
3.00 to 3.49 hours 12 30% 
3.50 to 3.99 hours 13 33% 
4.00 to 4.49 hours 10 25% 
4.50 to 4.99 hours 2 5% 
5.00 hours + 2 5% 
Total 40 100% 
 
Along with running, there is the incorporation of a strength and conditiong program. Not all 
the participants incorporate a strength and conditiong program into their weekly routine 
however there are 53% who do according to table F.47. Majority of the female participants 
incorporate a strength and conditiong program twice per week as per table F.48. 
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Table F.47: Descriptive Statistics: Frequency distribution of the Implementation of a 
weekly Strength and conditioning program 
Strength and Conditioning Program Number Percentage 
Yes 21 53% 
No 19 48% 
Total 40 100% 
 
Table F.48: Descriptive Statistics: Frequency distribution of Strength & conditioning 
frequency 
Strength and Conditioning Program Frequency Number Percentage 
<1 day/week 1 5% 
1 day/week 7 33% 
2 days/week 9 43% 
3 or more days/week 4 19% 
Total 21 100% 
 
RUNNING SHOE AND RUNNING STYLE 
The type of running shoe used is based solely on individual preferences, comfort, affordability, 
and injury prevention, therefore, there is no one type of shoe considered to be the ‘better’ 
option. As per the sample population of this study, majority run in Asics which is closely 
followed by Nike as per Table F.49. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 180 
Table F.49: Descriptive Statistics: Frequencies: Types of Running shoes brands 
Running Shoe Brands Number Percentage 
Adidas 5 13% 
Asics 15 38% 
Brooks 2 5% 
Inov-8 1 3% 
New Balance 2 5% 
Nike 14 35% 
Puma 1 3% 
Salomon 1 3% 
Newtons 2 5% 
Total 40 100% 
 
As per Table F.50, majority of the participants are not concerned about the type of shoe they 
use to run in. 
 
Table F.50: Descriptive Statistics: Frequency distribution of Concern about the type of 
running shoe 
Concerned about Type of Running Shoe Used Number Percentage 
Yes 12 30% 
No 28 70% 
Total 40 100% 
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Appendix G: Empirical Studies 
APPENDIX G 
References 
Study Design and 
Test Battery 
Participant 
Demographics 
Main Findings 
Ethnicity, BMD, Bone Health Indicators, Lifestyle Factors 
Wilkin, 
Jackson, Sims 
& Haddock 
(2010) 
 Convenience 
Sample 
 Nutritionist Pro 
Software 
 Seven-day activity 
recall 
 Lunar Prodigy DXA  
 103 participants 
 41 Whites, 26 
Blacks, 36 
Hispanics 
 18 to 34 years old 
Page 204 
 White and blacks are taller than Hispanics 
 Blacks had a higher BMD and T-scores compared to 
whites 
 Weight correlated with BMD for all racial groups 
 BMD is higher in physically active people 
Wallace, 
Ballard, Holiday 
& Wells (2005) 
 
 Oral questionnaire 
 DXA 
 Black or White 
females 
 5 years post 
menopause 
 35 to 80 years of 
age 
 Whites had a higher body fat (42.16 ± 8.09) compared 
to Blacks (38.64 ± 7.74) (p<0.05) 
 Blacks had higher BMD compared to Whites 
 Whites females had a family history of broken bones 
 Black females more prone to diseases such as diabetes 
 White females use hormones (76.7& vs 51.7%, p<0.05), 
greater consumption of alcohol (57.9% vs 28.3%, 
p<0.05), calcium intake (81.4% vs 45.0%, p<0.05) 
Chantler, 
Dickie, 
Goedecke, 
Levitt, Evans, 
Joffe & 
Micklesfield 
(2012) 
 Convenience 
sample 
 DXA 
 Questionnaires: 
Demographic 
Questionnaire, 
Global Physical 
Activity 
Questionnaire 
 240 Black and 
187 White 
premenopausal 
Females 
 18 to 45 years of 
age 
Page 543 
 BMD of femoral neck higher in Black compared to White 
(0.882±0.128 vs. 0.827±0.116 g/cm2, P<0.001). No 
difference in lumbar spine of ethnic groups 
 Black females use injectable contraception (24% vs 5%) 
and whites use oral contraception (30% vs 7%). 
 Black and white females had lower lumbar spine BMD 
when using contraception compared to those who do 
not 
 Lower calcium and protein intake in Blacks than Whites 
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 Black females with children had higher femoral neck 
BMD (0.902±0.1 vs. 0.865±0.1 g/cm2, P= 0.04). 
Age, BMD, BMI, Female Reproductive Factors, Bone Health Indicators, Lifestyle Factors, Training Load 
Runolfsdottir, 
Sigurdsson, 
Franzson & 
Indridason 
(2015) 
 
 Cross-sectional 
study 
 Questionnaire  
 DXA 
 Blood samples 
 589 Males and 
1041 Females 
 29 to 87 years of 
age 
Page 4 
 BMD is lower in females over age 40, in males it is low 
in relation to age until 45 years of age but only declines 
from age 65 to 70 
 Females at age 85 years had 18.4% lower BMD in total 
compared to age 30 
Page 24 
 BMD of femoral neck 37.5% lower in females and 
22.9% in males. BMD of hip total 10.6% lower in 
females and 6.9% lower in males 
 BMD and age have a strong association in females 
Page 29 
 Smoking negatively associated with BMD 
Andreoli, Celi, 
Volpe, Sorge & 
Tarantino 
(2012) 
 Retrospective 
study 
 DXA  
 Questionnaire 
 48 post-
menopausal 
females  
 Age 54 to 73 
years 
 Weight bearing 
sports (running) 
(n=12), non-
weight bearing 
sports (swimming) 
(n=12) 
Page 69 
 BMD significantly higher in athletes compared to 
controls (p<0.001) 
 Physical activity associated with increased BMD 
Page 73 
 Physical activity during adolescence, positively 
influences bone mass and prevents bone loss from 
aging 
 183 
Baheiraei, 
Pocock, 
Eisman, 
Nguyen & 
Nguyen 
 Questionnaire 
 DXA 
 90 females 
 35 years and older 
 No correlation between age of menarche and bone 
densitometer 
 Physical activity maintains BMD in postmenopausal 
women 
Kruger, Kruger, 
Wentzel-Viljoen 
& Kruger 
(2011) 
 
 Cross-sectional 
survey 
 Questionnaire  
 1006 rural, 1003 
urban males and 
females 
 Older than 35 
years 
Page 751 
 Diabetes mellitus was low: 0.3% in young, 5.8% in old 
(urban). 1% in young, 0% in old (rural) 
 Hypertension: 6% to 19% in younger than 60 years, 
39.4% in older than 60 years 
 Mean body weight higher in urban women younger than 
50 years (p=.013) 
 Females between 60 and 70 years of age consumed 
most alcohol 
 Contraception usage high in younger than 50 years, 
42% rural, 57% urban 
 Increased weight associated with increased bone mass 
due to mechanical loading of bone 
Chan, Liu & Chi 
(2004) 
 Cross-sectional 
study 
 DXA 
 3469 Participants 
 1514 males, 1955 
females 
 17 to 89-year olds 
Page 61 
 Females: peak lumbar BMD (1.078 ± 0.133g/cm²) in 30 
to 39-year olds. Decreased after 50 years of age. Peak 
BMD of proximal femur (0.873 ± 0.101g/cm²) in 17 to 
29-year olds. Decreased after 40 years of age. 
 Males: peak lumbar (1.095 ± 0.137g/cm²) and proximal 
femur (0.989 ± 0.140g/cm²) BMD in 17 to 29-year olds 
 Bone loss per year 0.69% of peak lumbar BMD in 
women older than 50 years, of femur 0.688% loss in 
women and 0.332% in men. 
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 Females older than 60 years, majority had lumbar spine 
osteoporosis 
 Black populations have a higher bone mass 
Kim, Chung, 
Kim, Seo, Oh, 
Yi & Kim (2014) 
 Multiple linear 
regression 
models 
 Korea National 
Health and 
Nutrition 
Examination 
Survey 
(KNHANES V-1) 
 DXA 
 International 
Physical Activity 
Questionnaire-
Short Form 
(IPAQ-SF) 
 4138 Participants 
 1133 Males <50 
years, 946 Males 
>50 years 
 1332 
Premenopausal 
females, 727 
postmenopausal 
females 
Page 715 
 Males <50 years had higher BMI 
 Postmenopausal females had higher BMI and body fat 
percentage 
 Body weight positively associates with BMD but body 
fat percentage negatively associates with BMD in 
postmenopausal women 
Page 716 
 Positive relationship between fat mass and hip total and 
lumbar spine BMD in males older than 50 years and 
pre- and postmenopausal females 
 Mechanical loading effects BMD 
 Adipose tissue synthesizes oestrogens which has a 
protective benefit on BMD 
Hernandez-de 
Sosa, 
Athanasiadis, 
Malouf, Laiz, 
Marin, Herrera, 
Farrerons, 
Soria & 
Casademont 
(2016) 
 Medical history 
 DXA 
 11 Extended 
Families 
 367 participants, 
family sample size 
15 to 91 
(mean=33, 
median=30) 
 Three or more 
generations of 
living individuals 
Age 5 to 93 
years 
 Structure and strength of femoral neck have a genetic 
component 
 Geometry influenced by age, sex, BMI, age of 
menopause 
 Large correlation between osteoporotic fracture status, 
low bone mass, osteoporotic condition, and genetics 
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 (mean=40.8, 
median=41) 
Male: female 
ratio 1.07 
Cavkaytar, 
Sevel, Atak, 
Findik, Ture & 
Kokanali, 
(2015) 
 Cross-sectional 
study 
 DXA 
 501 
Postmenopausal 
Females 
 Three groups: 
normal (n=107), 
osteopenic 
(n=170), 
osteoporotic 
(n=224) 
 
Page 690 
 No significant difference for age of first pregnancy and 
total period for lactation 
 Statistical significant different 
page 692 
 difference between age, BMI, and parity within the 
groups (p\0.001, p\0.001 and p=0.002) 
 Statistical significant difference between the groups for 
age at menopause, duration of fertility and duration of 
menopause (p=0.013, p=0.013, p\0.0001) 
 BMI >32kg/m² and fertility duration >33 years has a 
positive association with osteoporosis as it provides 
protective benefits against osteoporosis 
 Increasing age related to bone loss and osteoporosis 
Page 693 
 Higher BMD in NSAIDs users 
 Paracetamol prevents bone formation, increased 
fracture risk 
Bemben, 
Buchanan, 
Bemben & 
Knehans 
(2004) 
 Questionnaires 
 DXA 
 26 Female 
athletes 
 18 to 22 years of 
age 
 BMD increases with a high impact load on the body 
 No significant difference between BMD and 
eumenorrheic athletes, OC intake or menstrual 
irregularities 
 Regular menstruation associated with increased BMD 
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Silva, da Rosa, 
Fernandes, 
Lumertz, Diniz, 
Eduarda, dos 
Reis Damiani 
(2014) 
 Cross-sectional 
study 
 DXA 
 1871 females 
 Average age 59.2 
± 10.5 years 
 Mean weight 68.7 
± 12.8. Mean 
height 1.57 ± 0.06 
 Mean BMI 27.7 ± 
5.0 
 Increase in osteopenia and osteoporosis occurs with 
increasing age (p<0.001) 
 BMI inversely associated with decreased BMD 
(p<0.001) 
 Correlations on BMD at spine (r=-0.133), femur 
(r=0.590), femoral neck (p<0.001) and BMI (p<0.001) 
 BMD negatively correlates with increasing age 
 Increased BMI (>25kg.m²) and a hysterectomy provide 
protection 
Duncan, 
Blimkie, Cowell, 
Burke, Briody & 
Howman-Giles 
(2002) 
 DXA 
 Physical activity 
questionnaire 
 75 adolescent 
females 
 15 to 18 years old 
 Groups (n=15 
each): swimmers, 
runners, 
triathletes, non-
athlete controls 
Page 288 
 Runners: Higher BMD than controls (p<0.05). Higher 
BMD for legs compared to cyclists (p<0.05) 
 Age and BMI significantly correlated with all BMD sites 
 Weekly training hours correlated positively with arm 
BMD 
Page 294 
 BMD higher in weight-bearing sport running 
BMD, BMI, Female Reproductive Factors, Bone Health Indicators, Lifestyle Factors, Training load 
Pollock, 
Grogan, Perry, 
Pedlar, Cooke, 
Morrissey & 
Dimitriou 
(2010) 
 Cohort study 
 DXA 
 Questionnaires 
for training and 
for menstrual 
history 
 Three-factor 
eating 
questionnaire 
 44 elite female 
endurance 
runners 
 16 to 42 years 
old 
Cross-sectional Analysis 
Page 422 
 Low BMD for total body (4.9%) 
 Osteoporosis prevalent at lumbar spine (7.3%) and 
radius (33.3%) 
 12 athletes using the contraceptive pill, 4 were 
amenorrhoeic, 3 were oligomenorrheic, 5 were 
eumenorrheic 
 No correlation between training hours per week and 
BMD 
 Low BMD in areas not exposed to mechanical loading 
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 Females with low BMI can have a low BMD 
 Menstrual abnormalities, insufficient nutrient intake and 
low BMD found in 15.9% of participants 
Page 421 
Longitudinal analysis 
 Significant correlation between training hours per week 
and decreased BMD especially of lumbar spine 
 Emotional eating correlated to decreased lumbar spine 
BMD 
 Bone mineral content decreases 1% each year from 
age 30 years. At menopause, bone loss increases to 
5% per year 
 Athletes resemble bone loss that occurs during 
menopause 
Baheiraei, 
Pocock, 
Eisman, 
Nguyen & 
Nguyen (2005) 
 Cross-sectional 
 Questionnaire  
 DXA 
 96 Females 
 35 years and older 
 Post-menopausal females (42%, n=38) were older, 
lower height, decreased lumbar spine and femoral neck 
BMD 
 No significant difference between pre- and post-
menopausal females with weight, BMI, calcium intake, 
cigarette smoking 
 BMD for cigarette smokers of lumbar spine was 0.087 
g/cm² (8%) and of femoral neck was 0.075 g/cm² (8%) 
lower than non-smokers 
Folscher, 
Grant, Fletcher, 
Janse van 
Rensburg 
(2015) 
 Cross-sectional, 
descriptive study 
 Questionnaire: 
LEAF-Q and 
FAST 
 306 female 
participants 
 Comrades 
Marathon 
participants 
 Mean age was 39 
years old 
Page 5 
 Menstrual irregularities were common when exercise 
intensity and frequency was increased 
 Endurance athletes are at risk for female athlete triad 
 188 
Procter-Gray, 
Cobb, 
Crawford, 
Bachrach, 
Chirra, Sowers, 
Greendale, 
Nieves, Kent & 
Kelsey (2008) 
 DXA 
 Questionnaire 
  
 150 Female 
runners 
 18 to 26 years old, 
mean age 22.1 
years 
 Mean height: 
165.6cm, mean 
weight: 58.2kg, 
mean BMI: 
21.1kg/m² 
 Run 40 miles per 
week, average of 
56.0km per week 
 Compete in 
running races 
 
 Females who stopped using oral contraceptive (OC) 
had lower body fat percentage, fewer menstrual cycles 
but increased disordered eating 
 OC group gained less weight and less fat 
 OC group had an increase in lean mass but only if 
eumenorrheic 
Lifestyle Factors, Bone Health Indicators, Female Reproductive Factors, BMD, BMI, BF% Training load 
Wentz, Liu, Ilich 
& Haymes 
(2012) 
 Retrospective 
analysis 
 DXA 
 Questionnaire 
on stress 
fractures, 
training, 
menstrual 
status 
 Three-day food 
record 
 27 female runners 
with 1 stress 
fracture compared 
to control group of 
32 female runners 
with no stress 
fracture history 
 18 to 40 years old 
 Ran 20 miles per 
week 
 Not pregnant 
 2 groups: stress 
fractures (n=27) 
 Stress fractures occurred in tibia and fibula (47.7%), 
metatarsals (36.4%), femur (11.3%), calcaneus 
(2.3%), spine (2.3%). 
 No relationship between dairy intake and stress 
fractures 
Page 376 
 Significant relationship between milk servings and 
total femur BMD (p=.010) and femoral neck BMD 
(p=.003). Inverse relationship between total femur 
BMD and average training pace per mile (p=.039). 
 Significant relationship between femoral neck BMD and 
menstrual cycles within the year (p=.004) 
 Caffeine intake negatively correlates with femoral BMD 
(p=.010) and femoral neck BMD (p=.003) 
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and those with no 
stress fractures 
Page 380 
 The number of training hours per week negatively 
associates with the lumbar spine (p=.011) and total 
body BMD (p=.021). Due to energy deficiency and 
reduced oestrogen levels 
 Runners have a lower BMD 
 Risk of stress fractures due to longer running history, 
menstrual irregularities, insufficient intake of calcium, 
decreased BMD, hard training surfaces 
Hanekom & 
Kluyts (2003) 
 Questionnaire  
 SAHARA Clinical 
Sonometer 
 18 females 
 Adolescent 
runners. Ages 
16.083 to 18.25 
years 
 Control: 
adolescent non-
athletes. Ages 
17.167 to 18.250 
Page 16 
 BMD statistically significantly higher in athletic group 
(p=0.0278) 
 Statistically significant difference in onset of menarche, 
due to later maturation in endurance athletes 
 BMD of legs is higher in adolescent female endurance 
runners compared to controls 
 Endurance runners have more menstrual abnormalities 
 95% maximum bone density reached at 18 years old 
Stiles, Metcalf, 
Knapp & 
Rowlands 
(2017) 
 Cohort study 
 Questionnaire  
 Accelerometers  
 500 000 females 
 Pre-menopausal 
(n=1218), post-
menopausal 
(n=1316) 
 40 to 69 years old 
Page 1851 
 Time exercising positively associates with BMD T-score 
(p=0.04). 
 T-scores higher in pre-menopausal women who spent 1 
to 2 minutes exercising per day 
Page 1855 
 Better bone health associated with 1 to 2 minutes per 
day of high intensity physical activity such as running in 
pre-menopausal women and slow jogging in post-
menopausal women   
 190 
da Silva, 
Mendonca, 
Conceicao, 
Zahar & Farias 
(2007) 
 Retrospective 
analysis 
 DXA 
 Caucasian 
 41 to 60 years old 
Page 943 
 Positive influence of obesity by significant differences in 
BMD of lumbar spine and femoral neck between groups 
(p<0.01) 
 Age negatively correlates with BMD (p=0.000) 
 Lower prevalence of osteoporosis at lumbar spine and 
femoral neck in obese participants 
Page 946 
 BMI positively correlates with BMD at all sites 
 Prevalence of osteoporosis lower in obese group 
 Obesity increases oestrogen which contributes to bone 
mass 
 Obese females lose bone at a slower rate after 
menopause 
 After menopause, lumbar spine and BMD was lower, 
also due to increased age 
Selingerova, 
Dolezajova, 
Selinger & 
Sedlacek 
(2015) 
 DXA  99 participants 
 Average Age 
boys: 14.2 years, 
girls: 13.7 years 
Page 273 
 Physical activity influence BMD of youth 
 Boys have higher bone mineralization in hip and spine 
Marques, 
Wanderley, 
Machado, 
Sousa, Viana, 
Moreira-
 Experimental 
design 
 DXA 
 Isokinetic 
dynamometer 
 accelerometer 
 71 White females 
 60 to 95 years old 
(69.0 ± 5.3) 
 Groups: 
resistance training 
(RE n=23), 
aerobic exercise 
Page 529 
 RE group had significant increases in lean and fat free 
mass with decreased body fat percentage 
 RE significantly increased BMD by 2.9% (0.020g/cm²) 
at trochanter, 1.5% (0.013g.cm²) at hip total 
Page 531 
 191 
Goncalves, 
Moreira, Mots & 
Carvalho 
(2011) 
(AE n=24), control 
(CON n=24) 
 8 months RE can cause significant bone adaptation in 
older women 
Barrack, Gibbs, 
de Souza, 
Williams, 
Nichols, Rauh 
& Nattiv (2014) 
 Cohort study 
 DXA 
 Three-factor eating 
questionnaire or 
Eating Disorder 
Examination 
Questionnaire 
 259 Participants in 
3 prospective 
cohort studies 
 Female athletes 
 13 to 18 years old 
Page 955 
 Bone injury common in endurance runners (n=18, 
64.3%) 
 Bone injury correlates to low body fat percentage, BMI 
and BMD at femoral neck, the hip, and the lumbar spine 
 Majority of participants who had a bone injury exercise 
for 12 hours per week, have a BMI of 21 kg/m² with 
BMD Z-scores of -1.0 and -2.0, have oligomenorrhea or 
amenorrhea 
Hammad 
(2015) 
 Questionnaire   101 Females with 
no fracture history 
 20 to 24.9-year 
age range 
 Osteopenia found in lumbar spine (37%) and femoral 
neck (34%). Osteoporosis in lumbar spine (5%) 
 Positive correlation between BMD, T-score in the 
lumbar spine and femoral neck and BMI (p <0.001) 
 Association between BMD and weight 
Knechtle, Rust, 
Patrizia & 
Knechtle (2012) 
 Multi-variate 
analysis 
 Athletes over 35 
years of age 
 Half-marathon 
(n=103), marathon 
(n=91)and ultra-
marathon (n=155) 
runners 
 Body fat was related to half-marathon (p=0.0003), 
marathon (p<0.0001) and ultra-marathon (p<0.0001) 
running times. 
 Speed training correlated to running times of master 
half marathon runners (p<0.0001) and master marathon 
runners (p<0.0001) 
 Weekly running distance (Km) was related to running 
times of ultra-marathon runners (p<0.0001) 
 Body fat and training correlated to running times 
 192 
Bacelar, 
Almeida, 
Sauaia, Novais, 
Furtado, 
Quintanilha, 
Pulcherio, Filho 
& Gambassi 
(2015) 
 UNICEUMA 
Without Borders 
 BMD, muscular 
strength 
 18 Elderly, 
sedentary females 
 Age 61 to 67 
years, Mean age 
64 ± 3 years 
 
 No significant correlation for the change in BMD of the 
lumbar spine and femoral neck 
 Significant increase in upper and lower body muscle 
strength 
Kim, Morton & 
Elizabeth 
(1997)  
 DXA  1000 Females 
 44 to 98 years of 
age, mean age 72 
years 
Page 281 
 No significant association between BMD and the intake 
of carbonated beverages for 10 to 20 years (n=140), 20 
to 30 years (n=19) or more than 30 years (n=28) 
Bukhar, Nada & 
Header (2012) 
 
 Cross-sectional 
study 
 Questionnaire 
 BMD and body 
composition 
 257 Female 
students 
 19-24 years of 
age 
Page 682 
 Osteoporosis (7%, T-Score -2.5), osteopenia (32.3%, T-
Score -1 to -2.4) 
 Significant relationship (1%) between osteoporosis, 
body fat percentage, BMI 
 Osteoporosis associated with increased body fat 
(p<0.001) 
 Improved bone health by decreased body fat and 
weight, less intake of carbonated beverages, adequate 
nutritional intake 
 Statistically higher significance between osteoporosis 
and BMI) p<0.05) compared to osteopenia with normal 
students 
 Significant difference for osteoporosis and fat mass 
(p<0.001) 
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 Page 686 
 Correlation between carbonated beverages and 
decreased BMD. Due to phosphorus content which 
decreases blood calcium levels resulting in 
osteoporosis 
Gibson, 
Harries, 
Mitchell, 
Godfrey, Lunt & 
Reeve (2000) 
 Cross-sectional 
study 
 DXA 
 124 Female 
athletes 
 16 to 35 years of 
age 
 Trained and 
competed in 
middle or long 
distance running 
for 3 years, 3 
hours per week, 
25 miles per week 
 Elite running is beneficial for BMD but only if 
eumenorrheic 
 Body weight influences femoral neck, height influences 
lumbar spine 
Pregnancy, BMD, Bone Health Indicators, Lifestyle Factors, Chronic Diseases, Medication 
Shao, Tao, 
Fan, Jing & Lu 
(2012) 
 
 Ultrasonic 
measurement 
 130 pregnant 
females, mean 
age 26.8 (SD ± 
3.4) 
 139 age-matched 
non-pregnant 
females, mean 
age 27.3 years 
(SD ± 3.1) 
Page 572 
 BMD declines during second and third trimester of 
pregnancy 
Page 574 
 No follow up was conducted 
Page 573 
 Levels of calcium, phosphorus and alkaline 
phosphate negatively correlates with BMD 
Lebel, 
Mishukov, 
Babchenko, 
 Cohort study 
 Post hoc 
 Questionnaire  
 DXA 
 132 females 
(postpartum) 
Page 2 
 Femoral neck T-scores and Z-scores were higher than 
lumbar spine T-scores and Z-scores, but both were all 
 194 
Samueloff, 
Zimran & 
Elstein (2014) 
 
in range of normal mean values despite age, parity, and 
lactation duration 
 Significant differences between groups for gravidity, 
parity, the number of months pregnant and months of 
lactation (p=0.000) 
 Mean T-scores higher than mean Z-scores of femoral 
neck compared to lumbar spine 
Page 3 
 Significantly higher mean for femoral neck T-score and 
Z-score for those who never breastfed but no difference 
for lumbar spine T-scores and Z-scores 
Page 4 
 Months of lactation did not decrease mean of BMD T-
scores into osteopenia 
 No family history of osteoporosis recorded 
Derakhshan, 
Mahmousi, 
Shahsawari, 
(2016) 
 
 Retrospective 
analysis 
 DXA 
 Questionnaire  
 991 post-
menopausal 
women 
 Age 44 to 90 
years, Mean age 
58.95 ± 8.6 years  
 Females with 5 or more children, more than 60 months 
of breast feeding were older (p<0.001) with prevalence 
of osteoporosis (p<0.001) 
Page 45 
 Osteoporosis and osteopenia prevalence was 33% 
(n=326) and 55% (n=545). 
 No significant difference between the exercise and non-
exercise groups for osteoporosis and osteopenia 
prevalence 
 Osteoporosis higher in non-exercising group (p=0.0001) 
but was of a higher age group 
 Lumbar spine and femoral neck BMD was lower in 
those who had more than 5 children 
 Lumbar spine BMD was lower in those who breast fed 
more than 96 months. Femoral BMD was lower in those 
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who breast fed for 61 to 96 months and more than 96 
months 
Page 48 
 Normal BMD returned 6-12 months after weaning, 
therefore, unclear about the long-term effects on BMD 
Singh, 
Nimarpreet, 
Ashima, Das, 
Kumar & 
Prakash (2013) 
 DXA  100 cases of 
ankylosing 
spondylitis, 150 
healthy, age-
matched controls 
Page 2833 
 Decreased BMD at all sites, especially at lumbar spine 
Page 2834 
 Osteoporosis prevalence in Ankylosing Spondylitis 
patients, with 22% at spine, and 4% femur. Observed at 
early stages of disease 
Nakatoh (2017)    97 
postmenopausal 
women diagnosed 
with primary 
osteoporosis 
Page 3: 
 Analyses of minodronate, raloxifene, eldecalcitol 
 BMD of lumbar spine and femur were higher after 24 
weeks of intake 
 Statistical significance for increase in lumbar spine and 
femur BMD with minodronate use 
 Teriparatide effect to increase BMD of spine decreases 
after 12 months 
 Raloxifene group showed increased BMD of lumbar 
spine and femur after 24 months 
Kalkwarf, 
Khoury & 
Lanphear 
(2003) 
 Stratified, 
multistage, 
probability design 
 NHANES III Survey 
 DXA 
 3251 White 
females 
 >20 years old 
Page 262 
 Low milk intake during childhood and adolescence 
resulted in low BMD of hip during adulthood 
 BMD of hip 2-3% lower in females who consumed <1 
serving of milk during childhood compared to those who 
consumed >1 serving of milk. Increased risk of 
osteoporotic fracture (11%) 
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 Page 260 
 Current dietary calcium had a positive correlation with 
BMD (p=0.007-0,12) 
 Milk intake during adolescence positively correlates to 
BMD of hip (p< 0.02) 
Jang, Hong, 
Han, Lee, Shin, 
Choi, Suh, 
Yang, Park, 
bang (2017) 
 Cross-sectional 
study 
 KNHANES Survey 
 3312 participants 
 No males or pre- 
and post-
menopausal 
females 
Page 5 
 Statistically significant difference for mean BMD was 
greater in light-drinkers compared to non-drinkers and 
heavy drinkers 
 Alcohol consumption >4 times per week had lower BMD 
 Femoral neck BMD (0.633 ± 0.004g/cm²) higher in 
drinkers of 1-2 glasses compared to BMD of non-
drinkers (0.619 ± 0.004g/cm²) 
Page 9 
 Light alcohol intake 2-3 times per week of 1-2 or 5-6 
glasses associated with high femoral BMD 
 Non-drinkers and heavy drinkers had 1.7 times greater 
osteoporosis risk compared to light drinkers 
Williams, Green 
& Wurzinger 
(2012) 
   10 Males, 10 
Females 
 Age 20-30 years 
 Run 6 miles/week, 
3 times per week 
Page 531 
 Reduced power absorption at knee with forefoot strike 
and barefoot strike patterns. Power absorption shifted to 
ankle 
 Can result in injury when absorption occurs distally 
Isley (2017)  Review  Females Page 94: 
 Progestin-only implants, pills, and IUD have no impact 
on BMD 
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Appendix H: Letter from the Language Editor 
 
